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Abstract 
Background: Cancer is a leading causes of morbidity and mortality worldwide. The 
quality of life of cancer survivors has been highlighted worldwide as a major health 
concern (Ferrell al., 1995). Also, post-traumatic stress disorder (PTSD) has been 
increasingly diagnosed as a co-morbidity among patients with cancer and PTSD 
symptoms are negatively related to QOL (Mehnert & Koch, 2008). 
Aim of the study:  
The aim was  to assess QOL and PTSD symptoms among adult female patients with 
cancer attending Beit-Jala Governmental Hospital in Bethlehem. 
Design of the study 
 A cross-sectional design was utilized to achieve the purpose of the study. The data was 
gathered from the 4
th
 of April ,2015 and finished at the end of July, 2015. 
Sample size:  
The sample included 253 female patients with cancer attending Beit-Jala Governmental 
Hospital in Bethlehem 
Sampling method:  
Convenience sampling was used to recruit the participants  
Instruments 
 Data was collected by using self-reported questionnaire including socio-demographic 
data sheet, “European Organization for Research and Treatment of Cancer (EORTC) 
Quality of Life Questionnaire Core 30 (QLQC30) and Post traumatic stress disorder 
checklist  (PCL-S) for PTSD symptom.  
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Data analysis 
 Statistical analysis was performed using the statistical package for social sciences 
(SPSS), version 20 and data were analyzed by using parametric tests including 
descriptive statistics, T-test, ANOVAs test, Tukey test, Chi-square test and Pearson's test. 
Findings 
 Analysis of the patients’ characteristics showed that the mean age of the participants was 
52.6 years old of which 56.1% were 50 years and older. The majority of the participants 
(77.9%) were married, 64.8% were from Hebron 58.5% lived in villages, 62.4% had 
education equal to or less than secondary education and 64% had income less than 2,000 
NIS monthly.  
For the participants’ medical history, 85% had breast cancer, 69.2% had less than one 
year of cancer diagnosis and 73.9% were treated with surgery and chemotherapy. 
The current study showed poor global quality of life (57.4%) and physical function  
(48.5%) for female patients with cancer. The indications for poor QOL were: old age, 
low educational level , low economic class, being unmarried, low number of family 
members and dependence on others for care. However, the means of other QOL 
functions were high particularly social function (87.7%), role function (64.3%), 
emotional function  (77.8%), and cognitive function (77%), which was lower than 
the references values.  
Moreover,  the participants complained from physical symptoms that may affect 
their quality of life as  34.7% of the participants reported severe insomnia, 32.8% 
had severe loss of appetite, 24.1% had severe constipation and 20.5% had severe 
fatigue while  11.4% reported severe pain. 
The prevalence of PTSD symptoms was 3%. For PTSD symptoms severity, (2%) 
reported severe symptoms, (23.3%) reported  moderate symptoms and (68.8%) 
reported mild symptoms based on Weathers et al. (1991) classification of PTSD 
v 
 
symptoms severity scores. Also PTSD symptoms were associated with young age 
and having other types of cancer rather than breast cancer. 
Furthermore, the Pearson’s test revealed a strong inversed statistically significant 
relationship between quality of life domains and PTSD. The strongest relationship 
was with emotional function. 
Conclusion 
 The study found that the overall quality of life of female patients with cancer was 
low and is strongly associated with PTSD symptoms, so early detection and 
treatment for these symptoms are important to improve their quality of life.  
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 نوعية الحياة وأعراض ما بعد الصدمة لدى مريضات السرطان في مستشفى بيت جالا الحكومي
 في بيت لحم 
 مرقه. محمد نادر  بيسان: إعداد
 .حميد منى .د  :إشراف
 ملخصال
 الدراسة خلفية
ط الضوء يسلو قد تم تالسرطان هو السبب المباشر للعديد من المشكلات الصحية والوفيات في جميع انحاء العالم . 
. اضافة الى انه )5991 ,.la llerreF(في الآونة الاخيرة على نوعية الحياة لمرض السرطان في جميع أنحاء العالم 
ين يعانون من السرطان وقد ) على نحو متزايد بين المرضى الذDSTPتشخيص اضطراب ما بعد الصدمة (قد تم 
 & trenheM(نوعية الحياة لمرضى السرطان  ؤثر سلبا علىدمة يأعراض اضطراب ما بعد الص وجد ان
 .)8002,hcoK
 العام الهدف 
واتي يتلقين لال بين المريضات  البالغات المصابات بالسرطان  تقييم نوعية الحياة وأعراض اضطراب ما بعد الصدمة 
 مستشفى بيت جالا الحكومي في بيت لحم.في العلاج 
 الدراسة منهجية
تموز  31إلى  نيسان 4شهور من   4 خلال البيانات عيتجمتم   حيثه المقطعية الكميالمنهجية  الدراسة ستخدمتا 
 .2315عام 
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 عينه الدراسة
مريضة مصابة بالسرطان في مستشفى بيت جالا الحكومي في بيت لحم بواسطة  125  ضمت عينه الدراسة
استعمال استبيان ذاتي التعبئة يتكون من جزء لفحص البيانات الاجتماعية والديموغرافية و جزء يقيم نوعية الحياة 
ث وعلاج مرض  لمريضات السرطان باستعمال اداة فحص نوعية الحياة لمرضى السرطان للمنظمة الأوروبية للأبحا
بعد تشخيص مرض السرطان باستخدام  بعد الصدمة ) وجزء لتقييم اعراض ما03CQLQ CTROE(السرطان 
 . تم إجراء التحليل الإحصائي باستخدام الحزم)S- LCP(أعراض اضطراب ما بعد الصدمة  المنهجية لقياس داةالا
 تحليل واختبار التكرار باستخدام اختبار البيانات و تم تحليل 15)، الإصدار SSPS(الإحصائية للعلوم الاجتماعية 
 .بيرسونواختبار  تيتيست واختبار توكي واختبار كاي تربيع الأحادي واختبار التباين
 النتائج
 %3.52 عمر كانت حين في. سنة 5.52 كان المشاركات عمرأظهرت نتائج  تحليل بيانات المرضى أن متوسط  
 2.62 و كن من الخليل % 6.45) و %7.... غالبية المشاركات كن متزوجات (وما فوقسنة  12من المشاركات 
منهن  %45، وكان الدخل الشهري ل ن التعليم الثانويمنهن  أقل م % 4.55 تعليم يعيشن في القرى. في حين %
 شيكل شهريا . 1115أقل من 
% 5.75و قد تم تشخيص  الثدي. بسرطان كن مصاباتركات امن المش %26، للمشاركاتمن ناحية التاريخ الطبي 
 . علاج الكيميائيالو  منهم يشمل العلاج الجراحي% 7.1.في حين كان علاج   أقل من سنةفي  من المشاركات
%) لمريضات السرطان في  2.64و الوظائف الجسدية (  %) 4..2الحياة  ( ظهرت الدراسة الحالية  تدني جودةأ
 : العمرالكمية التي أثرت بشكل سلبي على نوعية الحياة المحدداتجالا الحكومي. حيث كانت مستشفى بيت 
 . العزوبية وانخفاض المستوى التعليمي و الاقتصادي  و
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%) 1.45دور (%) و ال ...6: الاجتماعية (ةجيدالحياة  اييس الوظائف الاخرى لمقياس جودةنتائج مقكانت و لكن 
 الأرق الشديد % من المشاركات انهن يعانين من ..41أفادت  ) . في حين %..( ) و الادراك%6...( و العاطفة
التعب الشديد بينما  % عانين من 2.15 %عانين من إمساك شديد و 3.45 % عانين من فقدان الشهية و6.51 و
 ألم شديد . % فقط عانين من4.33
ب ما بعد اضطراو بالنسبة لشدة أعراض % بين المشاركات. 1ار أعراض اضطراب ما بعد الصدمة كان انتش
لديهن  كانت  %6.65 كانت الاعراض لديهن معتدلة و % 1.15انت الأعراض لديهن شديدة و ك %5الصدمة فان 
بينما كانت . لتصنيف شدة أعراض ما بعد الصدمة )1991 ,.la te srehtaeW( باستخدام تصنيف أعراض خفيفة
الاخرى  وجود أنواع السرطان و السن عراض اضطراب ما بعد الصدمة هي صغرالكمية التي ارتبطت بأ المحددات
 .لدى المشاركةغير سرطان الثدي 
الحياة و اضطرابات ما  إحصائية قوية بين جودةذات دلالة  عكسية علاقةبار بيرسون كشف اختعلاوة على ذلك فقد 
 .ي في مقياس جودة الحياةالعاطفالجانب مع  بين اضطراب ما بعد الصدمة أقوى علاقة. وكانت بعد الصدمة
 الخلاصة
ما بعد  وجدت الدراسة أن نوعية حياة المرضى من النساء المصابات بالسرطان يرتبط بقوة مع أعراض اضطراب  
 حياتهم .و جودة علاج هذه الأعراض هي مهمة لتحسين نوعية الصدمة ، لذا الاكتشاف المبكر و 
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Abstract 
Background: Cancer is a leading causes of morbidity and mortality worldwide. The 
quality of life of cancer survivors has been highlighted worldwide as a major health 
concern (Ferrell al., 1995). Also, post-traumatic stress disorder (PTSD) has been 
increasingly diagnosed as a co-morbidity among patients with cancer and PTSD 
symptoms are negatively related to QOL (Mehnert & Koch, 2008). 
Aim of the study:  
The aim was  to assess QOL and PTSD symptoms among adult female patients with 
cancer attending Beit-Jala Governmental Hospital in Bethlehem. 
Design of the study 
 A cross-sectional design was utilized to achieve the purpose of the study. The data was 
gathered from the 4
th
 of April ,2015 and finished at the end of July, 2015. 
Sample size:  
The sample included 253 female patients with cancer attending Beit-Jala Governmental 
Hospital in Bethlehem 
Sampling method:  
Convenience sampling was used to recruit the participants  
Instruments 
 Data was collected by using self-reported questionnaire including socio-demographic 
data sheet, “European Organization for Research and Treatment of Cancer (EORTC) 
Quality of Life Questionnaire Core 30 (QLQC30) and Post traumatic stress disorder 
checklist  (PCL-S) for PTSD symptom.  
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Data analysis 
 Statistical analysis was performed using the statistical package for social sciences 
(SPSS), version 20 and data were analyzed by using parametric tests including 
descriptive statistics, T-test, ANOVAs test, Tukey test, Chi-square test and Pearson's test. 
Findings 
 Analysis of the patients’ characteristics showed that the mean age of the participants was 
52.6 years old of which 56.1% were 50 years and older. The majority of the participants 
(77.9%) were married, 64.8% were from Hebron 58.5% lived in villages, 62.4% had 
education equal to or less than secondary education and 64% had income less than 2,000 
NIS monthly.  
For the participants’ medical history, 85% had breast cancer, 69.2% had less than one 
year of cancer diagnosis and 73.9% were treated with surgery and chemotherapy. 
The current study showed poor global quality of life (57.4%) and physical function  
(48.5%) for female patients with cancer. The indications for poor QOL were: old age, 
low educational level , low economic class, being unmarried, low number of family 
members and dependence on others for care. However, the means of other QOL 
functions were high particularly social function (87.7%), role function (64.3%), 
emotional function  (77.8%), and cognitive function (77%), which was lower than 
the references values.  
Moreover,  the participants complained from physical symptoms that may affect 
their quality of life as  34.7% of the participants reported severe insomnia, 32.8% 
had severe loss of appetite, 24.1% had severe constipation and 20.5% had severe 
fatigue while  11.4% reported severe pain. 
The prevalence of PTSD symptoms was 3%. For PTSD symptoms severity, (2%) 
reported severe symptoms, (23.3%) reported  moderate symptoms and (68.8%) 
reported mild symptoms based on Weathers et al. (1991) classification of PTSD 
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symptoms severity scores. Also PTSD symptoms were associated with young age 
and having other types of cancer rather than breast cancer. 
Furthermore, the Pearson’s test revealed a strong inversed statistically significant 
relationship between quality of life domains and PTSD. The strongest relationship 
was with emotional function. 
Conclusion 
 The study found that the overall quality of life of female patients with cancer was 
low and is strongly associated with PTSD symptoms, so early detection and 
treatment for these symptoms are important to improve their quality of life.  
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 نوعية الحياة وأعراض ما بعد الصدمة لدى مريضات السرطان في مستشفى بيت جالا الحكومي
 في بيت لحم 
 مرقه. محمد نادر  بيسان: إعداد
 .حميد منى .د  :إشراف
 ملخصال
 الدراسة خلفية
ط الضوء يسلو قد تم تالسرطان هو السبب المباشر للعديد من المشكلات الصحية والوفيات في جميع انحاء العالم . 
. اضافة الى انه )5991 ,.la llerreF(في الآونة الاخيرة على نوعية الحياة لمرض السرطان في جميع أنحاء العالم 
ين يعانون من السرطان وقد ) على نحو متزايد بين المرضى الذDSTPتشخيص اضطراب ما بعد الصدمة (قد تم 
 & trenheM(نوعية الحياة لمرضى السرطان  ؤثر سلبا علىدمة يأعراض اضطراب ما بعد الص وجد ان
 .)8002,hcoK
 العام الهدف 
واتي يتلقين لال بين المريضات  البالغات المصابات بالسرطان  تقييم نوعية الحياة وأعراض اضطراب ما بعد الصدمة 
 مستشفى بيت جالا الحكومي في بيت لحم.في العلاج 
 الدراسة منهجية
تموز  31إلى  نيسان 4شهور من   4 خلال البيانات عيتجمتم   حيثه المقطعية الكميالمنهجية  الدراسة ستخدمتا 
 .2315عام 
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 عينه الدراسة
مريضة مصابة بالسرطان في مستشفى بيت جالا الحكومي في بيت لحم بواسطة  125  ضمت عينه الدراسة
استعمال استبيان ذاتي التعبئة يتكون من جزء لفحص البيانات الاجتماعية والديموغرافية و جزء يقيم نوعية الحياة 
ث وعلاج مرض  لمريضات السرطان باستعمال اداة فحص نوعية الحياة لمرضى السرطان للمنظمة الأوروبية للأبحا
بعد تشخيص مرض السرطان باستخدام  بعد الصدمة ) وجزء لتقييم اعراض ما03CQLQ CTROE(السرطان 
 . تم إجراء التحليل الإحصائي باستخدام الحزم)S- LCP(أعراض اضطراب ما بعد الصدمة  المنهجية لقياس داةالا
 تحليل واختبار التكرار باستخدام اختبار البيانات و تم تحليل 15)، الإصدار SSPS(الإحصائية للعلوم الاجتماعية 
 .بيرسونواختبار  تيتيست واختبار توكي واختبار كاي تربيع الأحادي واختبار التباين
 النتائج
 %3.52 عمر كانت حين في. سنة 5.52 كان المشاركات عمرأظهرت نتائج  تحليل بيانات المرضى أن متوسط  
 2.62 و كن من الخليل % 6.45) و %7.... غالبية المشاركات كن متزوجات (وما فوقسنة  12من المشاركات 
منهن  %45، وكان الدخل الشهري ل ن التعليم الثانويمنهن  أقل م % 4.55 تعليم يعيشن في القرى. في حين %
 شيكل شهريا . 1115أقل من 
% 5.75و قد تم تشخيص  الثدي. بسرطان كن مصاباتركات امن المش %26، للمشاركاتمن ناحية التاريخ الطبي 
 . علاج الكيميائيالو  منهم يشمل العلاج الجراحي% 7.1.في حين كان علاج   أقل من سنةفي  من المشاركات
%) لمريضات السرطان في  2.64و الوظائف الجسدية (  %) 4..2الحياة  ( ظهرت الدراسة الحالية  تدني جودةأ
 : العمرالكمية التي أثرت بشكل سلبي على نوعية الحياة المحدداتجالا الحكومي. حيث كانت مستشفى بيت 
 . العزوبية وانخفاض المستوى التعليمي و الاقتصادي  و
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%) 1.45دور (%) و ال ...6: الاجتماعية (ةجيدالحياة  اييس الوظائف الاخرى لمقياس جودةنتائج مقكانت و لكن 
 الأرق الشديد % من المشاركات انهن يعانين من ..41أفادت  ) . في حين %..( ) و الادراك%6...( و العاطفة
التعب الشديد بينما  % عانين من 2.15 %عانين من إمساك شديد و 3.45 % عانين من فقدان الشهية و6.51 و
 ألم شديد . % فقط عانين من4.33
ب ما بعد اضطراو بالنسبة لشدة أعراض % بين المشاركات. 1ار أعراض اضطراب ما بعد الصدمة كان انتش
لديهن  كانت  %6.65 كانت الاعراض لديهن معتدلة و % 1.15انت الأعراض لديهن شديدة و ك %5الصدمة فان 
بينما كانت . لتصنيف شدة أعراض ما بعد الصدمة )1991 ,.la te srehtaeW( باستخدام تصنيف أعراض خفيفة
الاخرى  وجود أنواع السرطان و السن عراض اضطراب ما بعد الصدمة هي صغرالكمية التي ارتبطت بأ المحددات
 .لدى المشاركةغير سرطان الثدي 
الحياة و اضطرابات ما  إحصائية قوية بين جودةذات دلالة  عكسية علاقةبار بيرسون كشف اختعلاوة على ذلك فقد 
 .ي في مقياس جودة الحياةالعاطفالجانب مع  بين اضطراب ما بعد الصدمة أقوى علاقة. وكانت بعد الصدمة
 الخلاصة
ما بعد  وجدت الدراسة أن نوعية حياة المرضى من النساء المصابات بالسرطان يرتبط بقوة مع أعراض اضطراب  
 حياتهم .و جودة علاج هذه الأعراض هي مهمة لتحسين نوعية الصدمة ، لذا الاكتشاف المبكر و 
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Chapter One 
ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ  
Introduction  
 
1.1. Introduction  
Cancer is a leading cause of morbidity and mortality worldwide, with approximately 14 
million new cases and 8.2 million cancer related deaths in 2012 in both sexes. The number 
of new cases is expected to rise by about 70% over the next decades (WHO, 2014a). About 
half of cancer cases and deaths occurred worldwide were among women. The top three 
were breast, colorectal and lung cancers, contributed more than 43% of all women cancers 
(excluding non-melanoma skin cancer). Breast  cancer was the most frequently diagnosed 
worldwide in women contributing to more than 25% of the total number of new cases 
diagnosed in 2012 (Stewart & Wild, 2014). 
Many of the greatest reductions in the morbidity and mortality of cancer  recently are a 
result of advances in cancer prevention. Importantly, healthy approaches to living can also 
reduce cancer recurrence and improve outcomes following a cancer diagnosis (Hartge et 
al., 2006). 
“Cancer survivorship” is a term that has come to represent the state or process of living 
following a diagnosis of cancer, regardless of how long a person lives. It is a concept used 
by many health care professionals, researchers, and patients with cancer to understand not 
only the physical but also the social, psychological, and spiritual/existential impact of 
cancer on one’s life and for the remainder of one’s life. When viewed as a continual, 
dynamic, and ever-changing process that begins at the moment of diagnosis and continues 
for the remainder of life, cancer survivorship can be defined as the experience of “living 
with, through, or beyond cancer” (Detre et al., 1992). 
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The term quality of life (QOL) is used to evaluate the general well-being of individuals and 
societies. According to the World Health Organization (WHO), QOL is defined as 
“individual’s perception of life, values, objectives, standards and interests in the 
framework of culture” (WHO, 1997b). 
As the definition of QOL points, a number of illness-related factors can affect QOL and 
QOL issues has become a vital area of concern to cancer survivors, their families and care 
providers (Ferrell et al., 1995).  Each patient with cancer experiences a range of practical, 
psychological and emotional challenges as a result of their diagnosis and treatment-related 
adverse effects, and each patient’s life may be further disrupted by changes in role and 
family functioning,  employment status and financial status. In addition, some patients will 
have to come to terms with progressive illness and may approach death, and others may be 
faced with the physical, emotional and social challenges of survival (Adler, 2008). 
Therefore, the amount of distress symptoms  experienced by an individual has been related 
to QOL in  people with cancer and is increasingly being used as a primary outcome 
measure in studies to evaluate the effectiveness of treatment among them  (Guyatt et al., 
1993). 
Also, when considering the psychological health of cancer survivors, anxiety disorders are 
the major mental disorders that were studied. The prevalence of anxiety disorders has been 
estimated to range from 6% to 23% among patients with cancer (Lynch et al., 2000). The 
wide range represented by these estimates reflects the difficulties involved in identifying 
the prevalence of specific psychological responses associated with the cancer experience 
(Adler, 2008). 
Anxiety and distress may affect a patient's ability to cope with cancer diagnosis or 
treatment and may cause patients to miss check-ups or delay treatment (NCI, 2015c). Post-
traumatic stress disorder (PTSD) is one of anxiety disorders with characteristic symptoms 
that occur following exposure to an extreme traumatic stress involving direct personal 
experience of an event that involves actual or threatened death or serious injury, or other 
threat to one's physical integrity; or witnessing an event that involves death, injury, or a 
threat to the physical integrity of another person; or learning about unexpected or violent 
death, serious harm, or threat of death or injury experienced by a family member or other 
close associate. These symptoms include persistent re-experiencing of the traumatic event, 
persistent avoidance of stimuli associated with the trauma and numbing of general 
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responsiveness, and persistent symptoms of increased arousal (American Psychiatric 
Association, 2000, 2013) . In 1994, the trauma criteria of post-traumatic stress disorder 
(PTSD) in Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) were 
expanded to include life-threatening illness, such as cancer (Mehnert & Koch, 2008). 
1.2. Problem statement  
Cancer survivors were more likely to have “worse” or impaired QoL compared with the 
general population, regardless of other demographic factors (Quinn et al., 2015). For 
example, a study assessed the quality of life for patients with breast cancer, and the results 
showed that patients had low global quality of life (mean=32) at 18 months post cancer 
diagnosis (Montazeri et al., 2008). 
In Palestine, a recent QOL study aimed to assess the determinants of quality of life (QOL) 
in patients with cancer showed a poor-health-related QOL. It also showed a low mean 
score for global quality of life (41.8) and other functional domains such as physical, role 
and emotional scales which  were below half of full functioning (48.5,48.8,46 
respectively). It recommended  to integrate special services, such as palliative care, into the 
health-care system for patients with  cancer to improve QOL and to reduce their suffering 
(Khleif & Imam, 2013). 
As cancer is an experience of repeated trauma, patients with cancer  may experience stress 
symptoms at any stage from diagnosis to completion of treatment or cancer recurrence 
(NCI, 2015). Post-traumatic stress disorder (PTSD) has been increasingly diagnosed as a 
co-morbidity among patients with cancer (Mulligan et al., 2014). For example, Cordova et 
al.  (1995) were the first who assessed quality of life (QOL) and PTSD-like symptoms in 
55 women post treatment for breast cancer. PTSD symptoms were negatively related to 
QOL, and PTSD prevalence was ranging from 5% to 10%.  
Also, a large study was conducted in Germany to measure  psychosocial co-morbidity 
(such as PTSD) and quality of life (QOL) and their association with each other and to 
assess the need for psychosocial support in long-term breast cancer survivors. 
Posttraumatic stress disorder was observed in 12% of the participants. Meanwhile, disease 
progress, less social support, a lower educational level, and younger age were the 
predictors of psychological co-morbidity with a significant impact of psychological co-
morbidity on  QOL of these patients with breast cancer (Mehnert & Koch, 2008). 
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Psychological problems are often neglected in patients with cancer, and consequently they 
remain untreated. There is a relationship between  health-related quality of life (HRQOL) 
and PTSD, and there is lack of studies to assess this relation in Palestine. So, this study will 
assess PTSD as a psychological squeal following cancer diagnosis and its relation to QOL. 
 
1.3. Significance of the study:   
Quality of life  of cancer survivors has been highlighted  worldwide  as a major health 
concern. The concept of health-related quality of life (HRQOL) and its determinants have 
evolved since the 1980s to encompass those aspects of overall quality of life that can be 
clearly shown to affect health—either physical or mental (McHorney, 1999). On the 
individual level, this includes physical and mental health perceptions and their correlates, 
including health risks and conditions, functional status, social support, and socioeconomic 
status (CDC, 2012). 
The literature reveals a lack of studies in Palestine that assess the quality of life in relation 
to psychological symptoms such as PTSD symptoms among female patients with cancer. 
Indeed, to our knowledge this may be the first study conducted for this purpose. The 
results of the current study may help Palestinian Ministry of Health in establishing 
evidence-based psychological support program for those patients and to  improve their 
quality of life and treat PTSD symptoms. 
 
1.4. Purpose of the study : 
The purpose of the study was to assess the QOL and PTSD symptoms prevalence among 
adult female patients with cancer attending Beit-Jala Governmental Hospital in Bethlehem. 
 
1.5. Specific objectives : 
 To assess the relationship between QOL and independent variables such as age, 
economic class, education, marital status, cancer type, treatment and length of 
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diagnosis and psychological history among adult female patients with cancer 
attending Beit-Jala Governmental Hospital in Bethlehem. 
 To assess the relationship between PTSD and independent variables such as  age , 
economic class, education, marital status, cancer type, treatment and length of 
diagnosis and psychological history among adult female patients with cancer 
attending Beit-Jala Governmental Hospital in Bethlehem. 
 To assess the relationship between PTSD and QOL among adult females patients 
with cancer aged 18 and above attending Beit-Jala Governmental Hospital in 
Bethlehem. 
 To assess the relationship between GQOL and symptoms scale in the QOL 
questionnaire. 
 
1.6. Research questions :  
 What is the quality of life of  adult female patients with cancer attending Beit-Jala 
Governmental Hospital in Bethlehem? 
 What is the prevalence of PTSD symptoms among adult  female patients with 
cancer attending Beit-Jala Governmental Hospital in Bethlehem? 
 Is there a relationship between QOL and PTSD symptoms among adult female 
patients with cancer attending in Beit-Jala Governmental Hospital in Bethlehem? 
 Is there a relationship between independent variables such as socio-demographic 
data (age, economic class, education and marital status), cancer type, and treatment, 
length of diagnosis and psychological history and QOL among adult female 
patients with cancer attending Beit-Jala Governmental Hospital in Bethlehem? 
 Is there a relationship between independent variables such as socio-demographic 
data (age, economic class, education, marital status), cancer type, treatment, length 
of diagnosis and psychological history and PTSD among adult female  patients with 
cancer attending Beit-Jala Governmental Hospital in Bethlehem? 
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1.7. Feasibility of the study 
 Ethical approval was obtained from Al-Quds University. 
 The researcher herself is working at the Palestinian Ministry of Health and she has 
a close contact with females underwent breast cancer screening.  Also, she  works 
as a doctor in Mammography Screening Unit in Bethlehem district and has a 
contact with surgical and oncology department in Beit-Jala Governmental Hospital 
in Bethlehem which facilitated the collection of data. 
 An approval from the Palestinian Ministry of Health was obtained before 
conducting the study in Beit-Jala Governmental Hospital. 
 
1.8. Summary: 
Cancer is one of the most prevalent non-communicable diseases worldwide. Future 
advances in cancer treatment prolong cancer survival and  highlighted the importance of 
quality of life issues among cancer survivors. Meanwhile, literature  showed that 
psychological morbidities including post-traumatic stress disorder (PTSD) have significant 
impact on quality of life of patients with cancer. However, there is a lack of studies that 
assessed the prevalence of PTSD symptoms and QOL among female patients with cancer 
in the Arab world including Palestine. So the current study aimed to assess the QOL and 
PTSD symptoms prevalence among adult female patients with cancer registered in Beit-
Jala Governmental Hospital in Bethlehem. 
This chapter presented the problem statement, the study objectives, research 
questions and feasibility of the current study. 
The next chapter discussed the literature review of the current study. 
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Chapter Two 
ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ   
Literature Review 
 
2.1 Cancer 
2.1.1. Introduction to Cancer 
Cancer is a term used for diseases in which abnormal cells divide without control and are 
able to invade other tissues. Cancer cells can spread to other parts of the body through  
blood and lymph systems.  Cancer is caused by both external factors (tobacco, chemicals, 
radiation, and infectious organisms) and internal factors (inherited mutations, hormones, 
immune conditions, and mutations that occur from metabolism). These causal factors may 
act together or in sequence to initiate or promote carcinogenesis (Nee, 2013). 
Basic epidemiologic, and clinical research lead to improve cancer prevention, screening, 
and treatment decreasing cancer death rates and increases  numbers of cancer 
survivors (NCI, 2015). Prolonged survival is attributable, in part, to improvements in early 
detection and combined modality treatments (De Moor et al., 2013). And because many 
modern cancer treatments result in side effects that must be managed after treatment 
completion, growing evidence indicates that care should extend into long-term 
survivorship with expanding attention to the psychosocial and physical consequences of 
surviving illness, psychological science and evidence-based practice are making important 
contributions to addressing the pressing needs of cancer survivors (Stanton et al., 2015). 
For example, cancer-,when diagnosed, is often associated with anxiety from diagnosis to 
treatment and survivorship, and it was found that anxiety disorders are elevated in samples 
of patients with cancer undergoing diagnosis and treatment compared with normative 
populations (Jacobsen & Andrykowski, 2015).  
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2.1.2.  Cancer  prevalence among women 
Cancer is among the leading causes of morbidity and mortality worldwide particularly 
among women. Approximately, among 14 million new cases and 8.2 million cancer related 
deaths in 2012, half of these cases occurred in females. The number of new cases is 
expected to rise by about 70% over the next two decades (WHO, 2012). 
Lung cancer was the most common cancer worldwide contributing 13% of the total 
number of new cases diagnosed in 2012, and breast cancer (women only) was the second 
most common cancer with nearly 1.7 million new cases in 2012, colorectal cancer was the 
third most common cancer with nearly 1.4 million new cases in 2012 (WHO, 2012). 
Among men, the top three were lung, prostate and colorectal cancers, contributed nearly 
42% of all cancers, other common cancers contributing more than 5% were stomach and 
liver (excluding non-melanoma skin cancer)(WHO, 2012). 
Whereas among women, the top three were breast, colorectal and lung cancers, contributed 
more than 43% (excluding non-melanoma skin cancer). Breast cancer was the most 
common cancer worldwide in women contributing more than 25% of the total number of 
new cases diagnosed in 2012 while cervical cancer contributed nearly 8% of all cancers 
(excluding non-melanoma skin cancer) (WHO, 2012).  
In 1990, it was estimated that 59% of female cancer cases occurred in more developed 
countries although these areas accounted for less than a quarter of the global female 
population at the time (Parkin, 1998). The situation changed considerably over the next 
two decades; by 2008, the total number of new diagnoses was evenly divided between 
more developed and less developed countries (Jemal et al., 2011; Youlden et al., 2012). By 
2012, it was estimated that the majority (53%) of cases of female cancer were occurring in 
less developed countries (Ferlay et al., 2013).  
Cancer is rising in developing countries, accounting for  55 percent of new cases world-
wide, a figure that could reach 60 percent of reported new cases world-wide by 2020 
(Frenk, 2009). It was found that approximately a quarter (24%) of all female breast cancers 
world-wide were diagnosed within the Asia-Pacific region (Youlden et al., 2014). 
Regarding cancer fatality among women, breast cancer has a relatively low fatality rate. 
Although it has the highest mortality rate among women with cancer (mortality rate of 12.9 
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per 100,000 women with cancer), this is less than one third of the incidence rate. However, 
lung cancer mortality rate is the next highest cause of cancer mortality among women with 
a mortality rate of 11.1 per 100, 000 women with cancer (Stewart & Wild, 2014). Lung 
cancer fatality is considered higher than other types of cancer when compared to lung 
cancer incidence among women (WHO, 2014b). 
In Palestine, cancer is the second most common cause of death, accounted for 14.2% of 
deaths in 2014. There were (2,294) new cancer cases reported in West Bank with an 
incidence rate of  82.2 per 100,000 of population according to  the Palestinian Ministry of 
Health (PMoH, 2014). 
Reported data for incidental cancer cases in Palestine showed approximately 1:1 male to 
female ratio. For example, the Palestinian Ministry of Health  reported 2294  cancer cases 
in 2014 , where  50.7% (n=1162) were among males and 49.3% (n=1132) were among 
females (PMOH, 2014) and data in 2013 showed that the number of reported cancer cases 
was 2189 of which 48.4% (n=1062) were among males and 51.5% (n=1127) were among 
females (PMoH, 2013). 
Cancer cases are distributed in eleven governorates in West Bank as seen in table (2.1). 
The highest number of reported female cancer cases was in Nablus where were 247 cancer 
cases representing 21.8% of all  reported cancer cases in females with incident rate of 
120.5 per 100,000 woman.  Hebron was the second governorate in the number of  reported 
cancer cases of females in 2014 as 221 cases were reported, although the incident rate was 
67.1 per 100,000 woman. In Whereas the lowest reported number of cases was in Jericho 
with 13 reported new cases females with cancer and the incidence rate was 67 per 100,00 
woman (PMoH, 2014). In 2013, the highest reported number of cancer cases among 
females was in Hebron as 225 cases were reported representing  22.6% of all reported 
cancer cases in females with incident rate of  74 per 100,000 woman, followed by Nablus 
which reported 205 cases of cancer among females representing 18.2% of all cancer cases 
in females with incident rate of 103.9 per 100,000 woman. The lowest reported number of 
cases was in Jericho with 17 reported new cases in females with cancer and incidence rate 
of 74.9 per 100,00 woman (PMoH, 2013). 
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Table (2.1) The distribution of reported cancer cases by gender & Governorate in  
Palestine, 2014. 
 
 
Gender  
 
Governorate  
 
Male 
 
Female 
 
Total 
 
Incidence 
Rate per 
100,000 
 
No. 
 
% 
 
No. 
 
% 
 
No. 
 
% 
Jenin 179 15.4 160 14.1 339 14.8 111.7 
Tubas 28 2.4 24 2.1 52 2.3 83 
Tulkarm 89 7.7 75 6.5 162 7.1 90.6 
Nablus 202 17.4 247 21.8 449 19.6 120.5 
Qalqiliya 47 4.0 50 4.4 97 4.2 89.9 
Salfit 30 2.6 32 2.8 62 2.7 89.6 
Ramallah  139 12.0 151 13.3 290 12.6 85.7 
Jericho 21 1.8 13 1.1 34 1.5 67 
Jerusalem  56 4.8 60 5.3 116 5.1 74.4 
Bethlehem  133 11.4 101 8.9 234 10.2 111.2 
Hebron 238 20.5 221 19.5 459 20.0 67.1 
Total  1162 50.7 1132 49.3 2294 100 82.2 
(PMoH, 2014) 
For cancer type, the most commonly diagnosed cancer in the West Bank in 2014 was 
breast cancer with 387 reported cases, accounting for 16.9% of all reported cancer cases 
followed by colon cancer with 226 reported cases (9.9%) and lung cancer with 224 
reported cases (9.8%) as seen in figure (2.1). In addition, lung cancer ranked the first  
among males while breast cancer was the most common among females (PMoH, 2014). 
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Figure (2.1) The most common reported cancer cases, West Bank (PMoH, 2014). 
For females, breast cancer contributed to 33.9% of all cancers with 384 new cancer 
diagnosed cases, followed by colon cancer with the percentage of  9.1% of all cancer cases 
and 103 reported new cases and all types of leukemia contributed to 5.7% of all cancer 
cases among females with 65 newly reported cases as  shown in figure (2.2) (PMoH, 
2014). This increase might be as a result of increasing the number of cancer because of 
early detection. 
Figure (2.2) the percentage of top ten reported cancer types among females, West Bank 
(PMOH, 2014). 
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In summary, cancer is considered common among Palestinian women particularly breast 
cancer and is the second cause of death among them.  
 
2.1.3. Most common types of cancer among women 
Different cancer types have different  epidemiology, etiology, pathology, genetics  and 
prognosis (Bannasc, 2012). Women with breast cancer and men with prostate cancer 
comprise the two largest survivor groups, owing to the relatively high incidence and 
favorable prognosis of those cancers (Stanton et al., 2015). The most common cancer types 
among females are: 
2.1.3.1 Breast cancer 
Cancer that forms in tissues of the breast either in the ducts (Ductal carcinoma), or the milk 
glands  (Lobular carcinoma) (Blackbourne et al., 2000). Breast cancer is the second most 
common cancer in the world and, by far, the most frequent cancer among women with an 
estimated 1.67 million new cancer cases diagnosed worldwide in 2012 (25% of all cancers) 
(Stewart & Wild, 2014).  
2.1.3.2 Lung cancer  
Lung cancer is a devastating malignant disease, it is the uncontrolled growth of cells in the 
lungs (Blackbourne et al., 2006). Although the rates of increase of new cases of lung 
cancer has leveled off,  lung cancer remained the leading cause of cancer related death in 
the world (Andreoli et al., 2009). 
In 2012, an estimated1.8 million new cases occurred worldwide (12.9% of the total), 58% 
of which occurred in the less developed regions (WHO, 2012). Tobacco smoking, 
including second-hand smoke, is the predominant risk factor of lung cancer worldwide. 
Other risk factors of lung cancer include radon, occupational exposure to polycyclic 
aromatic hydrocarbons, certain metals, asbestos, and crystalline silica, as well as exposure 
circumstances relevant to certain categories of work, and exposure to outdoor air pollution, 
and specifically to particulate matter and diesel engine exhaust, and to indoor air pollution, 
including second-hand tobacco smoke and emissions from household combustion of coal 
(Stewart & Wild, 2014). 
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2.1.3.3 Colo-rectal cancer  
Colon cancer is cancer of the large intestine (colon) including the rectum (terminal part of 
colon) (Blackbourne et al., 2006). Colorectal cancer is the third most common cancer in 
men (746,000 cases, 10.0% of the total) and the second in women (614,000 cases, 9.2% of 
the total). Almost 55% of the cases occur in more developed regions (WHO, 2012). 
2.1.3.4 Stomach cancer  
It is the type of cancer that arises from any part of the stomach (Blackbourne et al., 2006). 
Stomach cancer is the fifth most common cancer worldwide, with an estimated 
952 000 new cases (7% of total cancer incidence) and 723 000 deaths (9% of total cancer 
mortalities) in 2012 (Stewart & Wild, 2014). 
2.1.3.5 Leukemia  
Leukemia is a cancer of the bone marrow and blood and is classified into four main groups 
according to cell type and rate of growth: acute lymphocytic (ALL), chronic lymphocytic 
(CLL), acute myeloid (AML), and chronic myeloid (CML) (Leonard, 1993). There were 
almost 352 000 new cases of leukemia globally in 2012, and about 265 000 deaths. The 
disease ranks as the 11th most frequent in terms of cancer incidence and the 10th most 
common cause of cancer death (Stewart & Wild, 2014). 
2.1.3.6 Cervical cancer 
Cervical cancer originates at the junction between the columnar epithelium of the endo-
cervix and the squamous epithelium of the ecto-cervix, a site of continuous metaplastic 
change, especially at puberty and from after the first pregnancy until menopause. Persistent 
epithelial infection with one or more oncogenic types of human papilloma virus HPV may 
lead to the development of precancerous lesions, a small proportion of which may progress 
to invasive cervical cancer over a period of 10–20 years (Stewart & Wild, 2014). 
2.1.3.7 Endometrial cancer 
Cancer of the corpus uteri (endometrial cancer) is the sixth most common cancer 
among women (almost 5% of all cancers in women). There were an estimated 320,000 
new cases and 76 000 deaths from the disease in 2012 (WHO, 2012). 
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2.1.3.8 Ovarian cancers  
Finally, Ovarian carcinomas most commonly affects nulliparous women and occurs 
least frequently among women with suppressed ovulation, typically by pregnancy or oral 
contraceptives. These tumors  are generally considered to originate from the cells covering 
the ovarian surface or the pelvic peritoneum  (Andreoli et al., 2009). Ovarian cancer is the 
seventh most common cancer among women worldwide (18 most common cancer overall), 
with 239,000 new cases diagnosed in 2012 (WHO, 2012). 
 
2.1.4.  Risk factors of cancer among women  
Many risks factors contribute to increase cancer rates among women. These factors 
include: age, environmental factors, lifestyle, infection, reproductive history and family 
history. 
i. Age 
Cancer has a strong relationship with age. Many cancers among women increases with age 
such as breast, endomatium, ovarian and colon cancer (Andreoli et al., 2009). On the other 
hand, cervical cancer has relatively earlier age at onset (Stewart & Wild, 2014). 
ii. Environmental factors 
Numerous environmental factors increase the risk of developing cancer. For example, 
tobacco smoke contains carcinogens that substantially increase the risk of developing 
cancers of the lungs, mouth, throat, esophagus, kidneys, and bladder (Andreoli et al., 
2009). 
Pollutants in the air or water, such as asbestos, industrial waste, or cigarette smoke, can 
increase the cancer risk. For example, asbestos exposure may cause lung cancer and 
mesothelioma (cancer of the pleura). Exposure to pesticides is associated with a higher risk 
of some types of cancer (for example, leukemia and non-Hodgkin lymphoma) (Bruce et al., 
2015). 
Exposure to radiation is a risk factor for the development of cancer. Extended exposure to 
ultraviolet radiation, primarily from sunlight, causes skin cancer. Ionizing radiation is 
particularly carcinogenic. Also women who had radiation therapy to the chest (including 
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the breasts) before 30 years of old have an increased risk for breast cancer throughout their 
lives (Nee, 2013). 
iii. Lifestyle  
Substances consumed in the diet can increase the risk of cancer among women. For 
instance, a diet high in unsaturated fat has been linked to an increased risk of colon, breast 
cancer (Bruce et al., 2015). Also, diet high in smoked and pickled foods or in barbecued 
meats increases the risk of developing stomach cancer. Additionally, dietary intake of salt 
has been associated with increased incidence and mortality of stomach cancer 
(Guggenheim & Shah, 2013). Also, women who drinks alcohol has a greater risk for breast 
cancer (Nee, 2013). 
Regarding physical inactivity, World-wide physical inactivity is estimated to cause around 
21–25% of breast and colon cancer burden (Stevens, 2009) and women who are physically 
inactive throughout their life have increasing risk for breast cancer (Nee, 2013).  
For obesity, the latest world cancer report from World Health Organization (2014) stated 
that women who are overweight or obese have a higher risk of cancer of the breast, lining 
of the uterus (endometrial cancer), colon, kidneys, and esophagus cancer (Stewart & Wild, 
2014).  
iv. Drugs and medical treatments 
Certain drugs and medical treatments may increase the risk of developing cancer among 
women. For example, estrogens in oral contraceptives may slightly increase the risk of 
breast cancer and the hormones  that may be given to women during menopause (hormone 
replacement therapy) also increase its’ risk  (Bruce et al., 2015). Also, Diethylstilbestrol 
(DES) increases the risk of breast cancer in women who took the drug and in daughters of 
these women who were exposed before birth (Andreoli et al., 2009). Tamoxifen, a drug 
used to treat breast cancer, increases the risk of endometrial cancer. Long-term use 
of testosterone or other male hormones (androgens) may slightly increase the risk of liver 
cancer (Andreoli et al., 2009). Treatment of cancer with certain chemotherapy drugs 
(alkylating agents) and with radiation therapy may increase the risk of people developing a 
second cancer years later (Bruce et al., 2016). 
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v. Infections  
Infections among women can lead to cancer. The WHO reported that  deaths and unhealthy 
life years from cervical cancer are caused by human papilloma virus infection from unsafe 
sex (Stewart & Wild, 2014). 
For specific cancer sites, more than three quarters of deaths from mouth and oro-pharynx 
cancer, liver cancer, lung cancer and cervical cancer can be explained by infections, and 
environmental and behavioral exposures. For example, 63% of stomach cancer deaths are 
caused by infection with Helicobacter pylori, 73% of liver cancer deaths are caused by 
infection with viral hepatitis or liver flukes, and 100% of cervical cancer deaths are caused 
by infection with human papilloma virus (Stevens, 2009).  
vi. Reproductive history: 
Reproductive history associated with increased risk of breast cancer. The risk factors for 
breast cancer include: nulliparity or lower parity, younger age at first menstrual period, 
older age at first live birth and older age at menopause (Bevers et al., 2014). Also, women 
who used combined estrogen and progesterone hormonal therapy more than five years 
have an increased chance of developing breast cancer (Nee, 2013). On the other hand, 
hormone-replacement therapy (HRT) and estrogen exposure based on women menopausal 
status may increase their risk for colon cancer (Freedman et al., 2009). In addition, early 
menarche is associated with increased risk of ovarian cancer (Gong et al., 2013). 
vii. Family history 
Risk of cancer is also increased by a family history of cancer. For example, women who 
have sister with breast cancer associated with increased risk of breast cancer (Rebora et al., 
2008). Also, inherited mutations (genetic alterations) in BRCA1 and BRCA2, the most 
well-studied breast cancer susceptibility genes, account for 5%-10% of all female breast 
cancers, an estimated 5%-20% of male breast cancers, and 15%-20% of familial breast 
cancers (American Cancer Society, 2016a). Meanwhile, lifetime  risk of developing 
ovarian cancer reported to be 15%-45% with BRCA1 and 10%-20% with BRCA2 mutation 
in ovarian cancer and all patients with BRCA1 or BRCA2 mutations had high-grade serous 
ovarian cancer (Schrader et al., 2012). 
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2.1.5. Treatment of cancer : 
There are many types of cancer treatment, the type of treatment depend on the type of 
cancer and how advanced it is (Andreoli et al., 2009). Several new trends in cancer 
treatment worldwide are used, but  in Palestine the only available treatments are the basic 
types which are:  
Chemotherapy 
The term chemotherapy refers to the use of cytotoxic agents singly or in combination for 
the systemic treatment of cancer. Usually, patients need several chemotherapy treatment 
visits according to their treatment schedule which most of the time are  three weeks apart 
(NCI, 2015). Certain types of chemotherapy often have specific side effects, but each 
person’s experience is different including : fatigue, headaches, muscle pain, stomach pain, 
shooting pains (usually in the fingers and toes), mouth and throat sores, diarrhea or 
constipation, nausea and vomiting, appetite loss, hair loss and  low immunity (ASCO, 
2015). 
Radiation 
More than half of all cancer patients receive radiation therapy at some point during the 
course of their disease. Unlike surgery, regional treatment with radiation can preserve 
organ structure and function, resulting in enhanced quality of life for patients (Andreoli et 
al., 2009). 
High doses of radiation are used to destroy cancer cells. Side effects occur because 
radiation can also damage healthy cells and tissues near the treatment area (Walker et al. , 
2010).  Normal tissue responses to radiation therapy cancer acute or late. Acute effects 
occur within days to weeks of radiation and are seen in rapidly proliferating tissues such as 
skin and gastrointestinal mucosa. These effects include diarrhea or constipation, bone 
abnormalities and chest or eye infections. Late effects such as necrosis fibrosis or organ 
failure appears after months or years of radiation (Andreoli et al., 2009). 
Surgery 
Surgery is the primary method of treatment of most isolated solid cancers and may play a 
role in palliation and prolongation of survival. It is typically an important part of making 
the definitive diagnosis and staging the tumor as biopsies are usually required (NCI, 2015). 
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Side effects of cancer surgery may include pain, fatigue, appetite loss ,swelling around the 
site of surgery, drainage from the site of surgery, bruising around the site of surgery and 
organ dysfunction which are  usually temporary, and all generally goes away as the healing 
process proceeds. In addition, lymphedema (lymph collection at site of lymph node 
dissection), Organ dysfunction and changes in body image are common cancer surgeries 
side effects that  patients  may feel insecure about and make them struggle with their self-
image and lead to emotional side effects which may eventually  affect the patients’ well-
being (Walker et al., 2010). 
Palliative care 
Palliative care is an integral part of treatment of cancer, particularly in non-curative 
settings. Palliative care in treating cancer addresses not only physical symptoms, in 
particular pain syndromes, but also psychosocial and spiritual concerns. Chemotherapy and 
radiotherapy can be employed with palliative intent and can improve quality of life of 
patients with cancer (Andreoli et al., 2009). 
Palliative care is defined by the World Health Organization as an approach that improves 
the quality of life of patients and their families facing the problem associated with life-
threatening illness, through the prevention and relief of suffering by means of early 
identification and impeccable assessment and treatment of pain and other problems, 
physical, psychosocial and spiritual (WHO, 2016). 
In most of the world, the majority patients with cancer are in advanced stages of cancer 
when first seen by a medical professional. For them, the only realistic treatment option is 
pain relief and palliative care. Effective approaches to palliative care are available to 
improve the quality of life for patients with cancer (WHO, 2016). Cancer diagnosis, cancer  
treatment with different types of modalities and cancer prognosis  may adversely affect the 
quality of life of patients with cancer. 
 
 
 
 
19 
 
2.2.  Quality of life of patients with cancer 
2.2.1. Introduction 
Quality of life (QOL) is a popular term that conveys an overall sense of well-being, 
including aspects of happiness and satisfaction with life as a whole. It is broad and 
subjective rather than specific and objective (CDC, 2012). 
Quality of life (QOL) is defined as “ an individuals’ perception of their position in life in 
the context of the culture and value systems in which they live and in relation to their 
goals, expectations, standards and concerns. It is a broad-ranging concept affected in a 
complex way by the person’s physical health, psychological state, level of independence, 
social relationships and their relationships to salient features of their environment (WHO, 
1997a). 
The concept of health-related quality of life (HRQOL) and its determinants has evolved 
since the 1980s to encompass those aspects of overall quality of life that can be clearly 
shown to affect health—either physical or mental (Robert et al., 1999). On the basis of a 
synthesis of the scientific literature and advice from its public health partners, the CDC has 
defined Health related quality of life HRQOL as “an individual’s or group’s perceived 
physical and mental health over time.” At  individual’s level, this includes physical and 
mental health perceptions and their correlates, including health risks and conditions, 
functional status, social support and socioeconomic status (CDC, 2012). 
Generally, HRQOL covers the subjective perceptions of the positive and negative aspects 
of cancer patients' symptoms, including physical, emotional, social, and cognitive 
functions and, importantly, disease symptoms and side effects of treatment (Leplège & 
Hunt, 1997) 
While there is an increasing evidence for the value of HRQOL assessment, one of the most 
difficult tasks is actually measuring it as HRQOL is subjective and can prove a challenge 
to measure (Leplège & Hunt, 1997). Many of the components, such as social functioning 
and spirituality, cannot be directly observed. Therefore, these are measured using classical 
measurement paradigms. The measurement process draws on many different disciplines, 
including psychology and statistics (Andrew, 2002). 
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Ferrell model in measuring quality of life is widely used as it looks to QOL in four 
domains (Ferrell, 1996) : 
 Physical well-being: which is the control or relief of symptoms and the 
maintenance of function and independence. 
  Psychological well-being, and it is the attempt to maintain a sense of control in the 
face of life-threatening illness characterized by emotional distress, altered life 
priorities, and fear of the unknown, as well as positive life changes. 
 Social well-being is the effort to deal with the impact of cancer on individuals, 
their roles and relationships.  
 Spiritual well-being which is the ability to maintain hope and derive meaning from 
the cancer experience, which is characterized by uncertainty. 
Each aspect of quality of life is described in more details as the following:  
i. Physical Well-Being 
Cancer survivors describe several problematic physical effects that influence their ability 
to function and negatively influence their overall QOL. The most common effects affecting 
physical well-being are pain and fatigue. Pain most often occurs in advanced stages of the 
disease and is related to bone metastasis and compression of adjacent nerves, vascular 
structures and soft tissue, but it also occurs in non-metastatic disease and may be related to 
incisional pain, paresthesia, edema, and phantom limb sensations (Andreoli et al., 2009). 
For example, pain was highly correlated with QOL scores, and the change of pain scores 
was associated with significant change in patients' QOL (Thienthong et al., 2006). 
Fatigue is a prevalent and disturbing symptom of cancer treatment that has been largely 
ignored because it is not considered life-threatening. Pain and fatigue have often been 
reported to be the most common symptoms in long-term cancer survivors. Many other 
symptoms also occur such as menopausal symptoms in breast cancer  survivor which are 
an example of disease/treatment-specific problems related to physical well-being (Ferrell et 
al., 1997). 
Also patients with cancer especially women with breast cancer is prone to insomnia for 
various reasons including a possible disruption of sleep due to increased frequency and 
severity of hot flashes associated with the breast cancer treatment, and possible increased 
depression, anxiety and fatigue levels following the breast cancer diagnosis (Kryger, 
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2004). It was reported that up to 75% of women with breast cancer experienced problems 
in falling asleep or maintaining sleep, whereas a smaller group meet the criteria for 
insomnia (Fiorentino & Ancoli, 2006). 
For other cancer related symptoms, nausea and vomiting occurred in 30% (to 60% of 
patients with cancer and resulting in decrease the quality of life of patients with cancer 
(Shoemaker et al., 2011). Causes of nausea and vomiting include chemotherapy, radiation 
therapy, and other medications; infection; anxiety; constipation; bowel obstruction; organ 
failure; electrolyte disturbances; impaired gastric emptying; gastric/esophageal irritation; 
and brain metastases (Stephenson & Davies, 2006). Along with nausea and vomiting, 
patients with advanced cancer frequently report constipation (50%), especially if they are 
being treated with opioids (Shoemaker et al., 2011). 
ii. Psychological Well-Being 
The most problematic changes affecting QOL in the psychological domain include: 
anxiety; fear of recurrence, secondary or metastatic malignancies, concern over future tests 
and distress over recall of the initial cancer treatment. These changes in psychological 
well-being are manifested by marked anxiety, mood swings, and depression (Ferrell et al., 
1997). 
Despite the widely reported problems of fear of recurrence and uncertainty over the future 
and the need for interventions to help cancer survivors to manage these concerns, only few 
have been tested. Support groups have traditionally been found to provide the necessary 
emotional support and help patients cope with the fear of dying (Ferrell et al., 1997). For 
example, a  multicenter randomized- control trial performed in Canada (2001) and 
included 235 women with metastatic breast cancer that were randomly assigned  either to 
intervention group that participated in weekly supportive–expressive group therapy (158 
women)  or to a control group that received no such intervention (77 women). Women 
assigned to supportive–expressive therapy had greater improvement in psychological 
symptoms  and reported less pain  than women in the control group (Goodwin et al., 2001). 
Interventions to improve both physical and psychological well-being have become even 
more imperative as recent advances in cancer treatment have extended the length of cancer 
survivorship. Cancer survivors require attention to these important needs in order to 
resume employment or carry on roles and responsibilities. Both the physical and 
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psychological domains are often neglected in long-term survivorship when patient’s 
encountering with the health-care system become less frequent. Psychological support for 
long-term survivors is of special concern and is at particular risk amidst the current 
reductions in health-care delivery (Ferrell et al., 1997). 
iii. Social Well-Being 
Quality-of-life concerns affecting social well-being include family issues, such as sexual 
and marital problems and adjustment of children, and work-related issues, such as concern 
over cancer disclosure, stigma, reentry into the workplace, changes in work priorities, 
discrimination and health insurance. Also the long-term impact of cancer may affect 
patient’s family and work. As a result, specific interventions were described to alleviate 
social problems related to QOL of patients with cancer including coaching support, work-
site educational programs, and family counseling and intervention (Northouse, 1994). 
iv. Spiritual Well-Being 
Finally, QOL factors affecting spiritual well-being include: spiritual distress, grief and loss. 
A link between  religiosity and spiritual support with recovery from breast cancer has been 
reported; a sense of hopefulness and having a purpose in life were also important aspects 
influencing spiritual well-being (O’Connor, 2007).Religion might have affected patients 
with cancer quality of life positively as patients who practiced religious ritual levels had 
better quality of life than those didn’t (Tarakeshwar et al., 2006; Üstündag & Zencirci, 
2015).  
 
2.2.2 Measuring Quality of life  
In an attempt to examine “quality of life” as a specified construct in cancer survivors, some 
investigators have administered instruments designed specifically to assess multiple and 
varied aspects, or qualities, of cancer survivors’ such as the European Organization for the 
Research and Treatment of Cancer (EORTC) – C30 Questionnaire which is widely-used in 
quality of life research and have well-established norms derived from adult cancer 
populations. In addition,  the Quality of Life – Cancer Survivors (Ferrell et al., 1995) and 
the Quality of Life Index – Cancer (Ferrans & Powers, 1995) which have received less 
exposure and psychometric analysis. All of these instruments typically assess physical, 
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psychological, social and spiritual/existential domains, and address concerns regarding 
health status and physical function, sexuality and fertility, emotional distress, future 
outlook, school and work performance, social and family relationships, and spirituality, as 
well as other key medical, demographic and psychosocial elements (Andrew, 2002).  
Many studies were conducted to assess the quality of life of patients with cancer using The 
EORTC quality of life core questionnaire (QLQ-C30). For example, a Kuwaiti study 
measured the  quality of life (QOL) of 348 patients with breast cancer aged between 20–81 
years attended chemotherapy treatment sessions at the Kuwait Cancer Control Center using   
(EORTC QLQ-C30) questionnaire. The study showed that the mean scores for QLQ – C30 
(GQOL, 45.3; and five functional scales, 52.6–61.2)  indicating that the patients had poor 
to average functioning, and 5.8% to 11.2% had scores that met the  ≤33% criterion for 
problematic functioning, while 12.0% to 40.0% met the >66% criterion for more severe 
symptoms. In addition, between 47.8% and 70.1% met the >66% criterion for "good 
functioning" on the functional scales. These results provided an evidence to boost national 
health education about psychosocial prognosis in cancer, and to enhance the practices of 
clinicians treating women with breast cancer towards preparing them for the acute 
toxicities of treatment and address fatigue. The findings call for the institution of a psycho-
oncology service to address psycho-social issues (Alawadi & Ohaeri, 2009). 
The same QOL assessment questionnaire (EORTC QLQ-C30) was used  to assess QOL 
patients with cancer aged 15 years of old and above in three major cancer treatment centers 
in the West Bank include: Beit-Jala Governmental Hospital in Bethlehem, Augusta 
Victoria Hospital in Jerusalem and Al-Watani Hospital in Nablus. The study used a 
convenient sample of 323 patients with cancer, 62.2% (n=201) were recruited from Beit-
Jala Hospital, 29.7% (n=.96) from Augusta Victoria Hospital and 8% (n=26) from Al-
Watani Hospital.  While,  58.2% (n=188) of the study participants were females, 31% 
(n=102) of the participants had breast cancer. The study showed  that the mean scores for 
QLQ – C30 of (GQOL= 41.8) and five functional scales between  46 and 50, indicating 
that the patients had poor  functioning. Meanwhile,13.2% to 33.8% had scores that met the 
</= 33% criterion for problematic functioning, 14.4% to 62.1% met the >66% criterion for 
more severe symptoms and 59.2% met the ≥ 66% criterion of symptom severity for fatigue 
and pain respectively. The results Indicated a need to assess psychological aspects of QOL 
of  patients with cancer  in the West bank (Khleif & Imam, 2013). 
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Finally, another study was conducted to assess the physical, psychological and spiritual 
and social well-being among women with breast cancer in Palestine using Ferrell quality of 
life assessment tool. The sample consisted of 108 women aged between 30 and 70 years of 
old with breast cancer who were attending oncology clinics during June through August 
2008 from the oncology departments at the governmental hospitals and in non-
governmental organization. The linear transformation of the study results to be compared 
with  EORTC quality of life results showed that the mean score of  GQOL was 49%  and 
the means of the measured functional scales include: physical, social and emotional 
functions were 55.4%, 45.8% and 44% respectively (Samara & Saca, 2009). 
 
2.2.3 Factors affecting quality of life among patients with cancer 
Numerous studies have identified several factors influencing quality of life (QOL) in 
patients with cancer. Generally different socio-demographic variables were studied 
including gender, age, marital status and  educational level. For women with cancer 
especially breast cancer, different treatment modalities,  psychological distress-anxiety 
related to cancer diagnosis and treatment, symptoms such as pain, fatigue, supportive care-
clinical treatments and sexual functioning problems after breast cancer diagnosis especially 
younger patients and their relationship on quality of life of women with cancer were 
studied (Montazeri, 2008). 
For example, a large study was conducted in Harvard School of Public Health in USA to 
explore the changes in physical and psychosocial function before and after breast cancer by 
age at diagnosis. A total of 122,969 women from the Nurses’ Health Study (NHS)  aged 29 
to 71 years, who responded to pre- and post-functional status assessments were included 
from which 1,082 women were diagnosed with breast cancer. The results showed that 
women with breast cancer experienced significant functional declines, where young (age 
<40 years) women who developed breast cancer experienced the largest relative declines in 
HRQOL (as compared with middle-aged and elderly women) in multiple domains 
including physical roles, pain , social functioning  psychosocial dimensions after breast 
cancer diagnosis (Kroenke et al., 2004). 
Also, a cross-sectional study was conducted to measure the QOL in 200 patients with solid 
tumors at different chemotherapy cycles (CT) by using  (EORTC QLQ-C30) questionnaire. 
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One hundred  woman with cancer aged 18-75 participated  in this study and the results 
showed  a significant relationship between the cancer type, pain intensity, and fatigue and 
none of the demographic variables (age, education, marital status, income) and QOL. 
Nevertheless, significant difference was found between the level of QOL in patients with 
<2 CT cycles and/or with 3-5 cycles (p< 0.001) (Heydarnejad et al., 2011). 
Another study examined common symptoms such as pain intensity, fatigue and depression 
and their ability to predict QOL. A total of 114 oncology outpatients, including 34 males 
and 80 females, completed a demographic questionnaire, the Multidimensional Quality of 
Life Scale - Cancer, a Depression Scale, and a numeric rating scale for pain intensity. The 
finding showed that female patients reported significantly lower psychological dimension 
of QOL than their male counterparts (p=0.009). Also for the females, a significant negative 
correlation was found between pain intensity and QOL (p<0.0001), as well as significant 
positive correlations between pain intensity and fatigue (p<0.0001) and depression. 
Stepwise linear regression analyses showed that among the females, QOL was significantly 
predicted by pain intensity as well as by depression. However, among the males, 
depression was the only symptom found to predict QOL. The  study concluded that gender 
should be considered as an additional feature for further characterizing QOL. Gender 
differences in factors predicting QOL warrant different clinical approaches to male and 
female patients, and identifying these differences may assist health care providers in 
tailoring treatment modalities to individual patients for optimal outcomes (Pud, 2011). 
In addition, a study was conducted to examine the impact of various medical and 
demographic factors on the quality of life (QOL) of patients with breast cancer was 
performed as a routine follow up for these patients .Two -hundred and seventy-four women 
with breast cancer were evaluated by using the QLQ-C30 questionnaire Version 2.0 and a 
hypothesized psychological scale structure of the added items included a body image scale, 
satisfaction with the primary surgical treatment, fear of recurrence and  cosmetic results.  
The results showed minor impairment of QOL (mean 67.8) and body image (mean 24.8), 
but more fear of recurrence (mean 60.7). None of the studied factors such as age, tumor 
stage, treatment factors and follow up period  had a significant impact on overall QOL 
according to the QLQ-C30 questionnaire. In contrast, with the exception of the treatment 
factors which included ‘cytotoxic therapy’ and ‘radiotherapy’  influenced at least one of 
the psychological scales used in the study (Härtl et al., 2003). 
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It was found that various types of psychological interventions are associated with 
significant  effects on quality of life of adult patients with cancer (Faller et al., 2013). In 
patients with breast cancer, high psychological stress was associated with low physical and 
psychological quality of life highlighted the importance of studying psychological stress in 
female patients with cancer to improve their QOL (Golden-Kreutz et al., 2005). 
Recently there is a focus increasingly on potential post-traumatic stress disorder (PTSD) 
diagnosis or symptomatology following cancer. The latter may signal threat to life and 
body integrity including possible disfiguration, disability, pain, and loss of social and 
occupational roles. The uncertainty of outcome, experienced lack of control, and 
suddenness of the diagnosis may elicit intense emotions including fear and helplessness, as 
with single-event traumas, but the protracted, chronic, and multifaceted nature of cancer 
adds psychological complexity (Gurevich et al., 2002). 
Different aspects of the cancer experience might trigger PTSD from being diagnosed with 
the disease or diagnosis of an advanced cancer to painful tests and treatments, pain from 
the cancer itself or other physical issues ,long  hospital stays or treatments and  cancer 
recurrence (cancer that comes back after treatment) or the potential for recurrence (NCI, 
2015). 
The next section will discuss PTSD symptoms among patients with cancer in more details. 
 
2.3.  PTSD symptoms in patients with cancer 
Assessing PTSD symptoms in patients with medical diagnoses is becoming 
increasingly common, particularly since the inclusion in Diagnostic and Statistical Manual 
of Mental Disorders, Fourth Edition (DSM-IV) of a diagnosis with a life-threatening 
illness as a traumatic event that could precipitate PTSD (Josephine E.& Nicholas, 2003). 
 American Psychiatric Association in its fifth edition of Diagnostic and Statistical 
Manual of Mental Disorders- DSM-V defined PTSD as: the development of characteristic 
symptoms following exposure to an extreme traumatic stress or involving direct personal 
exposure to actual or threatened death, serious injury or sexual violation. The exposure 
must result from one of following scenarios:  the individual has directly experiences the 
traumatic event or indirectly by learning that a close relative or close friend was exposed to 
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trauma, or witnesses the traumatic event in other person (American Psychiatric 
Association, 2013).  
In DSM-IV, the person's response to the event must involve intense fear, helplessness, or 
horror (or in children, the response must involve disorganized or agitated behavior). The 
characteristic symptoms resulting from the exposure to the extreme trauma include 
persistent re-experiencing of the traumatic event , persistent avoidance of stimuli 
associated with the trauma and numbing of general responsiveness, and persistent 
symptoms of increased arousal . The full symptom picture must be present for more than 1 
month, and the disturbance must cause clinically significant distress or impairment in 
social, occupational, or other important areas of functioning (American Psychiatric 
Association, 2000). 
However, DSM-V pays more attention to the behavioral symptoms that accompany PTSD 
and proposes four distinct diagnostic. They are described as re-experiencing, avoidance, 
negative cognitions and mood, and arousal. Re-experiencing covers spontaneous memories 
of the traumatic event, recurrent dreams related to it, flashbacks or other intense or 
prolonged psychological distress. Avoidance refers to distressing memories, thoughts, 
feelings or external reminders of the event. Negative cognitions and mood represents 
myriad feelings, from a persistent and distorted sense of blame of self or others, to 
estrangement from others or markedly diminished interest in activities, to an inability to 
remember key aspects of the event. Finally, arousal is marked by aggressive, reckless or 
self-destructive behavior, sleep disturbances, hypervigilance or related problems. The 
current manual emphasizes the “flight” aspect associated with PTSD (American 
Psychiatric Association, 2013). 
Although PTSD is most often associated with traumatic events such as war, sexual and 
physical attacks, natural disasters and serious accidents, the disorder can also affect people 
with a history of cancer (NCI, 2015).  
It emerges from the literature that up to 19% of adults women receiving breast cancer 
diagnosis present a PTSD-like syndrome (Kwakkenbos et al.,2014). On the other hand, 
early detection of PTSD symptoms among female patients with cancer can help in 
improving psychological health of patients with cancer as well as QOL and medical 
prognosis. Therefore, it is important to detect PTSD symptoms to guide health care 
interventions as early as possible (Lutgendorf et al., 2012).  
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2.4  Studies that assessed PTSD and QOL among patients with cancer  
Post-traumatic stress had been measured in a variety of cancers including melanoma, 
Hodgkin lymphoma, breast cancer and mixed cancers. The incidence rates have varied 
accordingly; The incidence  of PTSD diagnosis ranges from 3% to 4% in early-stage 
patients recently diagnosed to 35% in patients evaluated after treatment (NCI, 2015b). 
For example, a case control study was conducted in Germany to test the hypothesis that 
pretreatment cognitive impairment is attributable to cancer-related post-traumatic stress. 
Cases were women aged 65 years or younger who were diagnosed with breast cancer and 
controls were patients undergone negative routine breast imaging at one of six participating 
breast centers underwent traditional and computerized neuropsychological testing, 
clinician-administered diagnostic assessment of stress disorders (CAPS) , and self-report 
assessments of cognitive function and depression. Results of  166 case patients and 60 
well-matched controls showed that prior to any treatment, patients with breast cancer may 
show limited cognitive impairment that is apparently largely caused by cancer-related post-
traumatic stress (Hermelink et al., 2015). 
Furthermore, Alter et al.(1996) conducted a study to assess PTSD in cancer survivors in 
USA. The study used CAPS tool and interviewed 27 breast cancer survivors. Only one  
woman  representing  (4%) of the sample meet the criteria for PTSD diagnosis (Alter et al., 
1996). 
Also, a prospective study measured the prevalence of acute and post-traumatic stress 
disorder and comorbid mental disorders in patients with breast cancer during primary 
cancer care. Screening measures were used to assess post-traumatic stress responses, 
anxiety, and depression at first time and at 6 months follow-up assessments included 
screening instruments for Acute Stress Disordered (ASD) and PTSD by using the IES-
Revised (IES-R) and the PTSD Checklist-Civilian (PCL-C) tools. The screening 
instruments IES-R and PCL-C identified PTSD in 18.5% of participants at the first 
assessment and in a range of 11.2% to 16.3% of participants at the second assessment. 
However, only 2.4% of participants met the criteria for mild to moderate cancer-related 
PTSD and 2.4% were diagnosed with ASD (Mehnert & Koch, 2007). 
Also, a variety of socio-demographic, disease-related, psychosocial and  psychological 
variables have been investigated to determine their relationship to post-traumatic stress 
disorder (PTSD)  in patients with cancer. Demographic variables that have been associated 
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with a higher incidence of PTSD include younger age ,fewer years of formal education, 
and lower income (Alkhyatt et al., 2012; Cordova et al., 1995). 
A large study was conducted to assess the prevalence and the risk factors for cancer-related 
PTSD symptoms in a nationwide inception cohort of women treated for primary breast 
cancer. In this study 3343 Danish women with primary breast cancer completed a 
questionnaire at 3 months post-surgery  and a follow-up questionnaire at 15 months post-
surgery. The questionnaire  included the impact of event scale (IES) to measure PTSD. The 
findings showed that 20.1% of the sample  had  total scores suggesting severe PTSD 
symptoms at 3 months post-surgery, compared with 14.3% at 15 months. In all, 48% with 
severe PTSD symptoms at 3 months also had scores above the cutoff at 15 months. Main 
predictors of severe PTSD symptoms at 15 months were low social status, previous 
physical and mental illness, axillary lymph node involvement (>3), and reduced physical 
functioning (PF) at 3 months (O’Connor et al., 2011). 
In addition, a follow up study was conducted to measure posttraumatic stress symptoms in 
patients with breast cancer. In this study one -hundred and two female patients with breast 
cancer aged 18 years or older were evaluated during their preoperative visit to the 
outpatient clinic of the department of surgery for posttraumatic stress symptomatology  at 
different stages of non-metastatic cancer diagnosis and treatment: during treatment, at the 
end of treatment, and at a 6–12 months follow-up. PTSD symptoms were measured using 
the Impact of Event Scale-Revised (IES-R). The study results indicated that PTSD 
symptoms remained constant across all phases. There were significant correlations 
between PTSD symptoms and other psychosocial variables and age in favor of younger 
age groups, but not with other socio-demographic or medical factors (Perez et al., 2014). 
Further, a study conducted to determine the prevalence of post-traumatic stress symptoms 
in a sample of cancer survivors and showed that  7–29% of the sample reported symptoms 
related to PTSD, depending on scoring method used – using different cut-off point. Results 
also  showed that none of the cancer history variables (treatment type, time since treatment, 
childhood cancer survivor, and multiple cancer diagnoses) had significant associations 
with the PCL-C total score. Age, race/ethnicity, income, marital status, health-related 
quality of life and psychosocial variables (social support, depressive symptoms) were all 
statistically significantly associated with the PCL-C total score. The study concluded that 
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assessing cancer survivors for PTSD symptoms with the PCL-C could detect those 
individuals in need of psychosocial support (Hahn et al., 2015). 
Cordova et al.  assessed the quality of life (QOL) and PTSD-like symptoms in 55 women 
post treatment for breast cancer. PTSD symptom measures included the PCL-C and IES. 
QOL was assessed using the 20-item Medical Outcomes Study Questionnaire. PTSD 
symptomatology was negatively related to QOL, income, and age. While time since 
treatment, type of cytotoxic treatment, and stage of disease were unrelated to PTSD 
symptoms. With suggested criteria for the PCL-C, 5% to 10% of the sample would likely 
meet DSM-IV PTSD criteria. Findings suggest that in survivors of breast cancer, these 
symptoms might be fairly common, may exceed the base rate of these symptoms in the 
general population, are associated with reports of poorer QOL, and, therefore, warrant 
further research and clinical attention (Cordova et al., 1995). 
Finally , a large study was conducted in Germany to measure  psychosocial co-morbidity 
(such as PTSD) and quality of life (QOL) and their association with each other and to 
assess the need for psychosocial support in long-term breast cancer survivors. In this study 
one thousand eighty-three patients responded to self-reported measures included a 
depression Scale, posttraumatic stress disorder checklist and QOL assessment tool. 
Posttraumatic stress disorder was observed in 12% in the participants. Meanwhile, disease 
progress, less social support, a lower educational level, and younger age were predictors of 
psychological co-morbidity with a significant impact of psychological co-morbidity on  
QOL of these patients with breast cancer (Mehnert & Koch, 2008). 
In summary, the previous studies showed that there is a relationship between quality of life 
of patients with cancer and PTSD occurrence. 
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2.5. Summary: 
This chapter presented the  worldwide prevalence of most common cancer types 
among women. The latest WHO statistics showed that breast cancer, lung cancer and 
colorectal cancer are the top three cancer types diagnosed in females. Also, Palestinian 
ministry of health statistics (2014) showed that breast cancer was the most common cancer 
diagnosed among women in the west bank followed by colon and lung cancer. Cancer 
types, stages and treatment were also defined in this chapter. 
QOL has become increasingly common in cancer research. Ferrel et al. (1995) 
demonstrated four domains for quality of life : physical, psychological, social and spiritual. 
Many studied assessed different domains of QOL using different instruments which 
generally showed low quality of life among patients with cancer. 
Finally, studies showed that PTSD symptoms were prevalent in patients with 
cancer and lead to negative impact on quality of life of patients with cancer 
The next chapter discussed the conceptual framework of the current study. 
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Chapter Three 
ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ 
Conceptual framework 
3.1.   Introduction 
Conceptual framework is a tool structured from a set of broad ideas and theories taken 
from relevant fields of enquiry that help researchers to properly identify the problem they 
are looking at, guide their inquiry, frame their questions and find suitable literature. Most 
academic researchers use a conceptual framework at the outset because it helps the 
researcher to clarify his/her research question and aims (Smyth, 2004). It can be a visual or 
written product that is explained either graphically or narrative (Polit & Beck, 2004). 
Also, conceptual framework has different purposes. It helps researchers to see the variables 
of the study clearly, it provides researchers with a general framework for data analysis, and 
it is essential in the preparation of a research proposal using cross sectional design 
methods. The conceptual framework also summarizes the major dependent and 
independent variables in the research, and it gives direction to the study (Smyth, 2004). 
The major concepts of the current framework focus on quality of life and PTSD symptoms 
as  dependent variables and other variables as independent variables such as the socio-
demographic data (which includes age, place of residence, educational level, economic and 
marital status), cancer medical history which includes  type of cancer, cancer treatment and 
onset since diagnosis and psychological history include: previous psychological problems, 
psychological treatment and self-harming. 
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Figure (3.1) Conceptual framework of the study. Each concept will be discussed in more details 
below. 
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3.2  Dependent variables:  
There were two dependent variables in the current study which are quality of life and 
PTSD symptoms. 
3.2.1 Quality of life  
As discussed in chapter two ; Quality of life (QOL) is defined as “ an individual’s 
perception of their position in life in the context of the culture and value systems in which 
they live, and in relation to their goals, expectations, standards and concerns, It is a broad-
ranging concept affected in a complex way by the person’s physical health , psychological 
state , level of independence , social relationships , and their relationships to salient 
features of their environment (WHO, 1997a). The CDC has defined Health related quality 
of life (HRQOL) as “an individual’s or group’s perceived physical and mental health over 
time” (CDC, 2012). 
In cancer, QOL has been defined as a personal sense of well-being encompassing a 
multidimensional perspective that generally includes physical, psychological, social, and 
spiritual dimensions or domains (Ferrell et al., 1995). 
Quality of life is assessed in the current study by using the “European Organization for 
Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-
C30). It  incorporates nine multi-item scales: five functional scales (physical, role, 
cognitive, emotional and social Functioning), three symptom scales (fatigue, pain and 
nausea/vomiting) and a global health status (GQOL).  Six single item scales are also 
included (dyspnea, insomnia, appetite Loss, constipation, diarrhea and financial 
Difficulties) (EORTC, 2001). 
 EORTC group provides a scoring manual which includes the operational definitions of all 
domains which include (physical, role, cognitive, emotional and social functioning),  
symptom scales (fatigue, pain and nausea/vomiting) and a global health status (GQOL). 
Definitions of single item scales which are: dyspnea, insomnia, appetite Loss, constipation, 
diarrhea and financial difficulties) are also included in EROTC manual (Aaronson et al., 
1993). 
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Physical function (PF) was  assessed by the following questions in the questionnaire (see 
appendix III ). 
Q1. Do you have any trouble doing strenuous activities,  like carrying a heavy shopping 
bag or a suitcase? 
Q2. Do you have any trouble taking a long walk?  
Q3. Do you have any trouble taking a short walk outside of the house?  
Q4. Do you need to stay in bed or a chair during the day?  
Q5. Do you need help with eating, dressing, washing  yourself or using the toilet? 
Role function (RF) was assessed by the following questions in the questionnaire (see 
appendix III ). 
Q6. Were you limited in doing either your work or other daily activities?   
Q7. Were you limited in pursuing your hobbies or other  leisure time activities? 
Social functioning (SF) was assessed by the following questions in the questionnaire (see 
appendix III ). 
Q26. Has your physical condition or medical treatment  interfered with your family life?  
Q27. Has your physical condition or medical treatment   interfered with your social 
activities? 
Emotional functioning (EF) was assessed by the following questions in the questionnaire 
(see appendix III ). 
Q21. Did you feel tense?  
Q22. Did you worry?  
Q23. Did you feel irritable?  
Q24. Did you feel depressed? 
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Cognitive functioning (CF) was assessed by the following questions in the questionnaire 
(see appendix III ). 
Q20. Have you had difficulty in concentrating on things,  like reading a newspaper or 
watching television? 
Q25. Have you had difficulty remembering things? 
Symptoms scale were assessed by the following questions in the questionnaire (see 
appendix III ). 
Pain  
Q9. Have you had pain? 
Q19. Did pain interfere with your daily activities? 
Fatigue  
Q10. Did you need to rest?  
Q12. Have you felt weak? 
Q18. Were you tired? 
Nausea and vomiting 
Q14. Have you felt nauseated?  
Q15. Have you vomited? 
Dyspnea  
Q8. Were you short of breath? 
Insomnia 
Q11. Have you had trouble sleeping? 
 Loss of appetite 
Q13. Have you lacked appetite? 
 
37 
 
Constipation 
Q16. Have you been constipated? 
 Diarrhea  
Q17. Have you had diarrhea? 
 
Financial impact  was assessed by  the following question in the questionnaire 
Q28. Has your physical condition or medical treatment caused you financial difficulties? 
 
Global Quality of life ( GQOL) was assessed by the following questions in the 
questionnaire (see appendix III ). 
Q29. How would you rate your overall health during the past week? 
Q30.  how would you rate your overall quality of life during the past week? 
 
3.2.2 PTSD symptoms : 
As mentioned previously, PTSD symptoms are the characteristic symptoms following 
exposure to an extreme traumatic stress involving direct personal experience of an event 
that involves actual or threatened death or serious injury, or other threat to one's physical 
integrity; or witnessing an event that involves death, injury, or a threat to the physical 
integrity of another person; or learning about unexpected or violent death, serious harm, or 
threat of death or injury experienced by a family member or other close associate. These 
symptoms include persistent re-experiencing of the traumatic event , persistent avoidance 
of stimuli associated with the trauma and numbing of general responsiveness, and 
persistent symptoms of increased arousal. The full symptom picture must be present for 
more than 1 month (American Psychiatric Association, 2013). 
Psychometric assessment of PTSD provides quantitative assessment of the degree of PTSD 
symptom severity. Psychometric instruments are typically present in a self-administered 
format ( i.e, the participant read the item and record the response  without the intervention 
38 
 
of the interviewer) (Preston John & Terence Martin, 2004).  Judgments about symptom 
severity can be made by comparing an individual ’scores against norms established on 
reference samples of individuals who are known to have or not have PTSD. Cutting scores 
have been established for the psychometric measures of PTSD based on their high 
sensitivity and specificity in discriminating individuals with PTSD from those without 
PTSD. Data from psychometric tests never serve as a “stand alone” means for diagnosing 
PTSD (Watson et al., 2012). The major psychometric instruments are PTSD Checklist 
(PCL) for individuals exposed to both combat and non-combat forms of trauma, and   
Mississippi Scale for Combat-Related PTSD (Watson et al., 2012). 
PTSD symptoms were assessed in the current study based on PTSD Checklist- specific 
version (PCL-S). The purpose of  PTSD Checklist (PCL) is to examine the psychometric 
properties of the 17 individual items of PTSD. Weathers et al. reported data on the 3 
symptom clusters which make up PTSD (Blanchard et al., 1996). These symptoms are : re-
experiencing (e.g., flashbacks, intrusive images and sensory impressions, 
dreams/nightmares); avoidance (e.g., avoiding people, situations, or circumstances 
resembling or associated with the event); and hyper-arousal (e.g., hypervigilance for 
threat, exaggerated startle response, irritability, difficulty concentrating, and sleep 
problems). These symptoms must cause significant distress or life impairment for a 
diagnosis to be made (Friedman, & Blanco, 2011). 
In PCL checklist  questions are categorized as the following (Weathers et al., 1991): (see 
appendix V) 
 Re-experiencing the event which includes the following questions: 
Q1. Repeated, disturbing memories, thoughts, or images of a stressful experience from the 
past? 
Q2.  Repeated, disturbing dreams of a stressful experience from the past? 
Q3. Suddenly acting or feeling as if a stressful experience were happening again (as if you 
were reliving it)? 
Q4. Feeling very upset when something reminded you of a stressful experience from the 
past? 
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Q5. Having physical reactions (e.g., heart pounding, trouble breathing, or sweating) when 
something reminded you of a stressful experience from the past? 
Avoidance/numbing which includes the following questions : 
Q6.  Avoid thinking about or talking about a stressful experience from the past or avoid 
having feelings related to it? 
Q7.  Avoid activities or situations because they remind you of a stressful experience from 
the past? 
Q8.  Trouble remembering important parts of a stressful experience from the past? 
Q9.  Loss of interest in things that you used to enjoy? 
Q10.  Feeling distant or cut off from other people? 
Q11.  Feeling emotionally numb or being unable to have loving feelings for those close to 
you? 
Q12.  Feeling as if your future will somehow be cut short? 
 
Arousal which includes the following questions:: 
Q13. Trouble falling or staying asleep? 
Q14.  Feeling irritable or having angry outbursts? 
Q15.  Having difficulty concentrating? 
Q16.  Being “super alert” or watchful on guard? 
Q17.  Feeling jumpy or easily startled? 
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3.3.  Independent variables : 
In the current study, independent variables included socio-demographic data (such 
as age, marital status, place of residency, educational level and economic status), cancer 
medical history included (type of cancer, cancer treatment and duration since diagnosis) 
and psychological history. 
3.3.1. Socio-demographic variables: 
These variables were presented in section one of the questionnaires . Questions number 1 
to 5 in the questionnaire were designed to assess these variables as the following (see 
appendix I). 
Age: Which is defined as the completed age in years of the enumerated person, which is 
the difference between the date of birth and the date of interview. The exact age is the time 
elapsed between the day of birth and a given day, including parts of a year (PCBS, 2004). 
In the current study  all females with cancer aged 18 and above were recruited ; as this age 
is considered the age for independency in life , were this age group expect to enjoy life and 
start families. In the current study, question number (1) assessed this . 
Marital status: which is defined as the status of those 12 years old and over in terms of 
marriage traditions and laws in the country (PCBS, 2012). Marital status in the current 
study was divided into 4 categories: single, married, divorced and widow.  Question  
number (2) assessed this. 
Educational level: It referred to the highest successfully completed educational attainment 
level, the educational level for persons aged 10 years and over (PCBS, 2012).In this study 
it had 4 categories, and question number (3) assessed this as the following: 
i. Illiterate: 0 education. 
ii.  Primary (1- 6 study years). 
iii. Secondary school (7 – 12 study years). 
iv.  University. 
Place of residency: It refers to the name of the locality in which the person spends most of 
his time during the year (lived there six months and above), irrespective of whether it is the 
person’s same place of existence during the census, or the place in which he works and 
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performs related activates or the place is his original place (PCBS, 2012). In the current 
study, a question number (4) assessed this as village, camp and city. 
Economic status: It defined as cash or in kind revenues for individual or household within 
a period of time; could be a week or a month or a year (PCBS, 2012). In the current study 
economic status was categorized into 4 categories depending on monthly income and 
assessed in question (5) as  :  
i. No income. 
ii. Less than 2000 NIS. 
iii. From 2000-4000 NIS. 
iv.  More than 4000 NIS. 
 
3.3.2. Cancer medical history 
Questions number 6 to 8 in the questionnaire were designed to assess these 
variables including: 
Type of cancer :it assessed  the site where cancer originated. Cancer can start any place in 
the body. It starts when cells grow out of control and crowd out normal cells (American 
Cancer Society,2016). This was assessed in this study in question (6) with open ended 
question about the location of cancer was used to identify the types of cancer for example: 
breast , thyroid , gynecological , lymphomas or other types of cancer. 
Duration science cancer diagnosis: duration of cancer diagnosis is the length of the disease 
reckoned since the occurrence of first signs and symptoms that lead to diagnosis (Walshe, 
1846). It  was assessed in the current study in question (7) which is an open ended 
question. The question was: how long have you been diagnosed with cancer? 
Treatment : as discussed in chapter two, there are many types of cancer treatment, and The 
type of treatment depend on the type of cancer and how advanced it is (Andreoli et al., 
2009). The current study assessed treatments that the participant had undergo from the 
diagnosis to the time of the study through 4 categories where the participant can choose 
different options at the same time in question (8). The categories included: 
i. Chemotherapy.  
ii. Radiotherapy. 
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iii. Surgery. 
iv. Other traditional treatments. 
 
3.3.3. Psychological history  
Psychological status was assessed in last seven questions in section one of the 
questionnaire from question 9 to 15. The questions address the following: 
Question number nine is a yes or no question about if the participant had any  
psychological treatment before cancer diagnosis. The question was: Did you go to 
psychotherapy to treat your psychological problems before cancer diagnosis? Yes / No. 
Question (10) is an open ended question. It assessed the psychological problem that the 
participant had before cancer diagnosis. If  answered yes to question eleven, the question 
was: what is your psychological problem that you had seek psychotherapy for?  
Question number eleven  is also  a yes or no question about if the participant had 
psychological treatment after cancer diagnosis, followed by an open ended question (12) if 
the answer was yes to identify her psychological problem. Question (11) was: Did you go 
to psychotherapy to treat psychological problems  after cancer diagnosis? Yes / No. if she 
answered yes,  question (12) was: what is you psychological problem after diagnosis with 
cancer ?  
The question number thirteen assessed the types of psychological treatment that the 
participant received. Psychological treatment included: different classes of medication 
prescribed by psychiatrists or by psychotherapy sessions or different other treatments 
(Nevid, 2012). In the current study psychological treatment was assessed in 3 categories in 
question (13) which included : medications, psychotherapy sessions, or an open question 
for any other type of treatment . 
The question number fourteen  is a yes or no question that assessed if the participant 
considered harming herself after cancer diagnosis to detect suicidal ideas or attempts. The 
question was: Did you think about harming yourself after being diagnosed with cancer? 
Yes / No.  
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Finally, the question number fifteen was an open ended question that assessed how many 
times the participant considered harming her-self . if answered  yes to question fourteen, 
the question was: how many did times you try to harm yourself? 
 
3.4 . Summary : 
This chapter presented the conceptual framework which was developed based on 
literature review. It defined two major concepts: the dependent variables which are quality 
of life and PTSD symptoms and the independent variables including : socio-demographic 
data (such as age, marital status, place of residency, educational level and economic 
status), cancer medical history (type of cancer, cancer treatment and duration since 
diagnosis) and the psychological history. 
 
The next chapter discussed methodology of the current study. 
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Chapter Four 
ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ 
Methodology 
 
4.1. Introduction 
This study aimed to examine quality of life and PTSD among female patients with cancer 
attending Beit-Jala Governmental Hospital in Bethlehem. To achieve this purpose, a cross 
sectional design was utilized. This chapter presented the methodology that had been used 
in the current study. 
 
4.2. Study design 
Quantitative research is a formal, objective, rigorous, and systematic scientific process for 
gathering information or for investigating quantifiable properties, phenomena and 
relationships. It involves a collection of numerical data where often there is considerable 
control and analysis of data by using statistical procedures  (Burns & Grove, 2011) The 
objective of quantitative research is to develop and employ mathematical models, theories 
and hypotheses, and it is used widely in social science such as psychology, social work, 
sociology, nursing and political science ( Polit & Beck, 2004). 
In the current study, a cross-sectional design was utilized using self-reported 
questionnaires because it is highly useful for descriptive purposes, and it shows both the 
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determining factors and the outcome at the same time. Moreover, it is less expensive and it 
saves time and effort. On the other hand, the cross-sectional design has many limitations: it 
does not lend to generalization of the result, it may not enable researchers to make causal 
inferences, and it is not appropriate for incident estimation especially in the case of long-
lasting outcomes (Burns & Grove, 2011). 
 
4.3. Target population   
Female  patients with cancer aged  18 and above were targeted. Patients were recruited 
from the oncology outpatient clinics and Day Care Unit, in the Beit-Jala Governmental 
Hospital in Bethlehem. 
Inclusion criteria 
 Any female patient with cancer registered in outpatient oncology clinics or Day 
Care Unit of the oncology department in Beit-Jala Governmental Hospital in 
Bethlehem regardless of her cancer type or treatment. 
 Female patient with cancer aged 18 years old and above. 
Exclusion criteria 
 Any patient with severe mental problem such as schizophrenia, mania or severe 
depression because these disorders may affect their ability to fill in the 
questionnaire. 
 Female patients aged below 18 years of old. 
 Patients with less than one month of cancer diagnosis as it is not applicable to 
PTSD diagnosis at this time because  the criteria of PTSD diagnosis in DSM-V  
is eligible if the duration of the event is more than 1 month (American 
Psychiatric Association, 2013). 
 Patients in terminal stages were excluded as these patients are expected to have 
severe medical and psychological condition that affect their ability to fill in the 
questionnaire.  
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4.4. Sample size and sampling approach  
Convenient sample method was  used in the current study. Convenient sampling uses the 
most readily available or most convenient group of people for the sample (Polit & Beck, 
2004). It was chosen  because of the sensitivity of research topic and the health status of 
participants may affect  their participation in the study. Female patients met the inclusion 
criteria  were asked to complete the questionnaire. Data collection was started on April and 
ended on the end of July, 2015. 
There were no formal statistics about the number of female patients with cancer in Beit-
Jala Governmental Hospital in the previous years so we approached  the hospital Statistical 
Unit to get data  manually about the number of females patients with cancer who were 
diagnosed from the years 2013, 2014 to April 2015 in order to calculate the sample size. 
Statistics showed that the number of female patients aged 18 years old and above who 
were diagnosed with a cancer was (266) patients in the year 2013 and  (283) patients in the 
year 2014.  Because they did not have statistical data for the year 2015;  we assumed  that 
the expected number of patients who met the inclusion criteria would be the average of the 
two previous  years  (2013 and 2014).  The total population  for the years 2013, 2014 was  
549 patients. As data collection started on April , 2015 (quarter of the year)  the number of  
total population would be 69 as shown in table (4.1). 
Table (4.1) Number of total population of the current study 
Year Number of female patients with cancer  Total population 
2013 266 patient 266+283= 549 
patient 2014 283 patient 
2015 549/2=274 patient  
April ,2015  274/4 69 patients 
Total population of the study 618 patients 
 
For sample size, 40% of the total population was taken in order to get a large sample size 
which was 253 participants as seen below. 
Sample size = 618 * 0.40 = 253 participants  
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4.5. Setting  
The study was held in  Beit-Jala Governmental Hospital in Bethlehem. It has 65 doctors 
and 135 nurses who served  75 thousand  case in 2014 (MOH, 2016). Beit-Jala 
Governmental Hospital is one of  the main governmental center for cancer treatment in 
Palestine. It is the only governmental hospital in south Palestine were all patients with 
cancer are referred for chemotherapy treatment. The hospital  provides also  diagnostic 
procedures  such as biopsies  and pathological classifications of cancer types and  other 
treatment of cancer including surgery but not radiotherapy (MOH, 2016).  
It has 130 beds, distributed into five specialties (medical , surgical, oncology,  pediatric 
and gynecology). The oncology department provide treatment for patients with cancer 
including inpatient care with the capacity of (20) beds for adults and a special department 
(Huda Al-Masri department) for pediatric cancer with (18) beds capacity. Huda Al-Masri 
department for child hood cancer was established in 2013. It served about 70 childhood 
cancer cases in 2014 where 80% of cases took the whole course of treatment in the same 
department. It has also a day care for chemotherapy treatment for patients with cancer with 
four beds capacity where the patients have regular visits for chemotherapy treatment 
scheduled sessions. The hospital has an out- patient oncology clinics  five days per week 
with different specialists (MOH, 2016). 
 
4.6. Study instrument 
Data was collected by using self-administered  questionnaire.  The questionnaire consisted 
of four sections :  
Section One: Information sheet  
It included questions related to socio-demographic data of the participant (such as age, 
marital status, residence place, education, economic class), cancer medical history which 
included (cancer type, cancer treatment, and onset of cancer diagnosis) and other seven 
questions assessed the psychological history of the participants. 
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Section Tow :  EORTC QLQ-C30 
“ European Organization for Research and Treatment of Cancer (EORTC) Quality of Life 
Questionnaire Core 30 (QLQ-C30)  was used to assess the quality of life of patients with 
cancer in the current study. It is a copyrighted instrument, which has been translated and 
validated into 81 languages and is used in more than 3,000 studies worldwide. QLQ-C30 
Version 3.0 is the most recent version and should be used for all new studies consists of 28 
four-point scale item and two seven-point scale item. It is composed of multi-item scale 
which measures quality of life of patients with cancer using five functional scales 
measuring (physical, role, cognitive , emotional, social functioning), three symptoms scale 
measuring (pain, fatigue, nausea and vomiting), six single items measuring dyspnea, 
insomnia, loss of appetite, constipation, diarrhea and financial impact. 28 four-point scale 
item each may be answered by “not”, “a little”, ‘quite a bit”, or “very much”, with two 
seven pointed scale items measuring global health and perception of respondent QOL 
(EORTC, 2001). 
The scoring algorithm recommended by the EORTC , was used to transform the responses 
to values on a scale of 0 – 100%. For the functional scales and GQOL, a higher score 
corresponds to better functioning and QOL. For symptom scales, a higher score 
corresponds to more frequent and/or more intense symptoms. A problematic group is 
defined as one with a GQOL or functional scale score of 33 or less, and a symptom scale 
score of 66 or more on the QLQ – C30 (Alawadi & Ohaeri, 2009). 
Section Three: PCL-S 
Post Traumatic Disorder Checklist (PCL) measured  Post-traumatic stress disorder (PTSD) 
symptoms in the participants. Three versions of the PCL are available : PCL-C ( civilian), 
PCL-S (specific), PCL-M (military).  
PCL-S is the version used in the current study. The  PCL-S is a widely used self-report 
measure that assesses PTSD symptoms following noncombat-related traumas regarding 
specific event (Weathers et al., 1991). 
 The PTSD Checklist specific version (PCL-S) is a 17-item scale based on the DSM-IV 
criteria. It is a self-administered questionnaire that assesses the full domain of DSM-IV 
PTSD symptoms. It inquires about the three symptom clusters of PTSD: five re-
experiencing symptoms, seven numbing/avoidance symptoms, and five hyper-arousal 
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symptoms. using  ( 1 : not at all, 2 : a little bit, 3 : moderately, 4 : quite a bit, and 5:  
extremely) (Blanchard et al., 1996). 
 PCL  can be scored by adding up all items for a total severity score(Weathers et al., 1991). 
A total symptom severity score (range = 17-85) can be obtained by summing the scores 
from each of the 17 items and the diagnostic cutoff score is 50(Blanchard et al., 1996). 
Also, PTSD severity score was used were a score of  (1-18) means no PTSD, (19-34) 
means mild, (35-52) means moderate, and (53-85) means severe PTSD (Weathers et 
al,1993). These methods were  utilized to assess PTSD in the current study. 
 
4.7. Reliability and validity of the instrument 
Reliability refers to the stability or consistency of information that is obtained when a 
measurement is performed more than once. It also can be defined as the degree to which an 
instrument yields the same data each time it used under the same conditions and with the 
same subjects (Polgar, 1997).There are different types of Reliability including: 
Test-retest reliability which is a measure of reliability obtained by administering the same 
test twice over a period of time to a group of individuals.  The scores from Time 1 and 
Time 2 can then be correlated in order to evaluate the test for stability over time. Inter-
rater reliability is also a measure of reliability used to assess the degree to which different 
judges or raters agree in their assessment decisions, and Internal consistency 
reliability which measures reliability by evaluating the degree to which different test items 
that probe the same construct produce similar results (Cozby, 2001). 
For the purpose of the current study internal consistency reliability was used by measuring 
cronbach’s alpha coefficient. Cronbach’s alpha coefficient  is one of the most common 
means of estimating internal consistency of items in a scale by measuring the correlation 
between grouped questions in a scale related to specific concept. Commonly , an alpha 
level of 0.7 or higher indicate acceptable reliability , and 0.8 or higher indicates good 
reliability , whereas alpha level higher than 0.95 very high reliability but it is not 
necessarily desirable (Rubin & Bobbie, 2010). Cronbach alpha in the current study was 
88.6 which indicates good reliability.  
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Validity refers to the adequacy with which the method of measurement is able to measure 
the issues or phenomena under study (Abramson, 1999). Cook and Campbell (1979) 
defined validity as the best available approximation to the truth or falsity of given 
inference, proposition or conclusion. Validity is one of the main concerns with research. 
"Any research can be affected by different kinds of factors which, while extraneous to the 
concerns of the research, can invalidate the findings" (Seliger et al., 1989).  
An instrument content validity is necessarily based on judgment. It is becoming 
increasingly common to use the panel of substantive experts to evaluate and document the 
content validity of the new instruments (Polit& Beck, 2004). Content validity of the 
questionnaires in the current study was examined by a committee of four of professionals ; 
three experts in mental health and public health who hold doctoral degree (PhDs) from Al-
Quds University and one psychologist from Dr.Kamal mental health hospital. Only one 
specialist suggests some changes in the information sheet by including the word 
"diagnosis" in the questions that assessed cancer medical history. No other changes were 
requested by them. 
 
4.8. Data collection process  
After sending a formal letter to the Palestinian Ministry of Health explaining the purpose 
of the study, permission was granted on March, 2015. 
The researcher is working as a medical doctor in the governmental primary health care 
centers in Bethlehem. She was not able to collect data by herself so she  trained a field 
worker to collect data. A female field worker who had B.A degree in medical laboratory 
sciences and had an experience in research. She worked with  patients with cancer in Beit-
Jala Governmental Hospital and she volunteered to work in the Blood Bank Unit several 
months before the study. The training included discussing the purpose of the study, the 
items of the questionnaire, the inclusion and the exclusion criteria of the study and ethical 
considerations. 
Self-reported questionnaires were distributed to the female patients with cancer who were 
waiting in the oncology out-patient clinic or  taking chemotherapy in the day care unit.  
253 patients agreed to participate in the study,  and the field worker filled in 103  
questionnaires because these participants did not know  how to read or write while the 
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others were filled in by the participants themselves (150  questionnaires) . The data 
collection took four months from April, 2015  to end of July, 2015. 
Each participant was asked for her willingness to participate in the study. Forty-five 
females patients with cancer refused to fill in the questionnaire  after the explanation of the 
study purpose to them during data collection period. 
Data collection was stopped after recruiting the sample size of 253 participants. 
 
4.9.  Data Analysis : 
Statistical package for social science (SPSS)  version 20 was used for data analysis. The 
data were checked for the entry errors (data clearance). Characteristics of the sample 
obtained through descriptive analysis (frequencies and means). The relation between socio-
demographic variables, cancer type and treatment and both QOL and PTSD was done by 
using one-way ANOVA, t-test, Tukey HSD test and chi-square tests. Correlation was used 
to measure the association between symptoms and QOL and regression analysis was  used 
to measure the association between QOL and PTSD. 
 
4.10. Ethical considerations 
Approval from Palestinian Ministry of Health was obtained after being formally 
approached. Information about the purpose of the study and the questionnaire were 
presented in  a formal letter from Al-Quds University to the Palestinian Ministry of Health. 
Also, School of Public Health at Al-Quds University approved  to conduct this study 
according to the thesis preparation guide of the Faculty of Postgraduate Studies. 
Participants were provided with the information sheet about the study including the aim of 
the study; objectives, and they were informed that they had the rights to refuse to 
participate in the study. Verbal consent was considered as the participant agreed to fulfill 
in the questionnaire.  
Confidentiality and privacy were assured for all the participants and they were informed 
that all the information would be kept strictly confidential. In addition, data was protected 
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and appropriately stored; all files were stored on computer and were protected by a 
password and nobody was allowed to access it except the researcher and the supervisor. No 
names or codes or any other mechanisms were used to trace responses back to an 
individual participant. 
 
4.11 Summary 
This study utilized a cross sectional study design to assess the quality of life and 
PTSD among females patients with cancer attending Beit-Jala Governmental Hospital in 
Bethlehem. The data tools used were self-reported questionnaires including socio-
demographic self-report questionnaire, EORTC QLQ-C30 questionnaire , PTSD Checklist 
– Specific (PCL-S). The validity of the questionnaires was assessed by committee of four 
of professionals ; one mental health specialist, two public health experts from Al-Quds 
University and one psychologist from “Dr.Kamal” Governmental Mental Health Hospital.  
A sample size of 253 participants  participated in the study with convenient sampling 
method. 
  Different ethical issues including consent forms and confidentiality were discussed 
in this chapter. The next chapter presented  the results of the current study. 
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Chapter  Five 
ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ 
Results 
 
5.1. Introduction 
As mentioned in previous chapter, a cross sectional study was utilized. A sample of 253 
female patients with cancer aged 18 and above in Beit-Jala Governmental hospital was 
obtained. Data was collected by: EROTC QLQ-C30 for quality of life and PCL-S  for 
PTSD. 
This chapter presented the findings of the current study as the following: 
 Section one:  Description of the characteristics of the participants and cancer 
medical history and psychological history. 
 Section two:  The results of EROTC QLQ-C30 and PCL-S scales. 
 Section Three: The relationship between dependent and independent variables. 
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5.2. Section one: The characteristics of the participants,  cancer medical 
history and psychological history: 
From 253 female patients with cancer aged 18 and above,19.4%(n=49) were 20 to below 
40 years old, 24.5% (n=62) were 40 to below 50 years old, 26.1% (n=66) were 50 to below 
60 years  old and 30%  (n=76) were 60 years old and over. The mean age of the participant 
was 52.6 years with minimum age of 20 years and maximum age of 81 years  old as seen 
in table (5.1). 
For the marital status, the majority of the participants were married (77.9%, n=197), while 
only  6.7% (n=17) were single, 15.4% (n=39) were widows and none of them was 
divorced. Considering the educational level of the participants; 40.7% (n=103) were  
illiterate, 21.7% (n=55) had only primary education, 24.9% (n=63) had secondary 
education and 12.6% (n=32) had university level (see table 5.1). 
64.8% (n=164) of the participants were from Hebron, while 31.6% (n=80) were from 
Bethlehem, 3.1% (n=8) were from Ramallah, and 0.4% (n=1) was from Jerusalem. 
Furthermore, 58.5% (n=148) of the participants lived in a village, 37.5% (n=95) were from 
a city and 4% (n=10) were from the refugee camps as shown in table (5.1). Meanwhile, 
regarding the economic status of the participants, 64% (n=162) had a monthly income of 
less than 2000 NIS and 36% (n=91) had a monthly income of more than 2000 NIS (see 
table 5.1). 
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Table (5.1) Distribution of the participants according to socio-demographic characteristics. 
 Frequency  Percentage  
Age* group 18 – below 40 years old 49 19.4% 
40  - below 50 years old 62 24.5% 
50 - below 60 years  old 66 26.1% 
60 years and over 
 
76 30 % 
 
Marital status 
Single  17 6.7% 
Married 197 77.9% 
Widow  39 15.4% 
 
 
Educational level 
Illiterate  103 40.7% 
Primary  55 21.7% 
Secondary  63 24.9% 
University  32 12.6% 
 
 
Governorate 
Hebron  164 64.8% 
Bethlehem  80 31.6% 
Ramallah  8 3.1% 
Jerusalem  1 0.4% 
 
 
Place  of  residence 
City  95 37.5% 
Village  148 58.5% 
Camp  10 4% 
 
 
Monthly income 
Less than 2000 NIS 162 64% 
2000-4000 NIS 91 36% 
 
More than 4000 0 0% 
*Mean age=52.6    Min.= 20   Max.=81 
 
Further, three questions related to participants' medical history were examined as seen in 
table (5.2). For example, the participants were asked about the type of cancer they has and 
their responses  were categorized  into two groups:  breast cancer and other cancer types 
(such as colon, stomach, bone , endometrium, liver, biliary, thyroid, ovarian, leukemia and 
lymphoma). The results showed that 85% (n=215) of the participants had breast cancer and 
15% (n=38) had other cancer types (such as colon, stomach, bone , endometrium, liver, 
biliary, thyroid, ovarian, leukemia and lymphoma). 
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Table (5.2) Distribution of the participants according to cancer types. 
Cancer site  Frequency  Percentage  
Breast cancer  215 85% 
Other cancer types 38 15% 
Total  253 100% 
 
Also, the onset since cancer diagnosis was classified into four groups; those who were 
diagnosed with cancer for less than 6 months, those who were diagnosed with cancer from 
6 months to less than one year, those who were diagnosed with cancer for one year to less 
than 2 years, and those who were ill for more than 2 years. Findings showed that 32% 
(n=81) of the participants reported that their duration of illness was less than 6 months, 
37.2%  (n=94) reported from 6 months to less than one year, 25.3% (n=64) reported from 
one year to less than 2 years, and 5.5% (n=14) stated more than 2 years (see table 5.3). 
 
Table (5.3) Distribution of the participants according to the onset of cancer diagnosis. 
Onset of diagnosis Frequency  Percentage  
Less than 6 months  81 32% 
6 months – less than 12 months  94 37.2% 
12 months – less than 24 months  64 25.3% 
24 months and above  14 5.5% 
Total  253 100% 
 
Regarding cancer treatment, 73.9% (n=187) of the participants reported receiving a 
combined treatment  of chemotherapy and surgical therapy in their treatment , while 22.1% 
(n=56) were treated with only chemotherapy and 4% (n=10) of the participants were 
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treated with other treatment modalities such as combinations of chemotherapy, surgical 
and radiotherapy as shown in table (5.4). 
 
Table (5.4) The frequencies and percentages of cancer treatment in the study participants. 
Cancer treatment  
 
Frequency Percentage  
Chemotherapy 56 22.1% 
Chemotherapy & 
surgical  
187 73.9% 
Other treatment 
modalities 
10 4% 
 
Finally, seven questions assessed the psychological history of the participants. For 
example, the participants were asked if they suffered from any psychological problems 
before or after their cancer diagnosis, what was that problem, what type of psychological 
treatment they had, and if the participant considered to harm herself after she had been 
diagnosed with cancer. There answers were negative for all the questions as none of the 
participants reported having any psychological problems before or after cancer diagnosis, 
and also none of them reported thinking about harming themselves after being diagnosed 
with cancer. 
 
5.3. Section two:  The results of EROTC QLQ-C30 and PCL-S. 
This section consisted of two parts: 
Part one: Quality of life related questions finding. 
Part two: PTSD related questions findings. 
5.3.1 Part one: Quality of life related questions finding. 
This part presented the descriptive statistics of quality of life, the means  QOL domains 
and the 33% cut off point of QOL domains findings. 
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Thirty questions were used to assess quality of life of female patients with cancer aged 18 
years old and above. Frequency  and percentages of the participants response are shown in 
table (5.5). In general, findings showed that participants’ responses varied between “not at 
all” and “a little” for most of the questions. The first three questions were the only 
questions that most of the participants responses were “quite a bit ” and “very much” . 
For example, the physical function of the participants was assessed in the  first five 
questions. The first three of them resulted in high percentages of responses as “quite a bit” 
and “very much”. The participants were asked if they had any trouble doing strenuous 
activities, like carrying a heavy shopping bag or a suitcase, 55.3% (n=140) answered “very 
much”, and 24.9% (n=63) answered “quite a bit”. The, second question assessed if 
participants had any trouble taking a long walk and 48.6% (n=123) answered “very much”, 
and 28.1% (n=71) answered “quite a bit”. Also, the third question assessed if the 
participant had  any trouble taking a short walk outside of the house and 32.8% (n=83) of 
the participants answered “very much”, and 27.3% (n=69) answered “quite a bit”. 
For the role function, the participants were asked if they had a limitation in doing either 
their work or other daily activities and if they had a limitation in pursuing their  hobbies or 
other leisure time activities during the past week  (questions six & seven respectively). 
32.8% (n=83) and 33.5 (n=85) of the participants answered “not at all” to question six and 
seven respectively, and 35.6% (n=90) answered “a little” to question six and seven 
respectively. 
Moreover, the cognitive function of the participants was assessed in questions number 
twenty and twenty five. The participants were asked if they had difficulty in concentrating 
on things, like reading a newspaper or watching television and  53% (n=134) answered 
“not at all” and when they were asked if they  had difficulty in remembering things, the 
majority (62.8%,n=159) answered “not at all”. 
In addition, the emotional functioning was assessed by four questions (question number 
twenty one to question number twenty four). Most of their  answers were  not at all. For 
example when the participants were asked if they felt tense in the past week, 55.7% 
(n=141) answered “not at all”, when they were asked if they were worried, 56.1% (n=142)  
answered “not at all”, when they were asked if they felt irritable in the past week, 46.2% 
(n=117) answered “not at all”, and when they were asked if they felt depressed in the past 
week, 67.2% (n=170) also answered “not at all”. 
59 
 
Furthermore, the social function was assessed by questions number twenty six and twenty 
seven and 76.7% (n=194) of the participants answered “not at all” when they were asked if 
their physical condition or medical treatment interfered with your family life (question 
number twenty six) whereas 74.7% (n=189) of the participants answered “not at all” when 
asked if their physical condition or medical treatment interfered with their social activities 
(question number twenty seven). 
Regarding symptoms, 50.2% (n=127) of the participants answered that did not have pain 
“at all” in the past week ,while 34% (n=86) answered that they need to rest “quite a bit” 
and 14.2% (n=36) reported that they needed rest “very much” . On the other hand,43.5% 
(n=110) of the participants answered “not at all” when asked if they had trouble sleeping in 
the past week, while 20.9% (n=53) answered “very much”.  
Also, the financial impact of cancer was assessed in question number twenty eight. The 
participants were asked their physical condition or medical treatment caused them financial 
difficulties and 52.6% (n=133) answered “not at all”, 26.5% (n=67) answered a little, 
13.8% (n=35) answered quite a bit and 7.1% (n=18) answered very much. 
Finally, the last two questions assessed the participants rating overall health and quality of 
life. The rating score was between one (indicating very poor condition) and seven 
(indicating excellent condition). The majority of the participants rated their QOL and 
overall health on score 4 and above which indicated good condition in general. For 
example, table (5.7) showed that 32.8% (n=83) of the participants rated their overall health 
in the past week as 4, and 33.2% (n=84) rated their overall quality of life in the past week 
as 4. However,  only 0.8% (n=2) rated the two questions as very poor, and 1.6% (n=4) 
rated them as “excellent”. 
In addition, participants’ responses were checked to assess which questions of QOL 
questionnaires had 60% or more of the participant’s responses  “quite a bit” or “very 
much” and the results revealed only three questions which were the first three questions 
(question number 1,2 and 3) that assessed the physical function of the participants. All  
other (23) questions had more than 60% of the responses in “not at all” and “a little” 
answers. For example, q12 (felt weak), 67.2% of the participants responded to it as “not at 
all” and “a little” they felt weak in the past week ,q13 (lacked appetite) 78.6% of the 
participants responded as “not at all” and “a little” they lacked appetite in the past week, 
q14 (felt nauseated)  86.9% of the participants responded as “not at all” and “a little” they 
60 
 
felt nauseated in the past week, q15. (vomited) as 94.9% of the participants responded as 
“not at all” and “a little” they vomited in the past week, q16.(had been constipated) as 
75.9% of the participants responded as “not at all” and “a little” of being constipated in the 
past week, q17( had diarrhea?) as 94.8% of the participants responded as “not at all” and “a 
little” had diarrhea in the past week, q18. (were tired) as 75.5% of the participants 
responded  “not at all” and “a little” being tired in the past week as seen in table (5.5). 
 
Table (5.5) The participants' answers to the questions related to their quality of life 
(EROTC QLQ-C30). 
Question  Percentage 
 Not at 
All  
A 
Little 
Quite a 
Bit 
Very 
Much  
1. Do you have any trouble doing strenuous activities, like 
carrying a heavy shopping bag or a suitcase? 
7.9% 11.9% 24.9% 55.3% 
2. Do you have any trouble taking a long walk? 12.3% 11.1% 28.1% 48.6% 
3. Do you have any trouble taking a short walk outside of 
the house? 
23.3% 16.6% 27.3% 32.8% 
4. Do you need to stay in bed or a chair during the day? 21.7% 39.9% 29.2% 9.1% 
5. Do you need help with eating, dressing, washing yourself 
or using the toilet? 
77.1% 12.3% 7.9% 2.8% 
During the past week:     
6. Were you limited in doing either your work or other daily 
activities? 
32.8% 35.6% 22.5% 9.1% 
7. Were you limited in pursuing your hobbies or other 
leisure time activities? 
33.5% 35.6% 21.7% 9.1% 
8. Were you short of breath? 53% 30.4% 7.9% 8.7% 
9. Have you had pain? 50.2% 34.8% 11.1% 4% 
10. Did you need to rest? 10.7% 41.1% 34% 14.2% 
11. Have you had trouble sleeping? 43.5% 21.7% 13.8% 20.9% 
12. Have you felt weak? 47.8% 30.8% 17.8% 3.6% 
13. Have you lacked appetite 41.5% 25.7% 17.8% 15% 
14. Have you felt nauseated? 56.1% 30.8% 8.3% 4.7% 
15. Have you vomited? 77.9% 17% 3.6% 1.6% 
16. Have you been constipated 55.3% 20.6% 11.9% 12.3% 
17. Have you had diarrhea? 73.1% 21.7% 4% 1.2% 
18. Were you tired? 30% 45.5% 17.4% 7.1% 
19. Did pain interfere with your daily activities? 39.5% 31.2% 24.5% 4.7% 
20. Have you had difficulty in concentrating on things, like 
reading a newspaper or watching television? 
53% 20.9% 18.2% 7.9% 
 
Continued  
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Table (5.5) continued  
 
21. Did you feel tense? 55.7% 27.3% 11.5% 5.5% 
22. Did you worry? 56.1% 27.7% 10.7% 5.5% 
23. Did you feel irritable? 46.2% 33.2% 11.1% 9.5% 
24. Did you feel depressed 67.2% 21.7% 5.1% 5.9% 
25. Have you had difficulty remembering things? 62.8% 26.5% 5.5% 5.1% 
26. Has your physical condition or medical treatment 
interfered with your family life? 
76.7% 14.2% 5.9% 3.2% 
27. Has your physical condition or medical treatment 
interfered with your social activities? 
74.7% 15.4% 6.7% 3.2% 
28. Has your physical condition or medical treatment caused 
you financial difficulties? 
52.6% 26.5% 13.8% 7.1% 
 
 Means of EORTC QOL domains 
As mentioned in chapter three, the scoring algorithm recommended by the EORTC was 
used to transform the responses to values on a scale of 0 – 100% using  a formula for every 
domain available in EORTC manual. The principle for scoring is to estimate the average of 
the items that contribute to the scale and use a linear transformation to standardize the  
score, so that scores range from 0 to 100. For the functional scales and GQOL, a higher 
score corresponds to better functioning and QOL. For symptom scales, a higher score 
corresponds to more frequent and/or more intense symptoms. The results showed that the 
mean for GQOL for the participants was 57.4 (SD=18.9) indicating average global quality 
of life and the mean of  physical functioning (PF) was 48.5 (SD=26.30) indicating lower 
than average physical functioning. On the other hand, the mean for role functioning was 
64.3 (SD=31.7), the mean for emotional functioning was 77.8 (SD=27), the mean for 
cognitive functioning was 77 (SD=25.7) and the mean of social functioning was 87.7 
(SD=24.6) indicating higher than average social functioning than all other  domains as seen 
in table (5.6). 
 Percentage 
 1 
Very 
poor  
2 3 4 5 6 7 
Excellent  
29. How would you rate your 
overall health during the past 
week? 
0.8% 3.6% 14.6% 32.8% 29.6% 17% 1.6% 
30. How would you rate your 
overall quality of life during the 
past week? 
0.8% 3.6% 14.2% 33.2% 29.6% 17% 1.6% 
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Table (5.6) Means and standard deviations for GQOL and Functions domains in QOL 
questionnaire : 
 N Mean* Std. Deviation 
Global quality of life (GQOL) 253 57.4 18.9 
Physical functioning (PF) 253 48.5 26.3 
Role functioning (RF) 253 64.3 31.7 
Emotional functioning (EF) 253 77.8 27 
Cognitive functioning (CF) 253 77 25.7 
Social functioning (SF) 253 87.7 24.6 
*Higher means indicates better GQOL and functioning 
As mentioned previously,  a higher score in symptomatic scale represents a high level of 
symptomatology/problem and indicated that insomnia, fatigue and loss of appetite were the 
most troublesome symptoms the participants complained of. Pain, constipation and 
dyspnea came next in participants symptoms responses and nausea and vomiting were the 
least in QOL questionnaire as seen in table (5.7). For example, for fatigue, the mean was 
36.7 (SD=26.3), for nausea and vomiting (NV) it was 15.1 (SD=22.5) and for pain (PA) it 
was 27.2 (SD=26). Moreover, the results showed that dyspnea (DY) had a mean of 24.1 
(SD=31.3), and  insomnia had a mean of 37.4 (SD=39.5). For loss of appetite (AP), the 
mean was 35.4 (SD=36.4), for constipation it was 27 (SD=35.4) and for diarrhea the mean 
was 11.5 with (SD=23).  
Also , the mean of financial impact of cancer on QOL of the participants was (25.2) with a 
standard deviation of (31.5) as seen in table (5.7). 
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Table (5.7) Means and standard deviations for responses of participants to the symptoms 
scales and the single items  affecting QOL of the participants 
 N Mean* Std. Deviation 
Fatigue (FA) 253 36.7 26.3 
Nausea and Vomiting(NV) 253 15.1 22.5 
Pain (PA) 253 27.2 26 
Dyspnea (DY) 253 24.1 31.3 
Insomnia (SL) 253 37.4 39.5 
Loss of appetite  (AP) 253 35.4 36.4 
Constipation (CO) 253 27 35.4 
Diarrhea (DI) 253 11.5 23 
Financial Difficulties (FI) 253 25.2 31.5 
*Higher mean represent higher symptom severity and worse financial difficulties. 
Furthermore, 33% cut-off scale score was used to categorize the participants responses,  
because this score was suggested from different studies for better understanding of QOL 
means generated from EROTC questionnaire (Alawadi & Ohaeri, 2009; Fayers, 2001; 
Khleif & Imam, 2013). For the functional scales and the GQOL, we defined subjects with 
problematic functioning as those who scored  <33%, while subjects in good condition 
scored >66%. For symptom scales, subjects scoring <33% were judged as having less 
severe symptoms, while those scoring > 66% had more intense symptoms (Alawadi& 
Ohaeri, 2009). 
The 33% cut off point classification for the physical function showed that 29.64% of the 
participants had severe problem in physical functioning corresponding to mean of (<33%), 
39.5% were moderately affected by cancer physically (33% to 66%) and 30.83% were 
having a good physical functioning as shown figure (5.1). 
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Figure (5.1) 33% cut of point of physical domain scores. 
Regarding the role functioning, About 67.9% had a good role  functioning based on the 
33% cut off point classification (>66%) and 22.9% had moderate effect of cancer on their 
role functioning (33% to 66%), while only 9.09% had severe problem in life roles after 
cancer diagnosis (see figure 5.2). 
 
 
 
 
 
 
 
 
Figure (5.2) 33% cut of point of role domain scores. 
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In the meanwhile, 80.63% of the participants had a good emotional  functioning (>66%) 
and only 6.7% had severe effect for cancer on their emotional functioning (<33%)(see 
figure 5.3). 
 
 
 
 
 
 
Figure (5.3) 33% cut of point of emotional domain scores. 
 
Also, 73.9% of the study participants had a good cognitive functioning (>66%) and about 
21.7%  had moderate effect of cancer on their cognitive functioning (33% to 66%) while 
only 4.35% had severe effect of cancer on their cognitive functioning (see figure 5.4). 
 
 
 
 
 
 
 
Figure (5.4) 33% cut of point of cognitive domain means 
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Regarding the social functioning, the majority of the study participants (90.1%) had good 
social functioning on 33% cut off point classification (>66%) and 6.7% had moderate 
social functioning, while the minority (3.1%) had below the 33% cut off value representing 
severe social functioning problem (see figure 5.5). 
 
 
 
 
 
 
Figure (5.5) 33% cut of point of social domain scores. 
 
Furthermore, 5.1% of the participants reported having severe effect of cancer on their 
global quality of life corresponding to (<33%) score and 47.4% had moderate effect of  
cancer on their global QOL (33% to 66%) while 47.4% reported having mild effect of 
cancer on their overall quality of life (see figure 5.6). 
 
 
 
 
 
 
Figure (5.6) 33% cut of point of GQOL domain scores. 
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For the symptoms scale of QOL, the 33% cut off point classification results of pain showed 
that 11.46% of the  participants had severe pain corresponding to (>66%) cut off point and 
35.18% had moderate level of pain corresponding to (33% to 66%), while 53.36% reported 
no pain in the past week as shown in figure (5.7).  
 
 
 
 
 
 
 
 
Figure (5.7) 33% cut of point of pain. 
 
Only 5.14% of the participants reported having severe nausea and vomiting (>66%) and 
about 18.97% had moderate level of nausea and vomiting (33% to 66%) while 75.89% 
reported no nausea and vomiting in the past week (see figure 5.8). 
 
 
 
 
 
 
 
 
Figure (5.8) 33% cut of point of nausea & vomiting. 
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Also, 20.5% of the participants reported having severe fatigue corresponding to (>66%) 
score and 35.1% had moderate level of fatigue corresponding to (33% to 66%) score and 
20.55% reported having severe fatigue (<33%)  based on the 33% cut off point 
classification (see figure 5.9).  
 
 
 
 
 
 
 
 
Figure (5.9) 33% cut of point off classifications for fatigue. 
In addition, 34.7% of the participants reported having severe insomnia corresponding to 
(>66%) score while 43.87% reported no insomnia  in the past week as shown in figure 
(5.10). 
 
 
 
 
 
 
 
Figure (5.10) 33% cut of point off classifications for insomnia. 
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Moreover, 16.6% of the participants reported having severe dyspnea corresponding to 
(>66%) score while  53.36% reported no dyspnea in the past week respectively (see figure 
5.11). 
 
 
 
 
 
 
 
Figure (5.11) 33% cut of point off classifications for dyspnea. 
 
Furthermore, only 5.1% of the participants reported having severe diarrhea and 73.9% 
reported having mild diarrhea in the past week (see figure 5.12). 
 
 
 
 
 
 
 
 
 
Figure (5.12) 33% cut of point off classifications for diarrhea. 
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On the other hand, 24.1% of the participants reported having  severe constipation 
corresponding to (>66%) score and about 54.9% reported mild constipation in the past 
week as shown in figure (5.13). 
 
 
 
 
 
 
 
Figure (5.13) 33% cut of point off classifications for constipation. 
 
For loss of appetite,  32.8% of the participants reported having severe loss of appetite 
corresponding to (>66%) score while  41.1% of the participants reported having mild effect 
of  cancer  on their appetite (see figure 5.14). 
 
 
 
 
 
 
 
 
Figure (5.14) 33% cut of point off classifications for appetite loss. 
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Finally, the results for  33% score cut off point for financial difficulties showed that 20.5% 
of the participants had severe financial difficulty after cancer diagnosis corresponding to 
(>66%) score, where about 26.5%  have moderate financial difficulties after cancer 
diagnosis (33% to 66%) and  53% of the participants reported mild financial difficulties 
after cancer diagnosis corresponding to <33% score as shown in figure (5.15).  
 
 
 
 
 
 
 
Figure (5.15) 33% cut of point off classifications for financial difficulties. 
 
5.3.2 Part two: Post traumatic stress disorder checklist  (PCL-S) 
PTSD was assessed by using  post-traumatic stress disorder checklist –specific version 
(PCL-S) which includes 17 items. The  scores of PTSD were classified into 4 categories: 
No PTSD, mild, moderate, and severe according to total symptoms severity 
score(Weathers et al., 1991). Frequency and percentage were used to assess the levels of 
PTSD among the participants. Clinically  significant symptoms of PTSD is considered 
when PCL-S score is 50 and above (Blanchard et al., 1996). The results showed that the 
prevalence of PTSD symptoms among the participants based on using 50 cut- off was 3% 
(n=8) (see table 5.8). 
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Table (5.8) Prevalence of clinical PTSD symptoms using 50 cut off point. 
 
PTSD 
 
Frequency  
 
Percentage  
No PTSD diagnostic symptoms 248 97% 
PTSD diagnostic symptoms 8 3% 
Total  253 100% 
 
Also, based on the PTSD severity score according to Weathers et al. (1991). The results 
showed that  2% (n=5) of the participants had severe PTSD score, 23.3% (n=59) had 
moderate score and 68.8% (n=174) had mild score. PTSD was absent  only in 5.9% (n=15) 
of the study participants (see table 5.10)  
Table (5.9) Severity of PTSD symptoms 
 
Severity  
 
PCL-S score 
 
Frequency  
 
Percentage  
No PTSD  (17-18) 15 5.9% 
Mild   (19-34) 174 68.8% 
Moderate  (35-52) 59 23.3% 
Severe  (53-85) 5 2% 
Total  253 100% 
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5.4 Section Three: The relationship between dependent and independent 
variables. 
This section consists of three parts : 
Part one: the relationship between QOL and independent variables. 
Part two: the relationship between PTSD and independent variables. 
Part three: the relationship between QOL and PTSD 
5.4.1 Part one: the relationship between QOL and independent variables. 
This section represented the relationship between the quality of life, and 
independent variables including: socio-demographic data, cancer medical history by 
using one-way ANOVA, t-tests and tukeys’ test. Tukeys’ test was used when a 
significant difference in three or more means were obtained by ANOVA test for 
additional exploration of the differences among means. 
Table (5.10) showed the relationship between the major components of QOL 
questionnaire such as PF, RF and SF functioning and the independent variables 
including age, , place of residency, educational level, economic status, marital status 
,number of family members caregiver, type of cancer, cancer treatment and duration 
since diagnosis). The relationship between PF, RF and SF functioning and age 
groups showed that there were significant differences between age and PF at a p 
value of (p<0.001), RF at a p value of (p=0.01) and SF with a p value of (p=0.03) . 
The mean difference in PF were between groups (20 - <40 years old) with the mean 
of 61.36, (40 -<50 years) age group with a mean of 56.77, (50 - <60  years) age 
group with a mean of 43.74 and (>=60 years) age group with a mean of 
37.63.Tukey comparison test showed that the difference were in the favor of 
younger age groups as seen in table (1) in appendix (VI), which indicated that 
younger patients with cancer had better physical function. In relation to role 
function, the difference were between the age group (40 - <50 years) with a mean of 
74.19 and (>=60 years) age group with a mean of 55.04. Tukey Comparison tests 
showed that the difference was also in the favor of the younger age group as seen in 
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table (1) in appendix (VI), which indicated that the younger the patient with cancer, 
the better role functioning they had. However, Tukey Comparison tests showed that 
the mean difference regarding social functioning was in the favor of the older age 
group as seen in table (1) in appendix (VI), which indicated that the older the 
patient with cancer is the better social function they had.  
Regarding the relationship between educational level and PF, RF and SF functions, 
one way ANOVA test showed that there were significant differences at (p<0.001) 
level between the means of PF components attributed to the educational level  of the 
participants. The mean difference was between illiterate group (mean= 40.78), 
secondary education group with a (mean=53.02) and university educational level 
group with a (mean=63.13) as seen in table (5.10). Tukey Comparison test showed 
that university education group had better PF than secondary and illiterate groups 
which indicated that the higher the educational level of the female patient with 
cancer, the better her physical function (see table (3) in appendix VI) 
In addition, t-test was used to assess the relationship between economic status and 
PF, RF and SF as shown in table (5.10).There was a significant difference between 
the means of PF (p<0.001) and SF (p<0.01) components attributed to economic 
status of the participants. For PF, the difference was in favor of the group that have 
income between (2000-4000 NIS) with a mean of 57 corresponding to the group 
(<2000 NIS) with a mean of 43.74. This  indicated that the higher the economic 
status of the participant, the better physical function they had. For SF, the 
differences were in favor of the group (<2000 NIS) with a mean of 90.84 than the 
group (2000-4000 NIS) with a mean of  82.05, indicating that the lower the 
economic level of patients with cancer the better social function they had (see table 
5.10). 
Moreover, table (5.10) indicated that there were significant differences between 
marital status in relation to PF with a p value (p<0.02) and RF  with a p value 
(p<0.01) by using one way ANOVA test. The differences were between single 
group (mean=52.16), married (mean=52.16) and widows (mean=37.78). Tukey 
comparison tests results showed that differences were between married and widows 
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in favor of married group at a p value (p=0.017) as seen in table (2) in appendix 
(VI). This means that married female patients with cancer had better physical 
function than widows female patients with cancer. Regarding RF, the differences 
were between  married (mean=67.6) than singles (mean=48.04) and Widows 
(mean=54.7). Tukey Comparison tests showed that the differences were the in favor 
of married than widows and single groups. This  indicated that married female 
patients with cancer had better role function than widows and single female patients 
with cancer (see table (2) in appendix VI). 
Further,  t-test was used to assess the relationship between PF, RF and SF 
components attributed to cancer type, and the results showed that there were 
significant difference between the means of PF at a p-value of (p<0.001), RF at a p-
value of (p<0.001) and SF at a p-value (p=0.01) attributed to cancer type. For PF, 
the differences were in favor of  breast cancer corresponding to the other type of 
cancer. Also, the differences were in favor of the breast cancer corresponding to the 
other type of cancer in relation to RF and SF as seen in table (5.10). The results 
indicated that patients with breast cancer had better physical function,  role 
functioning, and social  functioning than other types of cancer (such as colon, 
stomach, bone , endometrium, liver, biliary, thyroid, ovarian, leukemia and 
lymphoma). 
Finally, the results of ANOVA test showed that there were significant differences 
between the mean of RF components attributed to cancer treatment at p value 
(p=0.05). The differences were between chemotherapy & surgery group 
(mean=48.95), chemotherapy group (mean=49.4) and other treatment modalities 
group (mean=35.33) as seen in table (5.10). Tukey Comparison tests showed that 
the significant differences was between chemotherapy & surgery group and other 
treatment modalities group at (p=0.036) in favor of chemotherapy & surgery group 
as seen in  table (5) in appendix (VI). This indicated that female patient with cancer 
who underwent chemotherapy and surgery as a treatment for their cancer had better 
role function than female patient who took other treatment modalities (such as 
combinations of chemotherapy, surgical and radiotherapy). 
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Table (5.10): Relationships between the quality of life domains (physical, role, social 
functions) and socio-demographic &cancer medical history (ANOVA & t-test) 
Variables  
Physical Function 
 
Role Function 
Social Function 
Mean F/T 
P-
value 
Mean F/T 
P-
value 
Mean F/T 
P-
value 
Age  
20 - <40 years 61.36 12.5* 0.001 64.63 4.37* 0.01 79.25 2.93* 0.03 
40- <50  years 56.77   74.19   86.56   
50 - <60  years 43.74   65.40   90.91   
>=60 37.63   55.04   91.23   
Place of 
Residence 
City 49.89 0.93 0.39 63.86 0.12 0.88 87.37 0.69 0.50 
Village 48.33   64.86   87.27   
Camp 38.00   60.00   96.67   
  
  
 Education 
Level 
Illiterate  40.78 7.44* 0.001 60.36 1.09 0.35 91.59 2.21 0.09 
Primary 49.33 
  
65.45   88.79   
Secondary 53.02 
  
69.31   83.33   
University  
education 
63.13 
  
65.10 
  
81.77 
  
Economic 
status 
<2000 NIS 43.74 -3.9* 0.001 62.86 -0.96 0.34 90.84 2.77* 0.01 
2000-4000 NIS 57.00   66.85   82.05   
  
 Marital 
Status 
  
Single 52.16 3.97* 0.02 48.04 5.27* 0.01 77.45 1.62 0.20 
Married 50.32   
 
67.60   88.24 
  Widow 37.78 
  
54.70   89.32 
  
 
Type of 
cancer  
  
  
  
Breast Cancer 50.67 
-3.16 
* 
0.001 
 
66.67 
 
 
-2.87 
* 
 
0.00 89.38 -2.64 
* 0.01 
Other types  
 
36.32 
 
 
  
 
 
50.88 
  
78.07 
  
Cancer 
Treatment 
  
  
Chemotherapy 49.40 1.32 0.27 65.18 3.11* 0.05 88.39 1.78 0.17 
Chemotherapy and 
surgery 
48.95   
 
65.33    88.24   
 
other treatment 
modalities 
35.33   
 
40.00    73.33   
 
  
 Onset  of 
Diagnosis 
 
< 6 months 50.04 0.83 0.48 66.67 0.35 0.79 87.65 1.14 0.34 
6- <12 months 49.65   
 
64.54    88.30 
  
12 - <24 months 46.98   
 
61.46   89.32 
  
>= 24 months 39.05 
  
61.90    76.19 
  
*Significant at <0.05 level. 
 
 In addition one-way ANOVA, Tukey test and T-test were used to assess the 
relationship between independent variables and QOL domains including emotional 
function, cognitive function and global quality of life as seen in table (5.11). 
ANOVA test showed that there were significant differences between the means of 
CF at a p-value (p<0.001) and global QOL at a p-value (p<0.001) attributed to the 
age of the participants. The differences in CF were between the age groups (20 - 
<40 years old) with a mean of (mean =90.48), (40- <50  years) age group with a 
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mean of  (mean =85.75), (50 - <60  years) age group with a mean of  (mean=77.27) 
and (>=60 years) age group with a (mean=63.16). Tukey Comparison tests showed 
that the differences were in favor of younger age groups as shown in table (1) in 
appendix VI. This indicated that the young female patients with cancer had better 
cognitive function. In relation to global quality of life (GQoL), the difference were 
between the age groups (20 - <40 years old) with a mean of (mean =56.29), (40- 
<50  years) age group (mean =63.55), (50 - <60  years) age group (mean=59.22) 
and (>=60 years old) age group (mean=51.64). Tukey Comparison tests a 
significant difference at a p value (p=0.001) between (>=60 years old) age group 
and (40- <50  years) age group in favor of the later (see table (1) in appendix VI), 
which indicated that the older age group had less Global Quality of Life than 
younger age group. 
Moreover, ANOVA test results showed that there were significant differences 
between the means of EF at a p-value (p=0.04) and CF at a p-value (p<0.001) 
attributed to educational level of the participants. For EF, the difference was 
between illiterate group (mean=83.5), primary education group (mean=75.15), 
secondary education (mean=72.22) group, and university education group 
(mean=75.26) as seen in table (5.11). Tukey Comparison tests showed that the 
significant difference was between illiterate and secondary education groups at a p 
value (p=0.044). The difference was in favor of illiterate participants which 
indicated that the less education level that female patients with cancer had, the 
better emotional function they had. In  relation to CF, the differences were between 
illiterate group (mean=71.04), primary education group (mean=81.21), secondary 
education group (mean=76.72) and university education group (mean=94.79) as 
seen in table (5.11). Tukey Comparison tests showed that the difference was in 
favor of the participants with university education at a p value (p<0.001), which 
indicated that female patients with cancer with university educational level had 
better cognitive function than other levels of education (see table (3)  in  appendix 
VI). 
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Furthermore, t-test was used to assess the relationship between CF, EF, GQOL and 
economic status and the results indicated significant differences between the means 
of CF at a p-value of (p<0.001) and Global QOL at a p-value of (p=0.01) attributed 
to economic status of the participants. In both domains, the differences were in 
favor of the group that had income between (2000-4000 NIS) with means of (CF 
mean=85.71, GQOL mean=61.36) corresponding to the group(<2000 NIS) with 
means of (CF mean=73.15, GQOL mean=55.2). This indicated that the higher the 
economic status of the participant, the better cognitive function and global quality 
of life they had (see table 5.11). 
Also, in table (5.11) ANOVA test showed that there were significant difference at 
p-value (p<0.001) between the means of CF  components attributed to marital status 
of the participants. The differences were between  the single group (mean=96.08), 
the married group (mean=79.19) and the widow group (mean=61.97). Tukey 
Comparison tests showed that the differences were in favor of single group, while 
between the married and the widow groups in favor of the married. This means that 
single female patients with cancer had better cognitive function than both married 
and widows and married female patient with cancer had better cognitive function 
than widows (see table (2) in appendix VI). 
Finally, there was a significant difference at a p-value of (p=0.03) between the 
means of CF attributed to onset of  cancer diagnosis by using ANOVA test. The 
differences were between the group <6 months (mean=77.98), 6 months to <12 
months of cancer diagnosis (mean=82.8), 12 months to <24 months of cancer 
diagnosis (mean=71.61) and (>= 24 month) of cancer diagnosis as seen in table 
(5.11). Tukey Comparison tests showed that the significant difference was between 
6 months to <12 months of cancer diagnosis group and 12 months to <24 months of 
cancer diagnosis at a p value of (p=0.035) in favor of the former group as shown in 
table (6) in appendix (VI), which indicated that the shorter the onset of cancer 
diagnosis, the better cognitive function of female patients with cancer. However 
there were no significant differences between the means of EF and GQOL means 
and the duration of cancer diagnosis as seen in table (5.11). 
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Table (5.11): Relationships between the quality of life domains (emotional , cognitive 
functions and global quality of life) and socio-demographic & cancer medical history 
(ANOVA & t-test) 
Variables  
Emotional Functioning 
Cognitive  
Functioning 
Global Quality of Life 
Mean F/T 
P-
value 
Mean F/T 
P-
value 
Mean F/T 
P-
value 
Age  
20 - <40 years 68.54 2.62 0.51 90.48 16.8* 0.001 56.29 4.96* 0.001 
40- <50  years 78.36   85.75   63.44   
50 - <60  years 79.80   77.27   59.22   
>=60 81.69   63.16   51.64   
Place of 
Residence 
City 76.93 0.49 0.61 80.70 1.75 0.18 59.65 1.18 0.31 
Village 77.87   76.46   56.25   
Camp 85.83   66.67   53.33   
  
  
 Education 
Level 
Illiterate  83.50 2.74* 0.04 71.04 8.02* 0.001 55.10 2.09 0.10 
Primary 75.15 
  
81.21   58.64    
Secondary 72.22 
  
76.72   56.61    
University 
education 
75.26 
  
94.79 
  
64.32 
  
 
Economic 
status 
<2000 NIS 76.90 -7.3 0.47 73.15 -3.8* 0.001 55.2 -2.5* 0.01 
2000-4000 NIS 79.49   85.71   61.36   
  
 Marital 
Status 
  
Single 75.49 1.57 0.21 96.08 13.2* 0.001 55.39 1.75 0.18 
Married 76.65   
 
79.19   58.54 
  Widow 84.83 
  
61.97   52.56 
  
 
Type of 
cancer  
  
  
  
Breast Cancer 78.29 -0.65 0.52 
 
78.22 
 
 
-0.81 
 
0.42 58.26 -1.7 
 
0.09 
 
Other types  
 
75.22 
 
 
  
 
 
74.56 
  
52.63 
  
Cancer 
Treatment 
  
  
Chemotherapy 80.95 0.53 0.59 81.55 1.61 0.20 59.23 1.90 0.15 
Chemotherapy and 
surgery 
77.09   
 
77.09    57.44   
 
other treatment 
modalities 
74.17   
 
66.67    46.67   
 
  
 Onset  of 
Diagnosis 
 
< 6 months 82.30 1.46 0.23 77.98 3.04* 0.03 60.60 1.56 0.20 
6- <12 months 75.00   
 
82.80    57.00 
  
12 - <24 months 77.99   
 
71.61   55.34 
  
>= 24 months 70.24 
  
69.05    51.19 
  
*Significant at 0.05 level 
 
For symptomatic domains and financial impact of cancer, table (5.12) showed the 
relationships between pain, fatigue and financial impact QOL domains and 
independent variables including age, place of residency, educational level, 
economic status, marital status, type of cancer, cancer treatment and onset since 
diagnosis. 
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Regarding age, ANOVA test results indicated that there were significant differences 
between the means of PA at a p-value of (p=0.047) and FA at a p-value of (p=0.01) 
attributed to the age of the participant. The differences for PA were between the age 
group (20 - <40 years old) with a mean of (26.87), (40- <50  years) age group 
(mean =20.43) and (50 - <60  years) age group (mean=27.27) and (>=60 years old) 
age group (mean=32.98). The mean differences for FA were between the age group 
(20 - <40 years old) (mean =34.1),(40- <50  years) age group (mean =29.57), (50 - 
<60  years old) age group (mean=36.87) and (>=60 years old) age group 
(mean=44.15) as seen in table (5.12). Tukey Comparison tests showed that the 
differences in both PA and FA were between (40- <50  years) and (>=60 years of 
old) in favor of the later. This indicated that older  female patients with cancer had 
more pain and fatigue (see table (1) in appendix VI). 
In relation to place of residency, ANOVA test results showed that there were 
significant differences at a p-value (p<0.001) between the means of FI attributed to 
the place of residence. The differences were between those who lived in villages 
(mean=31.98), camps (mean=46.67) and city (mean=12.28) as seen table (5.12). 
Tukey Comparison tests showed that the significant differences were between those 
who lived in camp than those who lived in city at a p value of (p=0.02) in favor of 
the camp group, and  between those who lived in village than those who lived in 
city at a p value of (p<0.0001) in favor for those who lived in village as seen in 
table (4) in appendix (VI). This indicated that female patients with cancer who were 
living in a camp or a village had higher financial impact of cancer than those who 
were living in a city. 
Additionally, there were significant difference at a p-value (p=0.01) between the 
means of FI attributed to education Level by using ANOVA test. The results 
showed that the differences were between illiterate group (mean=30.74), primary 
education group (mean=23.64), secondary education group (mean=24.87) and 
university education group (mean=10.42) as seen in table (5.12). Tukey comparison 
test showed that the differences were between the university education group and 
illiterate group at a p value (p=0.007) in favor of the later group as seen in table (3) 
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in appendix (VI), which indicated that  illiterate participants had more financial 
impact of cancer. 
Moreover, t-test results showed that there were significant difference at p-value 
(p<0.001) between the means of FI attributed to economic status of the participants. 
The differences were in favor of the group that have income (<2000 NIS) 
(mean=33.74) in relation to those who had their income between (2000-4000 NIS) 
(mean=9.89) as seen in table (5.12). This indicated that the lower the economic 
status of the participants the more financial impact of cancer they had.  
Furthermore, the results of ANOVA test indicated that there were significant 
difference at p-value (p<0.001) between the means of FI  attributed to marital status 
of the participants. The differences were between single group (mean=9.8), married 
group (mean=23.69) and widow group (mean=39.32) in favor of widows group 
which indicated that widows participants had more financial impact of cancer than 
married and single participants as seen in table (5.12). 
In addition, the results of t-test showed that there were significant differences 
between the means of PA at p-value (p<0.001) and FA at p-value (p<0.001) and 
cancer type of the participants. The differences were in favor of the other type of 
cancer (PA mean=41.67 and FA mean=52.63) in comparison with breast cancer 
(PA mean=24.65 and FA mean=33.90). This indicated that the participants with 
other types of cancer such as (colon, stomach, bone, endometrium, liver, biliary, 
thyroid, ovarian, leukemia and lymphoma) had more pain and fatigue than the 
participants with breast cancer (see table 5.12). 
Finally, ANOVA results test showed that there were significant difference between 
the means of PA at p-value (p<0.001) and FA at p-value (p=0.02) attributed to 
cancer treatment modality. The  differences were between chemotherapy group with 
(PA mean=29.46 and FA mean=39.29), chemotherapy & surgery group with (PA 
mean=25.13 and FA mean=34.83) and other treatment modalities group with (PA 
mean=53.33 and FA mean=57.78) as seen in table (5.12). Tukey Comparison tests 
showed that the differences were in favor of the latter group which indicated that 
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female patients with cancer who undergo other treatment modalities (such as 
combinations of chemotherapy, surgical and radiotherapy) had more pain and 
fatigue  than those who had (chemotherapy and surgery only) or (chemotherapy 
only)(see table (5) in appendix VI). 
Table (5.12): Relationships between pain, fatigue and financial impact and socio-
demographic & cancer medical history (ANOVA & t-test) 
Variables  
Pain 
 
Fatigue  
Financial Impact 
Mean F/T 
P-
value 
Mean F/T 
P-
value 
Mean F/T 
P-
value 
Age  
20 - <40 years 26.87 2.68 0.04 34.01 3.86* 0.01 19.05 2.29 0.08 
40- <50  years 20.43   29.57   21.51   
50 - <60  years 27.27   36.87   24.75   
>=60 32.89   44.15   32.46   
Place of 
Residence 
City 25.09 1.04 0.36 34.27 0.96 0.38 12.28 
15.3 
* 
0.31 
Village 27.93   37.76   31.98   
Camp 36.67   44.44   46.67   
  
  
 Education 
Level 
Illiterate  28.16 0.90 0.44 39.48 1.73 0.16 30.74 3.57* 0.01 
Primary 29.09 
  
34.14   23.64   
Secondary 27.51 
  
38.62   24.87   
university 
education 
20.31 
  
28.47 
  
10.42 
  
Economic 
status 
<2000 NIS 29.42 1.82 0.07 38.82 1.71 0.09 33.74 6.20* 0.00 
2000-4000 NIS 23.26   32.97   9.89   
  
 Marital 
Status 
  
Single 27.45 0.26 0.77 37.25 1.37 0.26 9.80 6.45* 0.00 
Married 26.65   
 
35.42   23.69 
  Widow 29.91 
  
43.02   39.32 
  
 
Type of 
cancer  
  
  
  
Breast Cancer 24.65 3.8* 0.00 
 
33.9 
 
 
4.18* 
 
0.00 24.19 1.18 
 
0.24 
 
Other types  
 
41.67 
 
 
  
 
 
52.63 
  
30.7 
  
Cancer 
Treatment 
  
  
Chemotherapy 29.46 6.12* 0.00 39.29 4.06* 0.02 22.02 1.22 0.30 
Chemotherapy and 
surgery 
25.13   
 
34.82    26.74   
 
other treatment 
modalities 
53.33   
 
57.78    13.33   
 
  
 Onset  of 
Diagnosis 
 
< 6 months 26.34 1.36 0.26 37.86 1.89 0.13 20.99 1.04 0.38 
6- <12 months 24.65 
  
33.10    25.53   
 
12 - <24 months 29.69 
  
37.67    30.21 
  
>= 24 months 38.10 
  
50.00   23.81 
  
*Significant at 0.05 level. 
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By considering the symptoms in EROTC questionnaire as independent variables 
and related them to GQOL as dependent variable, Pearson's test was used to test the 
correlation between GQOL and pain (PA),nausea & vomiting (N&V), fatigue 
(FA),insomnia (SL), dyspnea (DY) , diarrhea (DI), constipation (CO), appetite loss 
(AP) and financial impact (FI). The results showed a significant negative correlation 
between pain, fatigue, appetite loss and financial impact on global quality of life. In 
other words;  the increase in pain, fatigue and appetite loss and the financial 
difficulties had inverse association on  GQOL. The strongest relationship was 
between GQOL and fatigue where (Pearson Correlation=-0.35), followed by pain 
(Pearson Correlation= -0.255) and loss of appetite  (Pearson Correlation= -0.205). 
The weakest relationship was with financial impact (Pearson Correlation= -0.141) 
as shown in table (5.13). 
Table (5.13) Relationships between GQOL and symptoms and financial difficulties 
(Pearson’s correlation) 
  
Pain 
 
N&V 
 
FA 
 
SL 
 
DY 
 
DI 
 
CO 
 
AP 
 
FI 
 
R 
 
-0.255 
 
0.017 
 
-0.35 
 
-0.029 
 
0.033 
 
0.059 
 
0.067 
 
-0.205 
 
-0.141 
 
P-value 
 
0.003* 
 
0.753 
 
0.000 
* 
 
0.613 
 
0.540 
 
0.232 
 
0.234 
 
0.000 * 
 
0.003 * 
. 
 
5.4.2 Part two: the relationship between PTSD and the  independent variables. 
This section presented the relationship between PTSD and other independent variable such 
as (age, place of residency, educational level, economic status, marital status, type of 
cancer, cancer treatment and duration since diagnosis ) by using Chi-Square test. 
 Table (5.14) showed that there were significant differences at (p=0.02) between PTSD 
symptoms severity scores attributed to the age. For example, the results showed that 46.9% 
(n=23) of participants in the age group (20 to<40 years old) had mild PTSD symptoms, 
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38.8% (n=19) had moderate PTSD symptoms and only 2% (n=1) of the participants  had 
severe PTSD symptoms. For the age group (40 to <50 years old), 72.6% (n=45) had mild 
PTSD symptoms, 21% (n=13) had moderate PTSD symptoms and 3.2% (n=2) of the 
participants had severe PTSD symptoms. While for the participants in the age group (50 to 
<60 years old), 69.7% (n=46) had mild PTSD symptoms, 21.2% (n=14) had moderate 
PTSD symptoms and only 1.5% (n=1) had severe PTSD symptoms. Further, regarding 
(>=60 years old) age group, 78.9% (n=60) had mild PTSD symptoms, 17.1% (n=13) had 
moderate PTSD symptoms and only 1.3% (n=1) had severe PTSD symptoms. Standardized 
residuals results showed that  the age group (20- <40 years old)  had no PTSD more than 
expected,  mild PTSD less than expected and moderate PTSD more than expected, 
however there was no differences between expected and resulted  PTSD counts in all other 
age groups. Generally, this indicated that if PTSD symptoms were present in young age it 
would be in favor of moderate  rather than mild symptoms. 
Finally, there were significant differences at p-value (p=0.04) between PTSD severity 
scores due to cancer type. As  shown in table (5.14), 57.9% (n=22) of the participants who 
had  other cancer types rather than breast cancer had mild PTSD symptoms, whereas 
36.8% (n=14) had moderate PTSD symptoms and 2.6% (n=1) had severe PTSD symptoms. 
On the other hand for the patients with breast cancer, 70.7% (n=152) had mild PTSD 
symptoms, 20.9% (n=45) had moderate PTSD symptoms and 1.9% (n=4) had severe PTSD 
symptoms. The standardized residuals results showed that  the other cancer types had  
moderate PTSD more than expected. Generally, this indicated that patients with  cancer 
types such as (colon, stomach, bone , endometrium, liver, biliary, thyroid, ovarian, 
leukemia and lymphoma) had more PTSD symptoms than patients with breast cancer . 
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Table (5.14): Significant relationships between PTSD severity and socio-demographic & 
cancer medical history (Chi Square test results, counts and percentages). 
Variable/Category 
 
PTSD 
Total 
  
No 
PTSD 
Mild 
PTSD 
Moderate 
PTSD 
Sever 
PTSD 
Chi 
Square 
P-
value 
Age 
20 - <40 years 
old 
Count 6 23 19 1 
49 
17.07* 0.02 
Expected 
count 
2.9 33.7 11.4 1   
Count % 12.2% 46.9% 38.8% 2.0% 100.0% 
  
Std. 
residual 
1.8 -1.8 2.2 0    
40- <50  years 
Count 2 45 13 2 
62 
  
Expected 
count 
3.7 42.6 14.5 1.2   
Count % 3.2% 72.6% 21.0% 3.2% 100.0% 
  
Std. 
residual 
-0.9 0.4 -0.4 0.7    
50 - <60  years 
Count 5 46 14 1 
66 
  
Expected 
count 
3.9 45.4 15.4 1.3   
Count % 7.6% 69.7% 21.2% 1.5% 100.0% 
  
Std. 
residual 
0.5 0.1 -0.4 -0.3    
>=60 
Count 2 60 13 1 
76 
  
Expected 
count 
4.5 52.3 17.7 1.5   
Count % 2.6% 78.9% 17.1% 1.3% 100.0% 
  
Std. 
residual 
-1.2 1.1 -1.1 -0.4    
Total 
Count 15 174 59 5 253 
  
Count % 5.9% 68.8% 23.3% 2.0% 100.0% 
  
Cancer 
Type 
Other CA 
Count 1 22 14 1 
38 
4.49* 0.04 
Expected 
count 
2.3 26.1 8.9 0.8   
Count % 2.6% 57.9% 36.8% 2.6% 100.0% 
  
Std. 
residual 
-0.8 -0.8 1.7 0.3    
Breast cancer 
Count 14 152 45 4 
215 
  
Expected 
count 
12.7 147.9 50.1 4.2   
Count % 6.5% 70.7% 20.9% 1.9% 100.0% 
  
Std. 
residual 
0.4 0.3 -0.7 -0.1    
Total 
Count 15 174 59 5 253 
  
Count % 5.9% 68.8% 23.3% 2.0% 100.0% 
  
*Significant at 0.05 level. 
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5.4.3 Part three: the relationship between QOL and PTSD  
This final analysis of the results represents the relationships between QOL domains 
(physical function, role function, social functioning, emotional functioning and cognitive 
functioning domains and global quality of life) and PTSD by using regression analysis. 
The results were revealed that there was a significant negative relationship between PTSD 
and  physical function (r = -0.32), role function (r = -0.38), social functioning (r = -0.48), 
emotional functioning (r = -0.57) and cognitive functioning domains (r = -0.23) and global 
quality of Life (r = 0.46). This means that  as GQOL and the functional domains decreased, 
PTSD symptoms increased. The  strongest  relationship was with emotional function 
indicating that when emotional function decreased PTSD symptoms increased as shown in  
table (5.15). 
On the other hand,  there was a significant positive relationship between PTSD and pain (r 
= 0.43) fatigue (r = 0.48), nausea and vomiting (r = 0.28), dyspnea (r = 0.20), insomnia (r = 
0.52), loss of appetite (r = 0.40) and constipation (r = 0.31). This means that as these 
symptoms increased,  PTSD symptoms increased. The strongest relationship was with  
insomnia and the weakest one was with dyspnea. 
Moreover , Pearson correlation results showed that there was a significant positive 
relationship between PTSD and financial impact (r= 0.21). This means that the increase on 
financial impact of cancer was associated with increase in  PTSD symptoms as shown in 
table (5.15). 
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Table (5.15): Regression Analysis to assess the relationships between PTSD and 
QOL domains.** 
Dependent Variable 
Pearson 
Correlation 
r 
r 
Square 
F-value 
ANOVA 
P-
value 
B-value 
(Regression) 
P-
value 
Physical Function -0.32 0.10 29.37 0.001 -14.87* 0.001 
Role Function -0.38 0.15 43.48 0.001 -21.28* 0.001 
Social Functioning -0.48 0.23 75.08 0.001 -20.63* 0.001 
Emotional Functioning -0.57 0.32 120.58 0.001 -26.91* 0.001 
Cognitive Functioning -0.23 0.05 14.33 0.001 -10.44* 0.001 
Pain 0.43 0.19 57.43 0.001 19.57* 0.001 
Fatigue 0.48 0.23 73.85 0.001 21.90* 0.001 
Nausea and Vomiting 0.28 0.08 21.11 0.001 10.94* 0.001 
Dyspnea 0.20 0.04 10.33 0.001 10.89* 0.001 
Insomnia 0.52 0.27 94.86 0.001 36.13* 0.001 
Loss of Appetite 0.40 0.16 47.02 0.001 25.29* 0.001 
Constipation 0.31 0.09 26.35 0.001 19.09* 0.001 
Diarrhea -0.08 0.01 1.56 0.21 -2.80 0.21 
Financial Impact 0.21 0.04 11.28 0.001 11.41* 0.001 
Global Quality of Life 
 
-0.46 0.21 66.16 0.001 -15.06* 0.001 
*Significant at 0.05 level. 
**Independent Variable: PTSD. 
 
Finally, regression analysis with covariate control was used to assess if there were  
confounders in the relationship between quality of life and PTSD, and the results 
were adjusted to age, cancer type and  cancer treatment as shown in table (5.16).  
The results showed that there was a significant negative relationship between PTSD 
and  physical function, role function, social functioning, emotional functioning and 
cognitive functioning domains and global quality of life when adjusted to age and 
type of cancer. This means that  the relationship in table (5.15) between GQOL and 
the functional domains and PTSD was a real relationship, and not as a result of the 
possible confounders (age and cancer type). 
Also, there was a significant positive relationship between PTSD symptoms and 
pain, fatigue, nausea and vomiting, dyspnea, insomnia, loss of appetite,  and 
constipation when adjusted to age, cancer type and treatment. This means that  the 
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relationship in table (5.15) between these symptoms and  PTSD symptoms was a 
real relationship not as a result of the possible confounders. 
Finally, table (5.16) showed that there was a significant positive relationship 
between PTSD symptoms and financial impact. This means that the relationship 
between  financial impact of cancer and PTSD symptoms was a real relationship , 
and not as a result of the possible confounders. 
Table (5.16): Adjusted relationships between PTSD and QOL.** 
Dependent Variable 
Multiple 
Correlation 
r 
r 
Square 
F-value 
ANOVA 
P-value 
B-value 
(Regression) 
P-value 
Physical Function 0.53 0.28 23.93 0.00 -15.28 0.001* 
Role Function 0.46 0.21 16.29 0.00 -20.82 0.001* 
Social Functioning 0.52 0.27 22.68 0.00 -19.15 0.001* 
Emotional Functioning 0.58 0.34 31.76 0.00 -26.49 0.001* 
Cognitive Functioning 0.49 0.24 19.70 0.00 -11.83 0.001* 
Pain 0.50 0.25 20.55 0.00 18.82 0.001* 
Fatigue 0.56 0.31 28.08 0.00 21.38 0.001* 
Nausea and Vomiting 0.35 0.12 8.72 0.00 9.85 0.001* 
Dyspnea 0.28 0.08 5.17 0.00 11.73 0.001* 
Insomnia 0.55 0.30 26.81 0.00 34.50 0.001* 
Loss of Appetite 0.46 0.21 16.59 0.00 25.98 0.001* 
Constipation 0.43 0.18 13.95 0.00 19.16 0.001* 
Diarrhea 0.19 0.04 2.25 0.07 -3.19 0.16 
Financial Impact 0.28 0.08 5.10 0.00 11.92 0.001* 
Global Quality of Life 0.50 0.25 20.56 0.00 -15.16 0.001* 
*Significant at 0.05 level. 
**Independent Variable: PTSD. 
***Adjusted to : Age, Cancer type and Treatment.  
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5.5 Summary: 
 The global quality of life mean was 57.4; within moderate quality of life range 
associated with high emotional and social functioning ( mean =77.8 and 87.7 
respectively). 
 The study showed a significant negative relationship at (p<0.05) level between the 
severity of pain, fatigue, loss of appetite symptoms with GQOL. 
 The study findings revealed that the prevalence of PTSD symptoms was 3%. While 
the prevalence of severe PTSD symptoms was 2%, moderate PTSD symptoms was 
23.3% and mild PTSD symptoms was 68.8%. 
 The study found statistically significant relationships at  (p<0.05) between quality 
of life and  age group, educational level, economic status, number of family 
members, care-giving person , cancer type and treatment. 
 The predictors of poor QOL are old age, low income, low educational level and 
dependent on self as care-giving. The finding revealed that other cancer types 
rather than breast cancer and combination of all treatment types of cancer are 
related to poor QOL. 
 The findings revealed statistically significant relationships at level (p<0.05) 
between PTSD and age group, number of family members and cancer type. 
 The findings did not show statistically significant relationships between PTSD and 
marital status, education Level ,place of  residence, economic status, cancer 
treatment and length of cancer diagnosis. 
 The study revealed a significant negative relationship between  GQOL and QOL 
functional domains and PTSD when adjusted to age and type of cancer.  
 The study revealed a significant positive relationship between each of  pain, 
fatigue, nausea and vomiting, dyspnea, insomnia, loss of appetite, constipation and 
financial impact of cancer and PTSD  when adjusted to age, cancer type and 
treatment. 
The next chapter discussed the findings of current study. 
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Chapter Six 
ـــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ 
Discussion 
6.1. Introduction 
 
This chapter discussed the major findings of the current study and the interpretation of its 
findings in relation to previously conducted studies found in literature review. This study 
aimed to assess the quality of life of adult female patients with cancer attended Beit-Jala 
Governmental Hospital as well as studying its correlation with one of anxiety disorders, 
which is PTSD.  
 
The participants’ characteristics and their responses to the questionnaire items, the 
relationships between dependent and independent variables by using many statistical 
analyses tests such as ANOVA test, t-test and chi-square test were discussed in 4 sections 
as the following: 
 
6.2. Section one: The characteristics of the participants, cancer medical history and 
psychological history. 
6.3. Section two: Quality of life and PTSD symptoms findings. 
6.4. Section three: The relationship between dependent and independent variables. 
6.5. The relationship between quality of life and PTSD 
6.6. Conclusion  
6.7. limitations and recommendations. 
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6.2. Section one: the characteristics of the participants, cancer medical 
history and psychological history. 
 
The study targeted female patients with cancer aged from 18 years old and older. The 
findings showed that from 253 female patients with cancer aged 18 and above, more than 
half of them (56.1%, n=142) were 50 years old and above, and 43.9% (n=111) were below 
50 years old. This may indicate that the number of cancer cases increase by age.  The 
Palestinian statistical reports in the years 2013 and 2014 showed that the trend in the top 
ten cancer reported cases in females increase with age (PMoH, 2014) and that (60%) were 
50 years old and above and (40%) were below  50 years old (PMoH, 2014). 
Also, the findings showed that 85% (n=215) of the study participants had breast cancer and 
the mean age was 52.6 years. The minimum age was 20 years old and the maximum age 
was 81 years old. These findings were consistent with the Palestinian Ministry of Health 
statistics in the years 2013 and 2014 which showed that the mean age of female reported 
cases with breast cancer was 52.7 years old and 51.5 years old respectively (PMoH, 2013, 
2014).  
For the marital status, the majority of the participants were married and widows (93.3%, 
n=236), while only 6.7% (n=17) were single. Odeh cohort study (2011) that assessed 
epidemiological indicators among Palestinian women who had breast cancer showed a 
similar result as 91.3% of the participants were married and 8.4% were singles (Odeh, 
2011). This finding might be in contrary to what was reported in the literature which 
showed higher rates of cancer  (especially  breast cancer) among women who were never 
married (Bevers et al., 2014; Ebrahimi et al., 2002; Osborne et al., 2005). On other hand,   
one recent study in USA showed that marriage increased cancer survival rate and being 
unmarried is associated with worse overall survival compared with being married, with up 
to 24% higher mortality among males and 6% higher mortality among females (Martínez 
et al., 2016). This suggest further studies to assess the relationship between marriage and 
cancer morbidity among Palestinian women including other risk factors such as 
reproductive health, hormonal therapy replacement, family history  exposure to radiation, 
and lifestyle (Gong et al., 2013; Nee, 2013). 
Further, the results showed that the majority of the participants had low educational level, 
as 62.4%  of them had an educational level less than secondary education. This is 
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considered higher than Khleif’s & Imam study (2013) in which (57.1%) of the participants 
(males and females) had an educational level less than secondary education. Palestinian 
Central Bureau of statistics latest report indicated that female Illiteracy rate was three and 
half times higher than that of males as 5.6% of Palestinian females were illiterates 
compared with 1.6% of males in 2014. (PCBS, 2015b).  Many studies reported a strong 
negative associations between education and cancer risk (Hussain et al., 2008; Leuven et 
al., 2014; Tavani et al., 1999). For example, a large case control study was conducted bt 
Tavani et al.  to assess such a relationship and the results showed that the risk of cancer 
was increased in low educated people (Tavani et al., 1999). This might be because 
educated women have more resources to devote to preventive and curative health care, 
prefer longer and healthier lives, are more able to detect cancer early, and are better 
informed on how to seek and respond to the cancer treatments (Leuven et al., 2014). 
Additionally, for the economic status, the study findings showed that the majority of the 
participants (64%) had monthly income less than 2000 NIS. This is even below the poverty 
line in Palestine that is calculated to be (2293 NIS) (PCBS, 2012). Also, Khleif’s &  Imam 
study (2013) showed  higher percentage than the current study as  75.2% of the participants  
had income less than 2000 NIS (Khleif & Imam, 2013). Many studies showed a 
relationship between income and cancer particularly breast cancer. Findings showed that 
high socioeconomic class has more risk for breast cancer than low socioeconomic class. 
This is attribute to their high life style in addition to reproductive factors such as low 
parity, later age of the first pregnancy, greater body weight, lower lactation duration and 
exposure to exogenous hormones (Braaten et al., 2004; Hussain et al., 2008; Kogevinas et 
al., 1997; Melnychuk, 2009; Robert et al., 2004).  Other studies showed that low 
socioeconomic class is a risk for cancer because it  affects people ability to get health care 
and they are less likely to get cancer screening tests, so their cancer is often found at a later 
stage, when it causes symptoms and need aggressive treatment (CDC, 2014).  
For place of residency, the majority of the study participants were from Hebron 
representing (64.8%) of the sample, while (31.7%) of the participants were from 
Bethlehem and (3.1%, 0.4%) were from Ramallah and Jerusalem respectively. This is 
consistent with the reported female cancer cases in Palestine in the years 2013 and 2014 
where Hebron: Bethlehem reported cases ratio was 2:1 (PMoH, 2013, 2014). For example, 
the number of reported female cancer cases from Hebron  was 221 cases and 101 cases 
were from Bethlehem  (PMoH, 2014).  
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Interestingly, 58.5% (n=148) of the participants were from villages, 37.5% (n=95) were 
from cities and 4% (n=10) were from refugee camps. The Palestinian Central Bureau of 
statistics latest report indicated that the percentage of urban population at the mid of 2015 
was 73.9%, while the percentages of population in rural and camps areas were 16.7% and 
9.4% respectively (PCBS, 2015). The World Health Organization stated that urbanization 
increased pressures of mass marketing, availability of unhealthy food choices and 
accessibility to automation and transport.  All of them have an effect on lifestyle that 
directly affect health and increased cancer incidence (WHO, 2010). The current study 
finding might be explained by the fact that convenience sampling method was used to 
select the participants so women from villages might accept more to participate in the 
study than women from cities or camps. Another explanation might be because women 
from villages tended to receive free treatment for their cancer in Beit-Jala Governmental 
Hospital and women from cities may seek treatment in other places such as Israel or Jordan 
while women from refugee camps may receive their treatment through UNRWA services. 
For cancer medical history, the study results showed that 85% of the participants (n=215) 
had breast cancer whereas the percentage of all other cancer types (such as colon, stomach, 
bone, endometrium, liver, biliary, thyroid, ovarian, leukemia and lymphoma) was 15% 
(n=38). The Palestinian Ministry of Health statistics (2014) showed that breast cancer 
contributed to 48.3% of cancer reported cases in women aged 18 years old and above. The 
high percentage of the participants with breast cancer in the current study  could be 
explained by the fact that all patients with breast cancer require chemotherapy treatment in 
addition to surgery (Andreoli et al., 2009) and Beit-Jala Governmental hospital is the only 
referral hospital for chemotherapy treatment in the south of West Bank. Other types of 
cancer (e.g. ovarian, Non-small lung cancers, uterus, leukemias, Non-Hodgkin lymphoma 
and brain cancer) will be referred to other treatment centers for special treatment options 
such as a radiotherapy in Augusta Victoria Hospital in Jerusalem which is not available in 
Beit-Jala Governmental hospital.  
Furthermore, the majority of the study participants were treated with a combination of 
treatments for their cancer, as (73.9%) had a combination of chemotherapy and surgical 
therapy and 4% of the participants were treated with other treatment modalities such as 
combinations of chemotherapy, surgical and radiotherapy while (22.1%) were treated with 
chemotherapy only. It was found that Palestinian women tended to have locally advanced 
disease when their cancer is detected and a large size of tumor at the time of diagnosis so 
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mastectomy is still performed in more than 80% of women with breast cancer (El Saghir et 
al., 2007; Nissan et al., 2004; Odeh, 2011). 
Regarding psychological history, seven open ended questions were used in the current 
study to assess this aspect and findings revealed that none of the participants reported 
having any psychological problems before or after cancer diagnosis, none of them reported 
receiving psychological treatments and none of them reported thinking about harming 
themselves after being diagnosed with cancer. This finding may be explained in different 
ways. First, psychological problems or mental problems are associated with stigma, so the 
participants may hesitate to report these problems. Second, feeling sad or worried might be 
considered normal reactions to stressors including cancer diagnosis among Palestinian 
women and it does not require treatment. Third, lack of knowledge among these women 
about mental health  problems and services in the Palestinian community. 
 
6.3. Section two: QOL and PTSD findings. 
This section discussed  the quality of life results with its domains in comparison with 
national and international studies. EORTC reference values manual was used as baseline 
international values for QOL domains. 
6.3.1 Quality of life and its domains  
In general,  the findings of the current study showed low general quality of life and  the 
majority of the participants reported having problems mainly  in the physical function 
domain of quality of life as the  statistical analysis showed lower values than EORTC 
reference in GQOL (mean= 57.4% ) and physical functioning domains (48.5 %). In 
addition,  these results were supported when the participants were asked to rate their 
overall  quality of life and general health, and less than half of them (48.2%)  rated them as 
good ( between 5-7), 33.2% rated them as (not good, not bad) (4)  and 18.6 % rated them 
as poor (1-3).  On other hand, other domains of QOL indicated good functioning 
particularly social functioning (mean=87.7%), then emotional functioning (mean= 77.8%), 
cognitive functioning (mean= 77%) and role functioning (mean =64.3%) .  
As mentioned previously, general quality of life is considered low for female patients with 
cancer as the results showed that the mean of global QOL was (57.4%) and it is lower than 
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the female  international reference value created by EORTC group (59.3%). However, this 
mean difference is higher than other national studies. For example, Khliefs & Imam’ study 
(2013)  showed a global QOL mean of (41.8%), and the calculated linear transformation of 
the global quality of life  of patients with breast cancer in Palestine by Samara & Saca 
study (2009) was (49%) while the mean of global quality of life of patients with breast 
cancer  in Kuwait was 45.3% (Alawadi & Ohaeri, 2009). On the other hand,  the mean of 
global quality of life of patients with breast cancer in Turkey was  more higher than the 
current study (62.8%) (Demirci et al., 2011). 
The  domain that might affect  negatively quality of life in the current study was physical 
domain where the mean was (48.4%) compared to (74.4%) in the female  international 
reference value created by EORTC group.  Also, the  results in the current study revealed 
that about (30%) of the study participants had  physical function score  less than 33% cut 
off point which indicated very poor functioning.  Physical function questions were the only 
questions were the majority (>60%) of the participants reported  problems or difficulty  
“very much” and “quite a bit”.  
 These results were consistent with Khleifs’ &Imam  study  (2013) which showed that  the 
mean of physical function was (48.5%), while  (25.7%) of the participants had physical 
function score below 33% cut off point (Khleif & Imam, 2013). Also,  Pinar et al. found 
that the troublesome domains of quality of life of patients with cancer were the 
psychological and the physical domains (Pinar, Salepc, & Affiar, 2003). Meanwhile, 
Ferrell et al. (1997) stated that cancer survivors had several problematic physical effects 
that influence their ability to function and negatively influence their overall QOL and the 
most common symptoms affected physical well-being were pain and fatigue  (Ferrell et al., 
1997). 
In the current study, physical domain was investigated in depth by asking the participants 
about “trouble doing strenuous activities, like carrying a heavy shopping bag or a 
suitcase”, and 55.3% of the participants answered that they faced very much problems. For 
“trouble for taking a long walk”, 48.6% of the participants answered that they faced 
problems very much, and for “trouble taking a short walk outside of the house”  32.8% the 
participants answered that they faced very much trouble. It was found that patients with 
cancer have several problematic physical effects that influence their ability to function and 
negatively influence their overall QOL (B R Ferrell, 1996). National Health Interview 
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Survey (NHIS) data showed that cancer survivors without any other chronic illnesses were 
more than twice as likely as individuals without a history of cancer or other chronic illness 
to report limitations in their ability to perform activities of daily living and significantly 
more likely to have other functional limitations (Hewitt, Rowland, & Yancik, 2003). Also, 
a study that assessed physical functioning in patients with breast cancer reported a decline 
in physical functioning following breast cancer diagnosis (Sehl et al., 2012).  
The high social and emotional functioning may be attributed to the fact that  patients’ 
social supports (family members and friends) provided substantial emotional, 
informational, and logistical support,  as  patients with cancer who had sufficient support 
groups had better emotional functioning (Adler, 2008). Other studies showed lower 
emotional functioning mean. For example, Samara & Saca (2009) reported low mean of 
emotional function (44%) (Samara & Saca, 2009) and Alawadi & Ohaeri, ( 2009) reported 
a mean of (60.3%). Bani-Odeh, (2013) qualitative study explored Palestinian females 
knowledge, attitude and practice among female patients of MOH clinics towards being 
diagnose with breast cancer and showed that breast cancer diagnosis was associated with 
scare, fear and  hopelessness (Bani-Odeh, 2013). This disparity in the findings of different 
studies regarding emotional function could be due the social support system and the 
cultural factors characterizing the different areas from which the participants were 
recruited or to the cancer types or prognosis that these participants had.  
Furthermore, the results revealed that role functioning was more towards good functioning. 
The mean in the current study was (64.3%) whereas 80% of the participants were in the 
good functioning range represented in > 66% cut off point. These results were not 
supported by Khleif’s & Imam study (2013) were the mean of role functioning was 
(48.8%) and 47.1% of the participants were in the good functioning score i.e. > 66% cut 
off point (Khleif & Imam, 2013). Also, Alawadi & Ohaeri (2009) found that the mean of 
role functioning for women with breast cancer was (55.1%) and (39.1%) of the patients 
were in the good functioning range (Alawadi & Ohaeri, 2009). On other hand,  another 
study reported a high mean for role function  which was 83.5% (Demirci et al., 2011). 
Kootstra et al. (2008) evaluated  QoL of patients with breast cancer and suggested that the 
timing of QOL assessment regarding surgical and chemotherapy complications had a 
significant effect on role, emotional and cognitive functioning (Kootstra et al., 2008).  
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Finally, about 74% of study participants reported a good cognitive functioning (>66% cut 
off point). However, the mean of cognitive functioning was low (77%) in comparison with 
the EORTC reference mean value but higher than both  Khleifs and Imam (2013) study 
and Alawadi & Ohaeri study (2009) with means of 60.5% and 59.9% for cognitive 
function respectively (Alawadi & Ohaeri, 2009; Khleif & Imam, 2013). Cognitive 
differences were observed in patients with breast cancer patients receiving chemotherapy 
compared with healthy controls (Brezden et al., 2000; Mandelblatt et al., 2014). Hermelink 
et al. (2015) reported that women with breast cancer had limited cognitive impairment after 
their cancer diagnosis (Hermelink et al., 2015).  
Symptoms scale of QOL 
Regarding symptomatic scale in QOL questionnaire, all means of symptoms were around 
the international reference value with a higher standard deviation from the mean.. 
Interestingly, insomnia was the most reported symptom followed by loss of appetite, 
constipation and finally fatigue. The current study results showed that (34.78%) had severe 
insomnia,(32.8%) have severe loss of appetite, (24.1%) had severe constipation and 
(20.55%) had severe fatigue. These results were supported in literature by other studies. 
For example one study included women with breast cancer reported severe insomnia 
(39.3%) , severe loss of appetite (32.7%), severe constipation (22%) and severe fatigue 
(13.6%) (Alawadi & Ohaeri, 2009).  Another study indicated that insomnia among patients 
with breast cancer was 18.46%, and clinically significant insomnia was highly associated 
with joint pain, hot flashes, anxiety and depression, age, and time since breast cancer 
diagnosis (Desai et al., 2013).   
The Institute of Medicine Committee on Psychosocial Services to Cancer Patients/Families 
in a Community Setting (USA)  showed that fatigue is the most frequently reported 
symptom in patients with cancer and is identified as causing the greatest interference with 
patients’ daily activities (Adler, 2008). Estimates of rates of fatigue among women with 
cancer vary greatly ranging from 4 percent in breast cancer patients prior to the start of 
chemotherapy to 91 percent in breast cancer patients after surgery and chemotherapy (Carr 
et al., 2002). Meanwhile, studies reported a low incidence of chronic pain in patients with 
breast cancer  ranging from 8% to 14% (Desai et al., 2013; Goudas, Bloch, Gialeli-Goudas, 
Lau, & Carr, 2005; Rowan et al., 2014).  These findings could be attributed to the fact that 
in general  the majority of patients with breast cancer require chemotherapy treatment 
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which has many side effects such as  fatigue, headaches, nausea and vomiting, appetite 
loss, hair loss and  low immunity and  radiotherapy which is associated  more with pain 
and fatigue than chemotherapy (Chawla, 2012). In the current study, 85% of the 
participants had breast cancer and 96% of them were taking chemotherapy. Also, in 
Alawadi & Ohaeri study (2009), 98% of the participants were taking chemotherapy 
(Alawadi & Ohaeri, 2009). 
However, when analyzing the association between these symptoms and GQOL, there were 
significant negative associations between pain, fatigue and loss of appetite and global 
quality of life. The strongest relationship was between GQOL and fatigue followed by pain 
and then loss of appetite. As mentioned previously, fatigue is the most frequently reported 
symptom in patients with cancer (Adler, 2008). Many studies demonstrate the association 
between fatigue and pain and QOL. For example, one study assessed the role of the 
symptom scales in predicting health-related QOL and  found that fatigue was the most 
important predictor of QOL (Arndt et al., 2006). Also, Pud (2011) showed a negative 
correlation  between pain intensity and QOL as well as positive correlations between pain 
intensity and fatigue in females patients with cancer (Pud, 2011). In addition, a study 
measured the QOL in patients with solid tumors and at the different chemotherapy cycles 
(CT) addressed a significant relationship between the cancer type, pain intensity, and 
fatigue and GQOL (Heydarnejad et al., 2011). Other studies showed that appetite loss, pain 
and fatigue were the most important or strongest independent predictors of survival on 
different cancer populations (Efficace et al., 2004; Montazeri, 2009). 
 As cancer-related fatigue affects the physical function of those patients and their overall 
quality of life. So including physical activity in the treatment plan for cancer related side 
effects is important to improve the patients’ quality of life (Gates & Fink, 2008; Network, 
2014). Literature indicated the importance of physical activity to improve quality of life of 
patient with cancer; and  an Italian study included 212 woman with breast cancer showed a 
significant relationship between physical exercise and the QOL (Valenti et al., 2008). 
Another study assessed QOL related to exercise in 1,829 Chinese women diagnosed with 
breast cancer and the results showed that regular exercise after breast cancer diagnosis 
improved QOL (Lu et al., 2009). So including physical activities with professional 
supervised exercises to patients with cancer can improve their physical function and hence 
improve their QOL. This should be implanted free of charge in cancer treatment protocol 
that is offered by the Palestinian Ministry of Health.  
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6.3.2 PTSD symptoms findings  
Prevalence rates of breast cancer related PTSD varied from 3% tom 19% in the literature 
(Darshit et al., 2015) . PTSD symptoms were assessed in the current study by using≥ 50 
cutoff point for posttraumatic stress disorder for clinical diagnosis and the prevalence of 
PTSD in the current study was (3%, n=8) .  This relatively low PTSD rate is consistent 
with those of Alter et al.(1996) and Cordova et al.(1995), who reported PTSD prevalence 
of 4% and 5% -10% in patients with cancer (Alter CL et al., 1996; Cordova et al., 1995). 
Other studies showed higher percentage of PTSD symptoms. For example, a study that was 
conducted in Germany to measure  psychosocial co-morbidity and quality of life (QOL) ,  
PTSD was assessed using PCL-C and posttraumatic stress disorder was observed in 12% 
(Mehnert & Koch, 2008). Also, a recent study showed that the prevalence of PTSD 
symptoms was 10.7% (Chan et al., 2011). Further,  a study  where a total of 100 women 
with  breast cancer were assessed using Impact Event Scale (IES) for PTSD showed  that  
5% of the participants  had PTSD symptoms at any time post cancer diagnosis (up to 20 
months) or treatment (Alkhyatt et al., 2012).  
By  using  ≥53 as a cutoff point  for severe PTSD symptoms (Weathers et al., 1991),  the 
prevalence was (2%, n=5) for severe symptoms, (23.3%, n=59) for moderate symptoms 
and (68.8%,n=174) for mild symptoms. This result means that 94.1% of the participants 
had PTSD symptoms and only 5.9% did not have. Therefore, interventions to treat mild, 
moderate and severe PTSD symptoms should concentrate on improving psychological 
wellbeing of women with breast cancer. These interventions aim to improve psycho-social 
involvement, psychological understanding, religious involvement, positive mental changes 
and reducing effects of PTSD in female patients with cancer especially patients with breast 
cancer (Darshit et al., 2015). Andreu et al., (2012) revealed in a study of 102 breast cancer 
survivors that psychological factors, strategies for coping with treatment and gaining social 
support from community and family were conducive to improved psychological status and 
thus improving the quality of life of patients with cancer (Andreu et al., 2012).  
Levine and colleagues found that that early psychological interventions effectively reduced 
PTSD and psychological distress after breast cancer diagnosis (Levine, Eckhardt, & Targ, 
2005). So psychological treatment and assessment should be integrated into governmental 
hospitals to treat PTSD symptoms among female patients with cancer. 
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6.4. Section three: the discussion of the relationship between QOL, PTSD 
and  independent variables. 
This section discussed the relationship between the quality of life, PTSD and other 
independent variables including socio-demographic data and cancer medical history for 
female patients with cancer. 
6.4.1. The relationship between quality of life and age. 
The current study findings revealed a statistically significant relationship between global 
QOL, the four functional and all symptoms domains of QOL and age group. The 
relationships were different with different domains in relation to age groups. For example, 
younger patients with cancer had better physical function, role functioning and cognitive 
function while older patients had better social function, global QOL and they had more 
pain & fatigue. These findings are consistent with Khleif’s & Imam study where younger 
patients had better physical and role functions and less fatigue (Khleif & Imam, 2013). 
Also, Pinar et al. (2003) revealed a significant negative association between age and 
physical function, as age of patients with cancer increased, the physical function decreased 
(Pinar et al., 2003). On contrary, another study did not express any significant association 
between age and any of QOL domains (Alawadi & Ohaeri, 2009). 
6.4.2. The relationship between quality of life and place of residence 
In addition, the study findings revealed a statistically significant relationship between 
financial impact of cancer and place of residence. The results showed that female patient 
with cancer living in a village or a camp had higher financial impact of cancer than those 
living in the city. Financial impact was especially noted in those who were living in camps 
and there were not any significant relationship between place of residence and all other 
QOL domains. On other hand, Khleif’s & Imam (2009) study showed no significant 
correlation between financial impact and place of residence.  However, it revealed a 
significant correlation between QOL domains and southern or northern regions in the West 
bank in which the participants from southern regions had poorer QOL in all domains and 
had more fatigue and financial difficulties than the participants from northern regions of 
Palestine (Khleif & Imam, 2013).  
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The higher financial impact of cancer in refugee camps may be because of the documented 
higher poverty in camps than other West Bank areas. For example, 38.6% of the refugee 
camp households suffered from poverty compared to 29.5% and 29.3% for rural and urban 
households, respectively. So, the participants from refugee camps may suffer more from 
the extra expense for cancer treatment such as the travelling expense to Beit-Jala 
Governmental Hospital for chemotherapy sessions (PCBS, 2008). 
6.4.3. The relationship between quality of life and educational level  
Further, the study findings revealed a significant relationship between the physical, 
cognitive and emotional functioning domain of QOL, and educational level. Female patient 
with breast cancer who had university education had better physical and cognitive 
functioning but they had low emotional functioning. Financial impact of cancer was 
significant among illiterate group. The same results were found in literature; Pinar et al. 
(2003) assessed quality of life of patients with cancer and found that illiterates had the 
lowest QOL score (Pinar et al., 2003). The better QOL in educated patients may be due to 
better coping mechanisms, better access, and/ or finding and benefiting from resources 
(Güner et al., 2006). 
For emotional function results, the low emotional function in patients with university level 
may attribute to their better communication  with doctors about their disease. This  was 
supported by a qualitative research which revealed that the more the patients understand 
their symptoms the better their emotional function; for example,  ‘... if I could understand 
what was happening to my body, then I could understand the symptoms, then they 
wouldn’t be frightening...’ (Van der, 2009). They revealed that communication with 
patients was the  second greatest predictor of quality of life in patients with breast cancer 
(Engel et al., 2003).  
6.4.4. The relationship between quality of life and economic status 
In addition, the findings showed a statistically significant relationship between the QOL 
and economic status. The findings revealed that quality of life was better for the 
participants with high economic status in physical, cognitive and global Quality of life 
domains. On the other hand, participants with low economic level patient with cancer had 
better social functioning and more financial impact of cancer. 
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The same results were obtained in other studies (Alawadi & Ohaeri, 2009; Güner et al., 
2006; Khleif & Imam, 2013). These studies showed that higher income was associated 
with better quality of life. Also, Khleif & Imam revealed by in-depth interviews that lower 
economic level is associated with more financial difficulties on patients with cancer 
(Khleif & Imam, 2013). 
This may be attributed to the fact that most of the patients with cancer  may lose their job 
after they got the disease, in addition to the extra expenses associated with treatment and 
most of the patients with cancer had low income as 64% of the current study participants 
had monthly income less than 2000 NIS. 
 6.4.5. The relationship between quality of life and marital status 
Regarding marital status, findings revealed that married female patients with cancer had 
better physical and role functions while singles had better cognitive function. Also, a study 
aimed to evaluate the impact of socioeconomic status on the altered appearance distress, 
body image, and quality of life among Korean patients  with breast cancer revealed that  
married  women and who had higher education had better quality of life (Chang et al., 
2014). On the contrary,  the Turkish study that assessed the quality of Life for patients with 
cancer found that higher QOL was among unmarried and related that for less 
responsibilities they had (Güner et al., 2006). The current study finding could be explained 
by the fact that Palestinian women with cancer continue to carry out their responsibilities 
towards their family and children even when they are sick particularly that they did not 
suffer from much pain or fatigue as reported by them in the current study. Further 
qualitative studies are required to assess the relationship between marital status and quality 
of life domains. 
6.4.6. The relationship between quality of life and cancer type. 
Regarding to the relationship between QOL and cancer type, the results revealed that 
patients with breast cancer had better physical function,  role functioning, and social  
functioning than other types of cancer (such as colon, stomach, bone, endometrium, liver, 
biliary, thyroid, ovarian, leukemia and lymphoma) and less pain and fatigue than other 
cancer types. This finding is similar to other studies which assessed the QOL of patients 
with different cancer types and showed that breast cancer had better QOL than other types 
of cancer while gastrointestinal cancer and lung cancer types had the lowest quality of life 
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(Heydarnejad et al., 2011; Pinar et al., 2003) . This  could be as a result of better prognosis 
of breast cancer in early stages with acceptable treatment side effects  than other types of 
cancer (Andreoli et al., 2009). 
6.4.7. The relationship between quality of life and onset of cancer diagnosis. 
The study revealed no significant relationship between QOL domains and length of cancer 
diagnosis except with cognitive functioning where the shorter the duration of diagnosis 
with cancer, the better cognitive function was. This is consistent with Pinar et al., (2003) 
findings which showed no significant relationship between the onset of cancer diagnosis 
and QOL (Pinar et al., 2003). Also, another study that assessed the predictors of quality of 
life of patients with breast cancer revealed no change on QOL of breast cancer patients on 
three years follow up (Engel et al., 2003). On the other hand, Alawadi & Ohaeri (2009) 
showed that the time since chemotherapy was a significant covariate for cognitive function 
(Alawadi & Ohaeri, 2009).  Also, a systemic review showed that cognitive function of 
patients with breast cancer was low for  patients who had received multiple chemotherapy 
sessions, the risk of cognitive impairment was 8.2 times higher than that of control subjects 
and it was 3.5 times higher than that of patients who had undergone one-dose 
chemotherapy (Phillips & Bernhard, 2003). The finding of the current study might be 
explained by the fact that 96% of the participants were taking chemotherapy treatment, 
which may affect the cognitive function. 
6.4.8. The relationship between quality of life and cancer treatment. 
Furthermore, the only significant association with cancer treatment was with role 
functioning domain in QOL. The results revealed that patients who had (Chemotherapy 
and surgery) as a treatment for their cancer, had better role function than patient who 
received other treatment modalities (such as combinations of chemotherapy, surgical and 
radiotherapy). The current study finding is consistent with Pinar et al., (2003) who reported 
no significant association between  the types of treatment an QOL (Pinar et al., 2003).  
As mentioned previously, cancer treatment had a significant relationship with role 
functioning might be explained  by the fact that treatment related side effects may affect 
role functioning as patients with a combination treatment of chemotherapy, surgical and 
radiotherapy experience more pain and fatigue than those who had chemotherapy and 
surgery. The results were supported by a study that assessed QOL of breast cancer where 
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there was significant association between radiotherapy treatment and pain and fatigue 
(Alawadi & Ohaeri, 2009). 
In summary, this study revealed that the predictors of poor QOL among female patients 
with cancer in Beit-Jala Governmental Hospital were: old age, low educational level , low 
economic class, being unmarried, low number of family members and dependence on 
others for care.  
Different domains had different association with each socio-demographic and cancer 
medical history variables. Table (6.1)  summarizes the factors associated with poor QOL in 
relation to functional domains, significant symptoms and financial difficulties. 
Table (6.1) The factors which were associated with poor QOL in relation to GQOL, 
functional domains, significant symptoms and financial difficulties. 
 
QOL  
 
Significant predictors of poor QOL (p<0.05) 
GQOL Old age, low economic status. 
 
PF 
Old age, low educational level, low income, widow/single , low 
number of family members, dependence on others for care and 
having other than breast cancer. 
 
RF 
Old age, widow/single, other than breast cancer as cancer diagnosis 
and combination treatment. 
SF Young age, higher income, and having other than breast cancer. 
EF Higher educational level 
CF Old age, low educational level, low income, being married , low 
number of family members, being dependent on others for care and 
longer duration of cancer diagnosis. 
PA Old age, being dependent on others for care, had other than breast 
cancer  and combination treatment. 
FA Old age, being dependent on others for care, had other than breast 
cancer , and combination treatment. 
FI Living in camp/village, low educational level, low income and 
being widow 
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The variables that did not show a significant relationship with QOL domains are shown in 
table (6.2). 
Table (6.2) variables that showed no relationship with QOL domains. 
QOL  No relationship found 
 
GQOL 
Place of residence, educational level, marital status, family 
members number, caregiver person, type of cancer, cancer 
treatment and length of cancer diagnosis. 
PF Place of residence, cancer treatment and length of cancer diagnosis. 
 
RF 
Place of residence, educational level, economic status, family 
members number, caregiver person and length of cancer diagnosis. 
SF Place of residence, educational level, marital status, family 
members number, caregiver person, cancer treatment and length of 
cancer diagnosis. 
EF Age, place of residence, economic status, marital status, family 
members number, caregiver person, type of cancer, cancer 
treatment and length of cancer diagnosis. 
CF Place of residence, type of cancer and  cancer treatment. 
PA Place of residence, educational level, economic status,  marital 
status, family members number and length of cancer diagnosis. 
FA Place of residence, educational level, economic status, marital 
status, family members number and length of cancer diagnosis. 
FI Age, family members number, caregiver person, type of cancer, 
cancer treatment and length of cancer diagnosis. 
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6.4.9. The relationship between PTSD and socio-demographic variables & cancer 
medical history 
Regarding PTSD, the current study findings revealed that PTSD symptoms were more 
likely to present in young age. This findings is consistent with the Swedish study which 
showed that posttraumatic stress symptoms in patients with breast cancer tended to be 
associated with younger age (Perez et al., 2014). Also an Iraqi study that assessed post-
traumatic stress in women with breast cancer showed that younger women were at a 
greater risk for PTSD symptoms than  older women (Alkhyatt et al., 2012).  
Further, the study findings showed  that PTSD symptoms were more related to  other 
cancer types such as (colon, stomach, bone , endometrium, liver, biliary, thyroid, ovarian, 
leukemia and lymphoma) rather  than breast cancer . Alkhyatt et al. (2012) suggested that 
receiving a breast cancer diagnosis does not fit the PTSD model well and that the breast 
cancer experience does not seem to have immediate  threat to life or bodily integrity 
usually associated with external trauma  (Alkhyatt et al., 2012). On other hand, the 
prevalence rate of PTSD in women with breast cancer varied between 1% to 58% in 
literature (Darshit et al., 2015). This can be related to multifactorial causes/risk factors for 
PTSD in breast cancer such as cancer stage, prognosis, patient-specific treatment 
approaches, presence or absence of pain, performance status, need for hospitalization and 
degree of social support (Andrykowski & Kangas, 2010; Rizalar et al., 2014). 
There were no significant relationships between cancer treatment , length of cancer 
diagnosis and PTSD symptoms. It has been postulated that PTSD symptoms  were related 
to more advanced stages of cancer and more aggressive and/or longer treatment, but 
research findings have been equivocal (Andrykowski & Kangas, 2010). Some studies have 
found PTSD symptoms were associated with the completion of therapy (Bleiker et al., 
2000) ,whereas others have reported symptoms months or even years after completing 
primary treatment (Green et al., 2000). 
Also, the current study found no relationship between PTSD and place of residence, 
marital status, economic status and educational level. Many studies revealed the same 
findings; for example, one study that  assessed  post-traumatic stress disorder in survivors 
of childhood cancer found that  all demographic variables were not risk factors for PTSD 
(DeKeyser et al., 2010). Also, another study that assessed posttraumatic stress symptoms 
in patients with breast cancer found that the only significant relationship with PTSD was 
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with age but  not with other socio-demographic or medical factors (Perez et al., 2014). 
In addition, Hahn et al., (2015) showed that demographic factors such as gender, 
education, and race were not significantly associated with PCL-C scores (Hahn et 
al., 2015). 
6.5. The relationship between quality of life and PTSD. 
Finally, the current study revealed a statistically significant relationship between QOL and 
PTSD. Results showed a negative relationship between PTSD and  physical function, role 
function, social functioning, emotional functioning and cognitive functioning domains and 
global quality of life when adjusted to age and type of cancer. This indicated that better 
QOL is associated with lower PTSD symptoms. The same association was expressed in a 
study that was conducted in USA where health-related quality of life was significantly 
associated with PCL-C scores (Hahn et al., 2015). In addition, reduced physical 
functioning was associated with PTSD symptoms in another  study that  assessed  the 
prevalence and the risk factors for cancer-related PTSD symptoms in women treated for 
primary breast cancer (O’Connor et al., 2011). Also, another study  found that altered 
appearance such as loss or disfigurement of breasts, discolored skin, and hair loss resulted 
in psychological distress and affects their quality of life (Chang et al., 2014). Further, a 
report indicated that psychosocial distress experienced within the first year post diagnosis 
has a huge impact on psychosocial wellbeing and quality of life in long term breast cancer 
survivors (Mehnert & Koch, 2008). 
On the other hand, the results showed a significant positive relationship between pain, 
fatigue, nausea and vomiting, dyspnea, insomnia, loss of appetite, constipation and PTSD. 
It means that the increase in the severity of symptoms of cancer is associated with increase 
in PTSD symptoms. Jones (2001) highlighted that as the physical symptoms of the disease 
reduced, the symptoms of psychological distress would resolve over a period of time in the 
majority of women (Jones, 2001) . 
As the finding indicated, PTSD symptoms interfered with patient functioning, it is the 
responsibility of health practitioners is to educate the patient, family, and caregivers 
regarding normal and expected symptoms related to diagnosis and treatment, including 
emotional responses. American Cancer Society (2009) recommended that health care 
workers should provide patients with safe and competent care that includes a 
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comprehensive psychosocial assessment for PTSD, individualized interventions, and 
referral when appropriate (NCI, 2009). 
Furthermore, the study revealed a positive relationship between PTSD and financial 
Impact, so the increasing financial impact of cancer is associated with increase in PTSD 
symptoms. Patients who face life threatening diseases like breast cancer experience 
different stressful events including financial and social worries (Darshit et al., 2015; 
Rizalar et al., 2014). 
 
6.6. Conclusion  
The current study assessed the QOL and PTSD prevalence among adult females patients 
with cancer in Beit-Jala Governmental Hospital in Bethlehem. The findings indicated that 
the global QOL in the current study  was  lower than the female  international reference 
value created by EORTC group. The most troublesome activities was  within daily life and 
were reflected in the physical domain which was in the range of poor functioning. On the 
other hand, role functioning, social functioning and emotional functioning where more 
towards very good functioning. The study revealed significant  association between pain, 
fatigue and loss of appetite with the global quality of life. 
Meanwhile, the study results showed that the prevalence of PTSD symptoms was (3%). 
For PTSD symptoms severity, (2%) reported severe symptoms, (23.3%) reported  
moderate symptoms and (68.8%) reported mild symptoms based on Weathers et al. (1991) 
classification of PTSD symptoms severity scores. In addition, It was found that  PTSD 
symptoms were more likely to present in young age and patients who were diagnosed with 
other types of cancer rather than breast cancer. 
Furthermore, the study revealed a statistically significant relationship between all QOL 
domains and PTSD. Results showed a negative relationship between PTSD and  physical 
function, role function, social functioning, emotional functioning and cognitive functioning 
domains and Global Quality of Life when adjusted to age and type of cancer. Also, there 
were a significant positive relationship between  pain, fatigue, nausea and vomiting, 
dyspnea, insomnia, loss of appetite, constipation and PTSD. 
So it is important that female patients with cancer undergo a careful assessment for 
posttraumatic stress disorder (PTSD), so that early symptoms may be identified and 
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treated.  By identifying the most vulnerable population among patients with cancer, it will 
enable us to provide better health care for cancer survivors and train health professionals to 
support such patients in more effective way. 
 
6.7. limitations and recommendations  
6.7.1 Limitations:  
There are many limitations in the current study. For example, this study utilized a cross 
sectional design, due to the limitation of the available time and scarcity of resources. This 
makes it difficult to assess accurately the magnitude of effect exerted by each factor or to 
differentiate precisely whether the interaction between these factors would be advised or 
antagonistic. Also, this type of design may have limitations in the generalization of the 
results to a wider population since it measures both the prevalence of the outcomes and the 
determinants in a population at a point in time or over a short period of time  (Stephen et 
al., 2011).  Nevertheless, the cross sectional studies are highly useful for descriptive 
purposes and it is relatively quick, cheap and easy to undertake (Burns & Grove, 2003). 
The data collection for this study was done by using a self- administered questionnaire. So, 
the reliability of the results may be affected, since the participants may hesitate to express 
their points of view or they may describe their own thoughts, feelings or behaviors in 
spurious way to please the researcher (Mitchell & Jolley, 2012) . Further, the sample 
included patients from Beit-Jala Hospital only which may limit the generalization of 
findings to female patients with cancer in other settings. 
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6.7.2 Recommendations:  
Recommendation for health policy makers 
 
 Strengthening mental health services to offer psychological treatment for patients 
with cancer  to improve their quality of life in the governmental hospitals. 
 
 Provide palliative care for female patients with cancer  to manage and improve 
physical functioning  and symptoms such as pain, fatigue, nausea, vomiting and 
insomnia, to decrease PTSD symptoms  severity and to improve overall quality of 
life. 
 
 Including physical activity in the treatment plan for cancer to improve the patients’ 
quality of life 
 
 Increase the knowledge and the awareness of health professional in the 
governmental hospitals and particularly oncology departments about the 
importance of assessing quality of life and PTSD symptoms among women with 
different types of cancer through workshops or lectures.  
 
 The Palestinian Ministry of Health might cooperate with NGOs, private and 
community based organizations that provide health services to women with 
different types of cancer to build a national plan to improve quality of life and 
mental health of these women in Palestine. 
 
 Integrate PTSD screening and quality of life components for all patients with 
cancer particularly for young women in the governmental or NGOs oncology 
clinics in West Bank.   
   
 Train primary mental and health care professional in the governmental hospitals 
particularly mental health counselors about QOL and PTSD symptoms assessment 
and treatment.      
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 Integrate regular assessment of quality of life for female patients with cancer every 
6 months.  
 
Recommended research in the future: 
 
Based on the results of the study, the following research topics are suggested: 
           
 Assessment of quality of life and PTSD symptoms among female patients with 
cancer in governmental and non-governmental clinical settings.   
 
 Assessment of quality of life and PTSD symptoms among female patients with 
cancer in  the middle and northern areas of Palestine. 
 
 Assessment of the relationships between socio-demographic data such as age, 
marital status, financial issues and   place of residence  and other cancer risks such 
as reproductive health, hormonal therapy replacement, family history  exposure to 
radiation, and lifestyle with cancer prevalence among  females. 
 
  Assessment of quality of life and PTSD symptoms among male patients with 
cancer in governmental and non-governmental clinical settings   
 
 Qualitative studies to explore the factors that affect quality of life and PTSD 
symptoms among  female patients with cancer in Palestine 
 
 Assessment of depression and anxiety disorder among  patients with cancer in 
Palestine.  
 
 Qualitative studies to explore the psychological and emotional experience of female 
patients with cancer. 
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  .9 ؟ألم شعرت بأهل  1 2 3 4
  .11 ؟للراحةهل كنت بحاجة  1 2 3 4
  .11 ؟النوم/ نوم متقطع) ڧيرق/ صعوبة أ( النوم ڧي ت من مشاكلهل عاني 1 2 3 4
  .21 ؟الضعفهل شعرت ب 1 2 3 4
  .31 ؟(القدرة على الاكل) هل ڧقدت شهيتك 1 2 3 4
  .41 ؟(اللعيان) هل شعرت بالغثيان 1 2 3 4
  .51 هل تقيأت؟ 1 2 3 4
  .61 ؟إمساكهل عانيت من  1 2 3 4
 
 انتقل إل  الصفحة التالية ن  فضلك
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 بما ڧيه كثيرا جدا
 الكفاية 
  الماضي: الأسبوعخلال  إطلاقًا قليلا
  .71 ؟إسهالهل كان لديك  1 2 3 4
  .81 ؟متعبهل كنت  1 2 3 4
  .91 اليومية؟ تكنشاطا 1 2 3 4
 أومثل قراءة الجريدة الأمور  بعض هل كان لديك صعوبة بالتركيز ڧي 1 2 3 4
 ز؟اتلفمشاهدة ال
  .12
  .12 هل شعرت بالتوتر؟ 1 2 3 4
  .22 هل شعرت بالقلق؟ 1 2 3 4
  .32 بالإنزعاج؟هل شعرت  1 2 3 4
  .42 ؟  1 2 3 4
  .52 ؟الأشياءهل كانت لديك صعوبة بتذكر  1 2 3 4
  .62 ؟العائليةحياتك على  بي أثرعلاجك الط أو الجسديةهل حالتك  1 2 3 4
  .72 ؟الاجتماعيةحياتك  على أثر علاجك الطبي أو جسديةالهل حالتك  1 2 3 4
  .82 ؟ماليةمشاكل  إلى أدياعلاجك الطبي  أو الجسديةهل حالتك  1 2 3 4
 
 
 
 الاكثر ملائمة لك 7 - 1م بين ارقبدائرة حول الأ الإشارةالتالية الرجاء  الأسئلةڧي 
 
 الماضي؟ الأسبوععموما خلال  صحتك مقّيُتكيف  .92
 7  6  5  4  3  2  1
 ممتاز            سيء جدا
 
 الماضي؟ الأسبوعخلال عمومًا / مستوى حياتك عموماجودة حياتك / مقّيُتكيف  .13
 7  6  5  4  3  2  1
 ممتاز            سيء جدا
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EORTC QLQ-C30 (version 3)  
 
We are interested in some things about you and your health. Please answer all of the questions yourself by circling the 
number that best applies to you. There are no "right" or "wrong" answers. The information that you provide will 
remain strictly confidential. 
 
Please fill in your initials: bbbb 
Your birthdate (Day, Month, Year): cececdde 
Today's date (Day, Month, Year):  31 cececdde 
__________________________________________________________________________________________ 
  Not at A Quite Very 
  All Little a Bit Much 
1. Do you have any trouble doing strenuous activities,  
 like carrying a heavy shopping bag or a suitcase? 1 2 3 4 
 
2. Do you have any trouble taking a long walk? 1 2 3 4 
 
3. Do you have any trouble taking a short walk outside of the house? 1 2 3 4 
 
4. Do you need to stay in bed or a chair during the day? 1 2 3 4  
 
5. Do you need help with eating, dressing, washing  
 yourself or using the toilet? 1 2 3 4 
 
 
During the past week:  Not at A Quite Very 
  All Little a Bit Much 
 
6. Were you limited in doing either your work or other daily activities? 1 2 3 4 
 
7. Were you limited in pursuing your hobbies or other 
 leisure time activities? 1 2 3 4 
 
8. Were you short of breath? 1 2 3 4 
 
9. Have you had pain? 1 2 3 4 
 
10. Did you need to rest? 1 2 3 4 
 
11. Have you had trouble sleeping? 1 2 3 4 
 
12. Have you felt weak? 1 2 3 4 
 
13. Have you lacked appetite? 1 2 3 4 
 
14. Have you felt nauseated? 1 2 3 4 
 
15. Have you vomited? 1 2 3 4 
 
16. Have you been constipated? 1 2 3 4 
 
 Please go on to the next page 
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During the past week:  Not at A Quite Very 
  All Little a Bit Much 
 
17. Have you had diarrhea? 1 2 3 4 
 
18. Were you tired? 1 2 3 4 
 
19. Did pain interfere with your daily activities? 1 2 3 4 
 
20. Have you had difficulty in concentrating on things, 
 like reading a newspaper or watching television? 1 2 3 4 
 
21. Did you feel tense? 1 2 3 4 
 
22. Did you worry? 1 2 3 4 
 
23. Did you feel irritable? 1 2 3 4 
 
24. Did you feel depressed? 1 2 3 4 
 
25. Have you had difficulty remembering things? 1 2 3 4 
 
26. Has your physical condition or medical treatment 
 interfered with your family life? 1 2 3 4 
 
27. Has your physical condition or medical treatment 
 interfered with your social activities? 1 2 3 4 
 
28. Has your physical condition or medical treatment 
 caused you financial difficulties? 1 2 3 4 
 
 
For the following questions please circle the number between 1 and 7 that  
best applies to you 
 
29. How would you rate your overall health during the past week? 
 
  1 2 3 4 5 6 7 
 
 Very poor      Excellent 
 
 
30. How would you rate your overall quality of life during the past week? 
 
  1 2 3 4 5 6 7 
 
 Very poor      Excellent 
 
 
© Copyright 1995 EORTC Quality of Life Group. All rights reserved. Version 3.0 
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 S-LCPمقياس 
 منى حميد / جامعة القدس فردوس عبد ربة و د. :ترجمة
  تشخيص مرض السرطان         التجربة الصعبة في الاستبيان تعني  
 التعليمات 
والشكاوي التي تظهر احيانا لدى الناس احيانا نتيجة تعرضهم  هذه الاستمارة تحتوي على قائمة من المشاكل 
لخبرات ضاغطة في حياتهم . أرجو منك أن تقرأي كل عبارة من خلال استخدام الأرقام التي على الجهة 
 .الشمال من الورقة الى أي مدى أزعجتك هذه التجارب خلال الأسبوع الماضي
 
 لمشكلةا الرقم 
أبدا 
 متوسط قليلا  لا 
ر اكث
 قليلا 
بشكر 
 كبير
 1
 التجربة الصعبة  "بإصابتك بصور مزعجة تتعلق  , أفكار أو ذكرياتتكرار 
 5 4 3 2 1 ." مرض السرطانتشخيص 
 5 4 3 2 1 ."مرض السرطانتشخيص  لتجربة الصعبة " , أحلام مزعجة حول اتكرار  2
 3
 تشخيص خباري بالحدث المزعج " ل مفاجئ أتصرف أو اشعر وكأن ابشك
 5 4 3 2 1 يتكرر ثانية (وكأنني اعيش التجربة مجددا) . "مصابة بالسرطان 
 4
تشخيص بالتجربة الصعبة " ما يحدث ما يذكرني الشعور بالانزعاج الشديد عند
 5 4 3 2 1 ."السرطانمرض 
 5
أعاني من ردة فعل جسمية مثل ( اضطرابات في القلب , صعوبات تنفس , 
 5 4 3 2 1 ."مرض السرطانتشخيص بالحدث المزعج "ما يحدث ما يذكرني العرق ) عند
 6
أو  " تشخيص مرض السرطانالتجربة الصعبة  "كير أو التحدث حول اتجنب التف
 5 4 3 2 1 . هب اتجنب المشاعر المرتبطة
 7
تشخيص مرض " . التجربة الصعبةواقف التي تذكرني بأتجنب الأنشطة أو الم
 5 4 3 2 1 "السرطان
 8
تشخيص التجربة الصعبة في الماضي "ذكر أجزاء مهمة من أجد صعوبة في ت
 5 4 3 2 1 "مرض السرطان
 5 4 3 2 1 فقدت الاهتمام في المشاركة بالأنشطة التي كنت استمتع بها سابقا . 9
 5 4 3 2 1 أشعر بوجود مسافة أو بعد بيني وبين الناس الاخرين . 01
 5 4 3 2 1 العاطفي أو الشعور بعدم القدرة على أن احب المقربين مني .أشعر بالتبلد  11
 5 4 3 2 1 أشعر انه لا يوجد مستقبل أو ان مستقبلي قد توقف . 21
 5 4 3 2 1 بالنوم أو البقاء مستغرقا في النوم البدءأواجه صعوبات  31
 5 4 3 2 1 الشعور بالانفعال ( الهيجان ) أو بنوبات غضب .  41
 5 4 3 2 1 أواجه صعوبات في التركيز 51
 5 4 3 2 1 أو انني في حالة ترقب . ةأشعر بأني متيقظ 61
 5 4 3 2 1 .أجفل بسهولة ( أذهل بسهولة ) 71
 لرقم 
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Appendix V 
PTSD CheckList – Civilian Version (PCL-S) 
 
Patient’s Name:    
Instructions: Below is a list of problems and complaints that people sometimes have in response to 
stressful life experiences. Please read each one carefully, put an “X” in the box to indicate how much you 
have been bothered by that problem in the past month. 
The event you experienced was on (date) 
 
No. Response: 
Not at all 
(1) 
A little bit 
(2) 
Moderately 
(3) 
Quite a bit 
(4) 
Extremely 
(5) 
1. Repeated, disturbing memories, thoughts, or images 
of a stressful experience from the past? 
     
2. Repeated, disturbing dreams of a stressful 
experience from the past? 
     
3. Suddenly acting or feeling as if a stressful 
experience were happening again (as if you were 
reliving it)? 
     
4. Feeling very upset when something reminded you of 
a stressful experience from the past? 
     
5. Having physical reactions (e.g., heart pounding, 
trouble breathing, or sweating) when something 
reminded you of a stressful experience from the 
past? 
     
6. Avoid thinking about or talking about a stressful 
experience from the past or avoid having feelings 
related to it? 
     
7. Avoid activities or situations because they remind 
you of a stressful experience from the past? 
     
8. Trouble remembering important parts of a stressful 
experience from the past? 
     
9. Loss of interest in things that you used to enjoy?      
10. Feeling distant or cut off from other people?      
11. Feeling emotionally numb or being unable to have 
loving feelings for those close to you? 
     
12. Feeling as if your future will somehow be cut short?      
13. Trouble falling or staying asleep?      
14. Feeling irritable or having angry outbursts?      
15. Having difficulty concentrating?      
16. Being “super alert” or watchful on guard?      
17. Feeling jumpy or easily startled?      
Weathers, F.W., Huska, J.A., Keane, T.M. PCL-S for DSM-IV. Boston: National Center for PTSD – 
Behavioral Science Division, 1991. 
 
 
This is a Government document in the public domain 
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Appendix VI 
Tukey Tests 
Multiple Comparisons 
Table (1) Tukey HSD  test for age variable 
Dependent Variable (I) Age (J) Age Mean Difference (I-J) Sig. 
Physical Function 20 - <40 years old 40- <50  years 4.58635 0.765 
50 - <60  years 17.62317(*) 0.001 
>=60 23.72897(*) 0.000 
40- <50  years 20 - <40 years old -4.58635 0.765 
50 - <60  years 13.03682(*) 0.016 
>=60 19.14261(*) 0.000 
50 - <60  years 20 - <40 years old -17.62317(*) 0.001 
40- <50  years -13.03682(*) 0.016 
>=60 6.10579 0.456 
>=60 20 - <40 years old -23.72897(*) 0.000 
40- <50  years -19.14261(*) 0.000 
50 - <60  years -6.10579 0.456 
Role Function 20 - <40 years old 40- <50  years -9.56770 0.374 
50 - <60  years -0.77819 0.999 
>=60 9.58199 0.335 
40- <50  years 20 - <40 years old 9.56770 0.374 
50 - <60  years 8.78951 0.381 
>=60 19.14969(*) 0.002 
50 - <60  years 20 - <40 years old 0.77819 0.999 
40- <50  years -8.78951 0.381 
>=60 10.36018 0.198 
>=60 20 - <40 years old -9.58199 0.335 
40- <50  years -19.14969(*) 0.002 
50 - <60  years -10.36018 0.198 
Social Functioning 20 - <40 years old 40- <50  years -7.30744 0.396 
50 - <60  years -11.65739 0.056 
>=60 -11.97637(*) 0.038 
40- <50  years 20 - <40 years old 7.30744 0.396 
50 - <60  years -4.34995 0.743 
>=60 -4.66893 0.676 
50 - <60  years 20 - <40 years old 11.65739 0.056 
40- <50  years 4.34995 0.743 
>=60 -0.31898 1.000 
>=60 20 - <40 years old 11.97637(*) 0.038 
40- <50  years 4.66893 0.676 
50 - <60  years 0.31898 1.000 
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Dependent Variable (I) Age (J) Age Mean Difference (I-J) Sig. 
Emotional Functioning 20 - <40 years’ old 40- <50 years -9.82280 0.222 
50 - <60 years -11.26056 0.118 
>=60 -13.15118(*) 0.039 
40- <50 years 20 - <40 years old 9.82280 0.222 
50 - <60  years -1.43776 0.990 
>=60 -3.32838 0.886 
50 - <60 years 20 - <40 years old 11.26056 0.118 
40- <50  years 1.43776 0.990 
>=60 -1.89062 0.975 
>=60 20 - <40 years old 13.15118(*) 0.039 
40- <50  years 3.32838 0.886 
50 - <60  years 1.89062 0.975 
Cognitive Functioning 20 - <40 years old 40- <50  years 4.72350 0.721 
50 - <60  years 13.20346(*) 0.017 
>=60 27.31830(*) 0.000 
40- <50  years 20 - <40 years old -4.72350 0.721 
50 - <60  years 8.47996 0.178 
>=60 22.59479(*) 0.000 
50 - <60  years 20 - <40 years old -13.20346(*) 0.017 
40- <50  years -8.47996 0.178 
>=60 14.11483(*) 0.002 
>=60 20 - <40 years old -27.31830(*) 0.000 
40- <50  years -22.59479(*) 0.000 
50 - <60  years -14.11483(*) 0.002 
Pain 20 - <40 years old 40- <50  years 6.44064 0.556 
50 - <60  years -0.40198 1.000 
>=60 -6.02399 0.577 
40- <50  years 20 - <40 years old -6.44064 0.556 
50 - <60  years -6.84262 0.435 
>=60 -12.46463(*) 0.025 
50 - <60  years 20 - <40 years old 0.40198 1.000 
40- <50  years 6.84262 0.435 
>=60 -5.62201 0.563 
>=60 20 - <40 years old 6.02399 0.577 
40- <50  years 12.46463(*) 0.025 
50 - <60  years 5.62201 0.563 
Fatigue 20 - <40 years old 40- <50  years 4.44371 0.805 
50 - <60  years -2.85508 0.936 
>=60 -10.13844 0.143 
40- <50  years 20 - <40 years old -4.44371 0.805 
50 - <60  years -7.29879 0.382 
>=60 -14.58215(*) 0.006 
50 - <60  years 20 - <40 years old 2.85508 0.936 
40- <50  years 7.29879 0.382 
>=60 -7.28336 0.339 
>=60 20 - <40 years old 10.13844 0.143 
40- <50  years 14.58215(*) 0.006 
50 - <60  years 7.28336 0.339 
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Dependent Variable (I) Age (J) Age Mean Difference (I-J) Sig. 
Financial Impact 20 - <40 years old 40- <50  years -2.45776 0.976 
50 - <60  years -5.69986 0.768 
>=60 -13.40852 0.091 
40- <50  years 20 - <40 years old 2.45776 0.976 
50 - <60  years -3.24210 0.936 
>=60 -10.95076 0.173 
50 - <60  years 20 - <40 years old 5.69986 0.768 
40- <50  years 3.24210 0.936 
>=60 -7.70867 0.459 
>=60 20 - <40 years old 13.40852 0.091 
40- <50  years 10.95076 0.173 
50 - <60  years 7.70867 0.459 
Global Quality of Life 20 - <40 years old 40- <50  years -7.14834 0.180 
50 - <60  years -2.92465 0.835 
>=60 4.64778 0.515 
40- <50  years 20 - <40 years old 7.14834 0.180 
50 - <60  years 4.22369 0.567 
>=60 11.79612(*) 0.001 
50 - <60  years 20 - <40 years old 2.92465 0.835 
40- <50  years -4.22369 0.567 
>=60 7.57243 0.072 
>=60 20 - <40 years old -4.64778 0.515 
40- <50  years -11.79612(*) 0.001 
50 - <60  years -7.57243 0.072 
 
  
     *. The mean difference is significant at the .05 level. 
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Post Hoc Tests 
Multiple Comparisons 
Table (2) Tukey HSD test for marital staus variable  
Dependent Variable (I) Marital Status (J) Marital Status Mean Difference (I-J) Sig. 
Physical Function Single Married 1.83537 0.958 
Widow 14.37908 0.139 
Married Single -1.83537 0.958 
Widow 12.54371(*) 0.017 
Widow Single -14.37908 0.139 
Married -12.54371(*) 0.017 
Role Function Single Married -19.55808(*) 0.036 
Widow -6.66164 0.743 
Married Single 19.55808(*) 0.036 
Widow 12.89644(*) 0.050 
Widow Single 6.66164 0.743 
Married -12.89644(*) 0.050 
Social Functioning Single Married -10.78929 0.193 
Widow -11.86526 0.221 
Married Single 10.78929 0.193 
Widow -1.07597 0.966 
Widow Single 11.86526 0.221 
Married 1.07597 0.966 
Emotional Functioning Single Married -1.15955 0.984 
Widow -9.33886 0.459 
Married Single 1.15955 0.984 
Widow -8.17931 0.196 
Widow Single 9.33886 0.459 
Married 8.17931 0.196 
Cognitive Functioning Single Married 16.89061(*) 0.019 
Widow 34.11262(*) 0.000 
Married Single -16.89061(*) 0.019 
Widow 17.22201(*) 0.000 
Widow Single -34.11262(*) 0.000 
Married -17.22201(*) 0.000 
Pain Single Married 0.80123 0.992 
Widow -2.46355 0.943 
Married Single -0.80123 0.992 
Widow -3.26478 0.754 
Widow Single 2.46355 0.943 
Married 3.26478 0.754 
Fatigue Single Married 1.83471 0.959 
Widow -5.76504 0.730 
Married Single -1.83471 0.959 
Widow -7.59975 0.226 
Widow Single 5.76504 0.730 
Married 7.59975 0.226 
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Dependent Variable
  
(I) Marital Status (J) Marital Status 
Mean Difference (I-J) Sig. 
Financial Impact Single Married -13.88474 0.178 
Widow -29.51232(*) 0.003 
Married Single 13.88474 0.178 
Widow -15.62758(*) 0.012 
Widow Single 29.51232(*) 0.003 
Married 15.62758(*) 0.012 
Global Quality of Life Single Married -3.15268 0.785 
Widow 2.82805 0.863 
Married Single 3.15268 0.785 
Widow 5.98074 0.167 
Widow Single -2.82805 0.863 
Married -5.98074 0.167 
*. The mean difference is significant at the .05 level. 
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Post Hoc Tests 
Multiple Comparisons 
Table (3) Tukey HSD test for educational level  variable  
Dependent Variable (I) Education Level (J) Education Level Mean Difference (I-J) Sig. 
Physical Function None Primary -8.55663 0.182 
Secondary -12.23917(*) 0.015 
university education -22.34830(*) 0.000 
Primary None 8.55663 0.182 
Secondary -3.68254 0.860 
 university education -13.79167 0.071 
Secondary None 12.23917(*) 0.015 
Primary 3.68254 0.860 
university education -10.10913 0.258 
university education None 22.34830(*) 0.000 
Primary 13.79167 0.071 
Secondary 10.10913 0.258 
Role Function None Primary -5.09856 0.770 
Secondary -8.95618 0.291 
university  education -4.74818 0.880 
Primary None 5.09856 0.770 
Secondary -3.85762 0.912 
Higher education 0.35038 1.000 
Secondary None 8.95618 0.291 
Primary 3.85762 0.912 
Higher education 4.20800 0.928 
university education None 4.74818 0.880 
Primary -0.35038 1.000 
Secondary -4.20800 0.928 
Social Functioning None Primary 2.79788 0.902 
Secondary 8.25243 0.152 
university r education 9.81493 0.196 
Primary None -2.79788 0.902 
Secondary 5.45455 0.621 
university education 7.01705 0.569 
Secondary None -8.25243 0.152 
Primary -5.45455 0.621 
university r education 1.56250 0.991 
university education None -9.81493 0.196 
Primary -7.01705 0.569 
Secondary -1.56250 0.991 
Emotional Functioning None Primary 8.34363 0.245 
Secondary 11.27292(*) 0.044 
university education 8.23473 0.426 
Primary None -8.34363 0.245 
Secondary 2.92929 0.934 
university education -0.10890 1.000 
Secondary None -11.27292(*) 0.044 
Primary -2.92929 0.934 
university r education -3.03819 0.953 
university education 
 
 
 
None -8.23473 0.426 
Primary 0.10890 1.000 
Secondary 
3.03819 0.953 
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Dependent Variable (I) Education Level (J) Education Level Mean Difference (I-J) Sig. 
Cognitive Functioning None Primary -10.17652 0.067 
Secondary -5.68398 0.476 
university  education -23.75607(*) 0.000 
Primary None 10.17652 0.067 
Secondary 4.49254 0.757 
university education -13.57955 0.066 
Secondary None 5.68398 0.476 
Primary -4.49254 0.757 
university education -18.07209(*) 0.005 
university education None 23.75607(*) 0.000 
Primary 13.57955 0.066 
Secondary 18.07209(*) 0.005 
Pain None Primary -0.93557 0.996 
Secondary 0.64211 0.999 
university education 7.84284 0.444 
Primary None 0.93557 0.996 
Secondary 1.57768 0.988 
university education 8.77841 0.427 
Secondary None -0.64211 0.999 
Primary -1.57768 0.988 
university education 7.20073 0.578 
university education None -7.84284 0.444 
Primary -8.77841 0.427 
Secondary -7.20073 0.578 
Fatigue None Primary 5.34079 0.613 
Secondary 0.85786 0.997 
university education 11.00998 0.163 
Primary None -5.34079 0.613 
Secondary -4.48292 0.790 
university education 5.66919 0.764 
Secondary None -0.85786 0.997 
Primary 4.48292 0.790 
university education 10.15212 0.282 
university education None -11.00998 0.163 
Primary -5.66919 0.764 
Secondary -10.15212 0.282 
   
Financial Impact None Primary 7.10797 0.518 
Secondary 5.87661 0.637 
university education 20.32767(*) 0.007 
Primary None -7.10797 0.518 
Secondary -1.23136 0.996 
university education 13.21970 0.223 
Secondary None -5.87661 0.637 
Primary 1.23136 0.996 
university education 14.45106 0.141 
university education None -20.32767(*) 0.007 
Primary -13.21970 0.223 
139 
 
Secondary -14.45106 0.141 
Global Quality of Life None Primary -3.53928 0.671 
Secondary -1.51667 0.958 
university education -9.22583 0.074 
Primary None 3.53928 0.671 
Secondary 2.02261 0.937 
university  education -5.68655 0.523 
Secondary None 1.51667 0.958 
Primary -2.02261 0.937 
university education -7.70916 0.233 
university education None 9.22583 0.074 
Primary 5.68655 0.523 
Secondary 7.70916 0.233 
*. The mean difference is significant at the .05 level. 
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Post Hoc Tests 
Multiple Comparisons 
 
Table (4) Tukey test for place of residence variable 
Dependent Variable (I) Place of Residence (J) Place of Residence Mean Difference (I-J) Sig. 
Physical Function City Village 1.56140 0.894 
Camp 11.89474 0.363 
Village City -1.56140 0.894 
Camp 10.33333 0.453 
Camp City -11.89474 0.363 
Village -10.33333 0.453 
Role Function City Village -1.00522 0.969 
Camp 3.85965 0.929 
Village City 1.00522 0.969 
Camp 4.86486 0.886 
Camp City -3.85965 0.929 
Village -4.86486 0.886 
Social Functioning City Village 0.09365 1.000 
Camp -9.29825 0.493 
Village City -0.09365 1.000 
Camp -9.39189 0.474 
Camp City 9.29825 0.493 
Village 9.39189 0.474 
Emotional Functioning City Village -0.94180 0.962 
Camp -8.90351 0.585 
Village City 0.94180 0.962 
Camp -7.96171 0.641 
Camp City 8.90351 0.585 
Village 7.96171 0.641 
Cognitive Functioning City Village 4.23779 0.420 
Camp 14.03509 0.228 
Village City -4.23779 0.420 
Camp 9.79730 0.472 
Camp City -14.03509 0.228 
Village -9.79730 0.472 
Pain City Village -2.84021 0.683 
Camp -11.57895 0.373 
Village City 2.84021 0.683 
Camp -8.73874 0.558 
Camp City 11.57895 0.373 
Village 8.73874 0.558 
Fatigue City Village -3.49376 0.571 
Camp -10.17544 0.476 
Village City 3.49376 0.571 
Camp -6.68168 0.717 
Camp 
 
City 10.17544 0.476 
Village 6.68168 0.717 
 
Financial Impact 
City Village -19.70128(*) 0.000 
Camp -34.38596(*) 0.002 
Village City 19.70128(*) 0.000 
Camp -14.68468 0.290 
Camp City 34.38596(*) 0.002 
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Village 14.68468 0.290 
Global Quality of Life City Village 3.39912 0.357 
Camp 6.31579 0.573 
Village City -3.39912 0.357 
Camp 2.91667 0.884 
Camp City -6.31579 0.573 
Village -2.91667 0.884 
*. The mean difference is significant at the .05 level. 
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Post Hoc Tests 
Multiple Comparisons 
Table (5) Tukey HSD test for treatment variable  
Dependent Variable (I) Treatment (J) Treatment 
Mean Difference 
(I-J) Sig. 
Physical Function Chemotherapy Chemotherapy and surgery 0.45646 0.993 
other treatment modalities 14.07143 0.264 
Chemotherapy and surgery Chemotherapy -0.45646 0.993 
other treatment modalities 13.61497 0.248 
other treatment modalities Chemotherapy -14.07143 0.264 
Chemotherapy and surgery -13.61497 0.248 
Role Function Chemotherapy Chemotherapy and surgery -0.15120 0.999 
other treatment modalities 25.17857 0.053 
Chemotherapy and surgery Chemotherapy 0.15120 0.999 
other treatment modalities 25.32977(*) 0.036 
other treatment modalities Chemotherapy -25.17857 0.053 
Chemotherapy and surgery -25.32977(*) 0.036 
Social Functioning Chemotherapy Chemotherapy and surgery 0.15756 0.999 
other treatment modalities 15.05952 0.175 
Chemotherapy and surgery Chemotherapy -0.15756 0.999 
other treatment modalities 14.90196 0.149 
other treatment modalities Chemotherapy -15.05952 0.175 
Chemotherapy and surgery -14.90196 0.149 
Emotional Functioning Chemotherapy Chemotherapy and surgery 3.85791 0.618 
other treatment modalities 6.78571 0.746 
Chemotherapy and surgery Chemotherapy -3.85791 0.618 
other treatment modalities 2.92781 0.941 
other treatment modalities Chemotherapy -6.78571 0.746 
Chemotherapy and surgery -2.92781 0.941 
Cognitive Functioning Chemotherapy Chemotherapy and surgery 4.45314 0.490 
other treatment modalities 14.88095 0.211 
Chemotherapy and surgery Chemotherapy -4.45314 0.490 
other treatment modalities 10.42781 0.423 
other treatment modalities Chemotherapy -14.88095 0.211 
Chemotherapy and surgery -10.42781 0.423 
Pain Chemotherapy Chemotherapy and surgery 4.33060 0.504 
other treatment modalities -23.86905(*) 0.018 
Chemotherapy and surgery Chemotherapy -4.33060 0.504 
other treatment modalities -28.19964(*) 0.002 
other treatment modalities Chemotherapy 23.86905(*) 0.018 
Chemotherapy and surgery 28.19964(*) 0.002 
Fatigue Chemotherapy Chemotherapy and surgery 4.46694 0.497 
other treatment modalities -18.49206 0.097 
Chemotherapy and surgery Chemotherapy -4.46694 0.497 
other treatment modalities -22.95900(*) 0.019 
other treatment modalities Chemotherapy 18.49206 0.097 
Chemotherapy and surgery 22.95900(*) 0.019 
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Dependent Variable (I) Treatment (J) Treatment 
Mean Difference 
(I-J) Sig. 
Financial Impact Chemotherapy Chemotherapy and surgery -4.71416 0.588 
other treatment modalities 8.69048 0.700 
Chemotherapy and surgery Chemotherapy 4.71416 0.588 
other treatment modalities 13.40463 0.389 
other treatment modalities Chemotherapy -8.69048 0.700 
Chemotherapy and surgery -13.40463 0.389 
Global Quality of Life 
 
 
Chemotherapy Chemotherapy and surgery 1.78412 0.808 
other treatment modalities 12.55952 0.128 
Chemotherapy and surgery Chemotherapy -1.78412 0.808 
other treatment modalities 10.77540 0.183 
other treatment modalities Chemotherapy -12.55952 0.128 
Chemotherapy and surgery -10.77540 0.183 
*. The mean difference is significant at the .05 level. 
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Post Hoc Tests 
Multiple Comparisons 
Table (6) Tukey HSD test for onset of cancer diagnosis 
Dependent Variable onset of diagnosis Onset of diagnosis Mean Difference (I-J) Sig. 
Physical Function < 6 months 6- <12 months 0.39576 1.000 
12 - <24 months 3.06199 0.899 
>= 24 months 10.99353 0.473 
6- <12 months < 6 months -0.39576 1.000 
12 - <24 months 2.66622 0.924 
>= 24 months 10.59777 0.497 
12 - <24 months < 6 months -3.06199 0.899 
6- <12 months -2.66622 0.924 
>= 24 months 7.93155 0.737 
>= 24 months < 6 months -10.99353 0.473 
6- <12 months -10.59777 0.497 
12 - <24 months -7.93155 0.737 
Role Function < 6 months 6- <12 months 2.12766 0.971 
12 - <24 months 5.20833 0.762 
>= 24 months 4.76190 0.955 
6- <12 months < 6 months -2.12766 0.971 
12 - <24 months 3.08067 0.933 
>= 24 months 2.63425 0.992 
12 - <24 months < 6 months -5.20833 0.762 
6- <12 months -3.08067 0.933 
>= 24 months -0.44643 1.000 
>= 24 months < 6 months -4.76190 0.955 
6- <12 months -2.63425 0.992 
12 - <24 months 0.44643 1.000 
Social Functioning < 6 months 6- <12 months -0.64355 0.998 
12 - <24 months -1.66860 0.977 
>= 24 months 11.46384 0.374 
6- <12 months < 6 months 0.64355 0.998 
12 - <24 months -1.02504 0.994 
>= 24 months 12.10740 0.316 
12 - <24 months < 6 months 1.66860 0.977 
6- <12 months 1.02504 0.994 
>= 24 months 13.13244 0.270 
>= 24 months < 6 months -11.46384 0.374 
6- <12 months -12.10740 0.316 
12 - <24 months -13.13244 0.270 
Emotional Functioning < 6 months 6- <12 months 7.30453 0.282 
12 - <24 months 4.30974 0.774 
>= 24 months 12.06643 0.411 
6- <12 months < 6 months -7.30453 0.282 
12 - <24 months -2.99479 0.903 
>= 24 months 4.76190 0.927 
12 - <24 months < 6 months -4.30974 0.774 
6- <12 months 2.99479 0.903 
>= 24 months 7.75670 0.764 
>= 24 months < 6 months -12.06643 0.411 
6- <12 months -4.76190 0.927 
12 - <24 months -7.75670 0.764 
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Dependent Variable Onset of Diagnosis onset of Diagnosis Mean Difference (I-J) Sig. 
Cognitive Functioning < 6 months 6- <12 months -4.81788 0.594 
12 - <24 months 6.36896 0.439 
>= 24 months 8.93592 0.617 
6- <12 months < 6 months 4.81788 0.594 
12 - <24 months 11.18684(*) 0.035 
>= 24 months 13.75380 0.234 
12 - <24 months < 6 months -6.36896 0.439 
6- <12 months -11.18684(*) 0.035 
>= 24 months 2.56696 0.986 
>= 24 months < 6 months -8.93592 0.617 
6- <12 months -13.75380 0.234 
12 - <24 months -2.56696 0.986 
Pain < 6 months 6- <12 months 1.69206 0.973 
12 - <24 months -3.35005 0.866 
>= 24 months -11.75779 0.398 
6- <12 months < 6 months -1.69206 0.973 
12 - <24 months -5.04211 0.626 
>= 24 months -13.44985 0.270 
12 - <24 months < 6 months 3.35005 0.866 
6- <12 months 5.04211 0.626 
>= 24 months -8.40774 0.690 
>= 24 months < 6 months 11.75779 0.398 
6- <12 months 13.44985 0.270 
12 - <24 months 8.40774 0.690 
Fatigue < 6 months 6- <12 months 4.76316 0.626 
12 - <24 months 0.18647 1.000 
>= 24 months -12.13992 0.378 
6- <12 months < 6 months -4.76316 0.626 
12 - <24 months -4.57668 0.702 
>= 24 months -16.90307 0.111 
12 - <24 months < 6 months -0.18647 1.000 
6- <12 months 4.57668 0.702 
>= 24 months -12.32639 0.382 
>= 24 months < 6 months 12.13992 0.378 
6- <12 months 16.90307 0.111 
12 - <24 months 12.32639 0.382 
 
 
 
 
 
 
 
 
146 
 
 
Dependent Variable onset of Diagnosis Onset of Diagnosis Mean Difference (I-J) Sig. 
Financial Impact < 6 months 6- <12 months -4.54426 0.777 
12 - <24 months -9.22068 0.299 
>= 24 months -2.82187 0.990 
6- <12 months < 6 months 4.54426 0.777 
12 - <24 months -4.67642 0.796 
>= 24 months 1.72239 0.998 
12 - <24 months < 6 months 9.22068 0.299 
6- <12 months 4.67642 0.796 
>= 24 months 6.39881 0.901 
>= 24 months < 6 months 2.82187 0.990 
6- <12 months -1.72239 0.998 
12 - <24 months -6.39881 0.901 
Global Quality of Life < 6 months 6- <12 months 3.59316 0.589 
12 - <24 months 5.25817 0.340 
>= 24 months 9.40623 0.311 
6- <12 months < 6 months -3.59316 0.589 
12 - <24 months 1.66500 0.947 
>= 24 months 5.81307 0.702 
12 - <24 months < 6 months -5.25817 0.340 
6- <12 months -1.66500 0.947 
>= 24 months 4.14807 0.878 
>= 24 months < 6 months -9.40623 0.311 
6- <12 months -5.81307 0.702 
12 - <24 months -4.14807 0.878 
*. The mean difference is significant at the .05 level. 
